JECT Journal of Experimental and Clinical Toxicology 2641-7669 Open Access Pub United States 10.14302/issn.2641-7669.ject-19-3040 JECT-19-3040 research-article Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1) Abdul Kader Mohiuddin 1 * Secretary & Treasurer, Dr. M. Nasirullah Memorial Trust, Tejgaon, Dhaka 1215 Corresponding author Wei Wu 1 Nanjing Medical University, China Correspondence: Abdul Kader Mohiuddin, Secretary & Treasurer, Dr. M. Nasirullah Memorial Trust, Tejgaon, Dhaka 1215, Bangladesh. ORCID: https://orcid.org/0000-0003-1596-9757. Web of Science Researcher ID: T-5428-2019. Phone: +8801631312741. Email: trymohi@gmail.com.

The authors have declared that no competing interests exist.

 14 10 2019 1 2 17 106 18 09 2019 27 09 2019 14 10 2019 © 2019 Abdul Kader Mohiuddin This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This article is available from http://openaccesspub.org//ject/article/1186

Many lay people along with some so called “key opinion leaders” have a common slogan “There's no answer for cancer”. Again, mistake delays proper treatment and make situation worse, more often. Compliance is crucial to obtain optimal health outcomes, such as cure or improvement in QoL. Patients may delay treatment or fail to seek care because of high out-of- pocket expenditures. Despite phenomenal development, conventional therapy falls short in cancer management. There are two major hurdles in anticancer drug development: dose-limiting toxic side effects that reduce either drug effectiveness or the QoL of patients and complicated drug development processes that are costly and time consuming. Cancer patients are increasingly seeking out alternative medicine and might be reluctant to disclose its use to their oncology treatment physicians. But there is limited available information on patterns of utilization and efficacy of alternative medicine for patients with cancer. As adjuvant therapy, many traditional medicines shown efficacy against brain, head and neck, skin, breast, liver, pancreas, kidney, bladder, prostate, colon and blood cancers. The literature reviews non-pharmacological interventions used against cancer, published trials, systematic reviews and meta-analyses.

 Cancer care alternative therapy complimentary medicine non-pharmacological cancer treatment Introduction

In 2019, 1.8 million new cancer cases and 0.6 cancer deaths are projected to occur in the USA 3. Globally, cancer responsible for at least 20% of all mortality 4, 18.1 million new cancer (9.5 million cases were in men and 8.6 million in women, according to AICR), 9.5 million death in 2018 56, 5- year prevalence 43.8 million (a nearly 67% of total cancer patients) 78, is predicted to rise by 61.4% to 27.5 million in 2040 9. Cancer is the second most common cause of death in the USA and rest of the world 1011. It is estimated that there will be 18 million new cases of cancer and 9.6 million cancer deaths in 2018 (GLOBOCAN 2018). Mortality rates in LMICs were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016 3, with around 70% of deaths from cancer reported in LMICs 1213. Asia, Africa, and Latin America are home of 50% of cancer patients collectively; with more than half of global cancer-associated mortalities occurring in Asia alone 13. Lung cancer is the leading cause of cancer death (nearly 1 in 5 of all cancer death) 14, stomach cancer is the 3rd15 and pancreatic cancer is the 7th16 leading cause of cancer-related deaths worldwide. Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of cancer deaths for males 17. Asia and Europe are the home of more than 60% prostate cancer patients 18. Breast cancer is prevalent in 12% of women in the USA more than 2.5 million new cases of breast cancer were diagnosed in 2017 19. The rate for breast cancer declined by 35% in last 3 decades but number of deaths remain same 20. The 3 most prevalent cancers in 2019 are prostate, colorectal and skin melanoma among males, and breast, uterine corpus, and colorectal among females 21. Overall cancer death rates declined faster in blacks than whites in US, although rates for cancers of the breast, uterine corpus, and pancreas are increasing in black people 22. Also, black men have a 70% higher prostate cancer and a more than 2-fold higher mortality rate compared with white men 23. The cost of delivering cancer treatment is estimated to rise globally with a projected total spending of $458 billion by 2030 24. However, the financial burden stems from employment loss, cost of care even when patients don't require chemotherapy, out of pocket costs' opportunity costs of informal care time and can continue long after the death of the patient 2526. Studies say 46 billion in productivity lost in major emerging economies due to cancer 27 and economic costs of tobacco-related cancers exceed USD 200 billion each year 28. Also, cancer causes 2.6 times more likely to file for bankruptcy than the non-cancer people 29. Cancer trends in young adults, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden 30. Cancer cachexia (anorexia, weight loss, loss of adipose tissue and skeletal muscle) is reported in 30%-80% cancer patients and causes 20% of all cancer deaths 31. Worldwide, some 60%-80% people depend on alternative medicines 323334, which is also true for nearly 40% to 70% European 3536, 50% Italian, 40% Korean, 30% British 37 and up to 87% of Australian cancer patients 38. Use of unapproved/unlabeled/wrong herbal treatment is not uncommon 3940 and also drug interactions reported phyto-therapeutics in oncology 41. So, Proper and up-to-date knowledge is necessary in using alternative treatment options as patients who received alternative medicines had a 2.5 greater risk of dying compared to those who received conventional cancer treatment 42.

Reasons Behind Choosing Alternative Care

Pain is affects approximately 66% cancer patients 43, distressing or intolerable in more than one‐third of patients 44 and chronic pain is associated with primary cancer itself or metastases or its treatment (chronic post-cancer treatment pain) 43444546. Although, WHO described opioids as essential medicines for pain control but distribution shows substantial inequity, a less than 20% of the world’s population consuming more than 90% of the world’s supply 46. Also, some 85% of PCPs perceived their training in pain management to be inadequate in a Pan-European survey 47. Along with these, fear of dependence, prescription diversion, regulatory scrutiny, withdrawal symptoms, opioid-related adverse events and deaths limit its use 46, 4849505152. There is a lack of high-quality evidence regarding the analgesic efficacy of NSAIDs in cancer; contradiction and inconsistent findings also reported 5354, although advocated as a useful adjunct for management of cancer pain 5556. In addition, long-term use of NSAIDs is often associated with many serious cardiovascular, gastrointestinal, renal, and other side effects 54, 57. Some other studies also reveal association of NSAIDs with certain cancer types 5859. Several studies support use of cannabis/marijuana in cancer pain management 6061626364656667686970. Its social acceptability is gradually increasing around the world 71, but many studies oppose it’s use or at least demand further investigation of benefit risk ratio 727374757677787980. Chemotherapy and radiotherapy are still commonly conventional approaches for treatment of patients harboring advanced cancer 81. Traditional chemotherapy also associated with neuropathic pain 82, fatigue and sleep disturbance 83, anxiety and depression 84, mouth sores, nausea and vomiting, early satiety 85, alopecia 86, bone and muscle wasting 31, 87. Futile medication use in management of terminally ill cancer patients has also been reported, one-fifth of cancer patients at the end of their life took futile medications (statins and antidementia drugs in nearly 100% cases, antihypertensives and bisphosphonates in nearly 30% cases) 88. The goal of cancer palliative care is to prevent or treat, the symptoms and side effects of the cancer type and its treatment, caregiving to any related physical, emotional, social, and spiritual aspects 899091. Some alternative therapies, like acupuncture, physical therapy, aromatherapy, CBT are widely recommended along with mind-body interventions like yoga, tai chi, meditation and mindfulness, that keep people fit and energetic as they undergo treatment 12.

 Herbal and Non-Herbal Plant Derivatives

Medicinal plants are a rich source of secondary metabolites with interesting biological and pharmacological activities 92. Kuruppu et.al, 2019 reported that there are 3000 plants possess some anticancer properties and nearly 75% cancer drugs are derived from natural sources, 40% of them are FDA approved 9394959697. Only a small number of natural anti-tumor products including vinblastine, vincristine, podophyllotoxin, paclitaxel (Taxol) and camptothecin have been tested clinically, while vinflunine ditartrate, anhydrovinblastine, NK-611, tafluposide, paclitaxel poliglumex, combretastatins, salvicine, curcumin, indirubin, triptolide, homoharringtonine are still on trial 98. In addition, there are 195,000 pharmacologically active compounds for which the interactions are quantitatively known 99. According to an estimate, more than 300,000 secondary metabolites exist in nature 100. Glycosides 92, alkaloids, polyphenols, saponins, tannins and terpenoids 101 have shown promising results in cancer research. Chinese herbal medicines (CHM) also have been demonstrated to exert synergistic effects with other anticancer drugs, improved efficacy and reduced side effects 81102103104105106107108109110. It is an independent medical profession in Hong Kong and mainland China 108. Cancer patients used CHM to improve their physical and emotional well-beings and to reduce cancer therapy-induced toxicities 111. Nutrition and foods are related to about 30% of all the cancers cases 112. Omega-3s from fish pack a stronger punch than other oils when it comes to cancer prevention 113114115. Seaweeds are specifically used to treat tumors in CHM 116. Several studies revealed that active metabolites among the terpenoids, including carotenoids, polyphenols and alkaloids that can obtained from marine source 117118119120121122123124125. Compounds from natural sources with anti-proliferative activity represent an important and novel alternative to treat several types of cancer.

 Lung Cancer

American Cancer Society estimated that in 2018 lung and bronchus cancers would be responsible for 234,030 new cases which represent 14% of all new cancer cases and 154,050 deaths 126. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 80%-85% of all cases 127128. More than half of the NSCLC cases are diagnosed at an advanced stage (stages III and IV) 129. Smoking causes at least 80% of lung cancer deaths 130. Lin et.al, 2019 concluded association between lung cancer incidence and increased reliance on coal for energy generation 131. Other possible reasons are exposure to indoor and outdoor air pollution, exposure to radiation, and occupational exposure to agents such as asbestos, nickel, chromium, and arsenic 132. Cannabidiol (a non-psychoactive compound from Cannabis sativa), significantly inhibits the recruitment of tumor-associated macrophages (TAM) in primary tumor stroma and secondary lung metastases 133. Table 1.

Medicinal Plants Used in Lung Cancer
Plant Plant Parts Used Important Constituents Mode of Action/ Pathway Modulation/ Study Results
Allium sativum L Bulbs Organo-sulfur compounds (OSCs) like allicin (Figure 2a), allixin (Figure 2b), diallyl sulfide, diallyl disulfide, etc. OSCs are antioxidant, detoxify carcinogen & have antiproliferative properties. Raw garlic intake, <2 times per week, ≥2 times per week was inversely associated with lung cancer 134135136.
Curcuma longa Rhizome Curcumin (Figure 2c) Inhibition of telomerase activity, dose-dependent cytotoxic effect on A549 lung cancer cell line 137.
Ferula assa-foetida Resin Conferone (Figure 2d), a sesquiterpene-coumarin Cytotoxic effect on A549 lung cancer cell line 138.
Astragalus cytosus Root Polysaccharide (and flavonoids of other Astragalus spp.) Inhibit the proliferation and delay the tumor growth xenograft of human NSCLC in vivo and in vitro through the down-regulation of NF-κB activity 139. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin offered an improved QOL for patients with advanced NSCLC 140. Astragalus-based CHM may increase effectiveness of platinum-based chemotherapy 141.
FritillariaeThunbergii(Bei-Mu) (Figure 3a) Plant extract Alkaloids MDR reversal activity on human lung adenocarcinoma parental cells A549 with dosage dependence and the apoptosis rate was increased over time 142.
Platycodon grandiflorum(Jie-Geng or balloon flower) (Figure 3b) Roots Platycodin D (Figure 2e) (Saponin) Blocks reduction of AKT expression by small interfering RNA (siRNA) and enhance apoptotic effect 143, Modulation of the AMPK/mTOR/AKT, MAPK signaling pathways in A549 cells 144145, reduces the protein level of PD-L1 in lung cancer cells 146 and enhances autophagic cell death.
Catharanthus roseus Root, stem, bark and flower Vinca alkaloids, vinblastine, vinorelbine (Figure 2f) and vincristine Vinorelbine plus cisplatin is used for non-small-cell lung cancer. vinorelbine and cisplatin combination in patients with stage III A and stage III B non-small-cell lung exhibited positive results 147. Resistance to chemotherapy of Vinca alkaloids (Microtubule-targeting agents) has been a major obstacle to the treatment of lung cancer 148. New generation agents that have the potential to overcome the mechanisms of resistance to the available drugs may provide new therapeutic opportunities 149. High vinorelbine blood levels were associated with severe toxicity 150.
Selaginellatamariscina(Spike Moss) (Figure 3d) Whole plant Amentoflavone (biflavonoid) S. tamariscina ethanolic extract (STE) potently inhibited human AKR1B10 and synergistically increased the doxorubicin anti-proliferative effect in A549 and NCI-H460 human lung cancer cells 151. STE decreased expressions of matrix metalloproteinase (MMP)-2, -9 and urokinase plasminogen activator (u-PA) reported in an older study 152. Oral administration of STE could not prevent the tumor formation but provided strong inhibition of tumor growth 153.
Crocus sativus L. (Saffron) Dried stigmas Crocetin (natural apocarotenoid dicarboxylic acid) In vivo protective effect 154, induction of apoptosis 155, suppression of pulmonary tumor promotion 156 and also chemosensitizer for vincristine via p53-dependent and independent pathway 157158.
Ophiopogonis Decoction(Mài-Mén- Dōng-Tāng) (Figure 3c) Tuber and Root Ginsenosides, lignans, steroidal saponins, and homoisoflavanones. Modulatory effects on apoptosis, autophagy, cell cycle progression, and cell proliferation 159.
Sesbania grandiflora (Humming-bird tree) (Figure 3e) Dried leaves Saponosides Methanolic fraction of S. grandiflora exerted potent antiproliferative effects in the human lung cancer cell line, A549, involve a pathway that prevents NFκB activation, induction of apoptosis with high levels of ROS intermediates 160.
Toona sinensis Leaves Terpenoids, phenylpropanoids, gallic acid (Figure 2g) and flavonoids Inhibited H441 xenograft tumor growth in vivo and in vitro, induction of apoptosis in vitro 161.
Phyllanthus emblica and Terminalia bellerica Fruits Pyrogallol and gallic acid (tannin) With doxorubicin or cisplatin resulted in a synergistic effect and the possibility of reducing the doses of the chemotherapeutic drugs 162. Antiproliferative and antitumor properties on lung cancer cells and lung adenocarcinoma xenografts due to presence of tannins (P. emblica) 163. T. belerica induced apoptosis in lung cancer through regulation of Bax/Bcl-2 is also reported 164.
Cinnamomum subavenium Leaves and bark Subamolide A (butanolide) Induced lung cancer cell death by ROS generation, which triggers mitotic catastrophe followed by apoptosis 165.
Camellia sinensis(Tea) Leaves Catechins (Polyphenol) (−)-Epigallocatechin-3-gallate (catechin), the major polyphenol in green tea induces ROS and oxidative DNA damages as well as apoptosis in vivo and in vitro 166.
Panax ginseng Roots Saponins Ginsenoside Rh2 mediates changes in the microRNA expression, related to angiogenesis, apoptosis, chromatic modification, cell proliferation and differentiation. Another important mechanism is the inhibition of tumor cells angiogenesis that inhibits VEGF expression in LLC. Rg3 has been found to be a potent inhibitor of invasion of several tumor cell lines H1650, H520 and H1963 in SCLC 167.
Taxus brevifolia Bark Paclitaxel (Figure 2h)(Taxol®) (taxane dipertene) The paclitaxel-based formulation Abraxane® is the only nanomedicine approved by EMA and the FDA in combination with carboplatin for the first-line treatment of advanced NSCLC in adult patients who are not candidates for potentially curative surgery and/or radiation therapy 168. Inhaled submicron particle paclitaxel (NanoPac®) demonstrated substantial deposition and retention of paclitaxel in sampled lung tissue in rodent model 169.
Curcuma longa Rhizomes Curcumin(yellow polyphenol compound) Curcumin (4 mg/kg every 2 days for a total of 7 injections) exhibits a better treatment efficacy of doxorubicin (0.4 mg/kg) in cancer due to its efflux inhibitory effect of curcumin 170.
Alternative Treatment Options 12. One third cancer patients use alternative medicine-are not well regulated and may interact with conventional treatments like chemotherapy and radiation. Some alternative therapies, like acupuncture, physical therapy, aromatherapy, CBT are widely recommended by oncologists for cancer pain management. Mind-body interventions like yoga, tai chi, meditation and mindfulness, which were each used by less than 10% of patients, can keep people fit and energetic as they undergo treatment, reduce the side effects of traditional therapies and improve patients’ sleep, stress and mental health. Many hospitals even have alternative medicine centers that offer these programs. Plant derived biomolecules studied in lung cancer

Chemotherapy remains the indispensable choice for the vast majority of patients with advanced NSCLC, including primary tumors and lung metastases 168, 171. Use of the pulmonary route is a promising way to decrease the severe systemic toxicities associated with chemotherapy. Inhalation allows the administration of high drug doses directly to lung tumors without prior distribution in the organism 172173. However, Bei-Mu, Jie-Geng, and Mai-Men-Dong-Tang are important CHMs that have improved the survival rate 174. Euphorbia mauritanica and Kedrostishirtella extracts may play a role in inducing cell death in lung cancer cells 175. Several 2019 reviews reveal fucoidans (sulfated polysaccharide mainly derived from brown seaweed) in lung cancer management. Brown algae like Fucusvesiculosus, Turbinariaconoides, Laminaria japonica (Figure 3g) are reported in inhibition of tumor migration and invasion, apoptosis induction and inhibition lung cancer cell progression respectively 176. Fucusevanescens, Sargassum sp., Saccharina Japonica was reported to inhibit proliferation and metastasis, and inducing apoptosis in vitro 177. Undaria pinnatifida acted on ERK1/2 MAPK and p38, PI3K/Akt signaling, F. evanescens increased metastatic activity of cyclophosphamide and showed cytolytic activity of natural killer cells in 2 different studies and F. vesiculosus (Figure 3f) decreased NF-κB in LLC 178. U. pinnatifida (Figure 3h) was found to show average antitumor and superior efficacy against LLC in review of Misra et.al, 2019 179. Sponge alkaloids from Aaptos showed potential in human lung adenocarcinoma A549, from Fascaplysinopsis exerted an anti-proliferative and pro-apoptotic effect in lung cancer, from blue sponge Xestospongia showed apoptosis as well as stimulate anoikis in H460 lung cancer cells in review by Ercolano et.al, 2019 180. Polyphyllin D from Paris polyphylla is well known for its induction of endoplasmic reticulum (ER) stress and mitochondria-mediated apoptotic pathways against lung cancer 181. High fish consumption was significantly associated with a decreased risk of lung cancer 182183. Possible mechanism could be changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation 184. However, other studies reveal healthy dietary intake like high fruit, vegetable, soy protein, poultry (white meat), low-CHO, fish oil-containing diets, together with exercise also decline risks of lung cancer among non-smokers 185186187. Conversely, long-term use of high doses of some supplements, such as retinol, β-carotene, B vitamins, and vitamin E, increase lung cancer risk in current and former smokers 188. Smokers should continue to avoid β-carotene supplementation 189190. When a person stops smoking before the age of 40, they reduce their chances of dying from smoking-related disease by 90% 191. Telephone counseling reduce cost of nicotine replacement therapy (NRT). Again, cessation with intensive telephone counseling and NRT could be over 20% 186. Also, lung cancer mortality can be reduced by 20% via low dose CT lung cancer screening and treatment of early-stage disease 192.

Plants studied in lung cancer (3a). Fritillariae Thunbergii (Bei-Mu) (Source: Inner Path) Platycodon grandiflorum (Jie-Geng) (Source: Wikipedia) Ophiopogonis Decoction (Mài-Mén- Dōng-Tāng) Selaginella tamariscina (Spike Moss) Fucus vesiculosus L. (Source: Seaweed Site of M.D. Guiry) Sesbania grandiflora (Humming-bird tree) Undaria pinnatifida (Source: The Marine Life Information Network) Blood and Bone Marrow Cancer (Leukemia)

Hematopoietic cancers constitute a diverse group of diseases including leukemias, lymphomas, plasma cell tumors, myelodysplastic syndromes, and mastocytosis. They arise primarily from two categories of immunological cell types, myeloid and lymphoid cells 193. AML is the most common form of acute leukemia in adults, accounting for over 80% of all diagnosed acute leukemias 194195. Globally, between 1990 to 2018, the number of leukemia cases markedly increased from 297,000 to 437, 033 196, accounting for close to 250,000 annual deaths due to AML worldwide 197. Optimization of post-remission therapies to maintain complete remission and prevent relapse is a major challenge in treating patients with AML 198. Children with Down syndrome have a 150-fold increased risk of developing AML and 20-fold increased risk of developing ALL 199. The incidence of ALL is about 3.3 cases per 100,000 children 200. Outcomes for patients with CML have substantially improved due to advances in drug development and rational treatment intervention strategies 201. Allowed costs for leukemia patients averaged almost $157,000 in the year after diagnosis, with costs for AML almost tripling that amount, according to a new report from the Leukemia & Lymphoma Society (LLS) 202. Table 2.

Traditional Plants Used in Leukemia
Plant Plant Parts Used Important Constituents Mode of Action/ Pathway Modulation/ Study Results
Zingiber officinale Rhizome 6-gingerol (Figure 4a), 6-shogaol (Figure 4b), and 6-paradol. Combined with MTX showed synergistic effects on CCRF-CEM, Nalm-6 and ALL primary cells 203. 8-shogaol, originated from ginger, elevated the level of ROS, c-caspase-3, -9, c-PARP, c-DFF-45, and decreased the level of glutathione, MMP, caspase-8 and Bid 204. Enhanced cell growth inhibition while combined with Nerium oleander and imatinib 205.
Paris polyphylla Tubers Polyphyllin D (Figure 4c) (Steroids) Polyphyllin D induces apoptosis and differentiation in K562/A02 cells through G2/M phase arrest 206207.
Withaniasomnifera(Ashwagandha/'Indian ginseng') Root or the whole plant Alkaloids, flavonoids, steroids, and terpenoids Significant cytotoxic and cytostatic potential human T-lymphoblastoid cell line, and induces ICD. Its proapoptotic mechanism involves intracellular Ca2+ accumulation and the generation of ROS 208. Withaferin- A (Withanolides, steroids) from the root induced oxidative stress in human leukemia HL-60 cells 209210.
Cephalotaxusharringtonia(Korean plum) Leaves Homoharringtonine (Figure 4d) (non-proprietory name omacetaxine mepesuccinate, alkaloid) Suppression of the SP1/TET1/5hmC/FLT3/MYC signaling pathways in AML 211. Elevated ROS generation in *etoposide-treated AML cells and exhibited synergistic cytotoxicity 212. Combined treatment with HSP90 inhibitor provides an alternative way for the treatment of FLT3-ITD positive AML 213. FDA approved for treatment of patients with CML resistant or intolerant to tyrosine kinase inhibitors (TKI) 214. Also reported synergism with Ibrutinib (BTK) 215 and arsenic trioxide on AML stem cells by KG-1 (CD34+/CD96+/CD38+/-) and Kasumi-1 (CD34+/CD38-) cells 216 and by suppressing Mcl-1 through glycogen synthase kinase-3β (GSK3β) 217. Deregulates MYC transcriptional expression by directly binding NF-κB repressing factor and potentiates the therapeutic efficacy of anthracycline/cytarabine induction regimens 218.
Ancistrocladus cochinchinensis Leaves Naphthalene derivatives and isoquinoline alkaloids Expresses cytotoxicity against HL-60 cancer cells 219.
Chondrodendron platyphyllum Root barks Curine (4e)(Bisbenzyl-isoquinoline alkaloid) Disrupts MMP and curine presented a cytotoxic effect and induced apoptosis in HL-60 cells 220.
Alpinia intermedia (Hardy Wild Ginger) Seeds Intermedin A (calcitonin family peptide, labdane diterpene) Increases cleaved (c)-PARP and c-caspase-3 levels, thus inducing apoptosis in HL-60 cells at a dose of 30 µg/mL 221.
Thalictrum cultratum(Meadow-rue) Root Thalicultratine C (Aporphinoid Alkaloids) Downregulates MMP and induces apoptosis 222
Artemisia annua L. (sweet wormwood) Leaves Artemisinin (Figure 4f) (sesquiterpene lactone) Initiation of apoptotic cell death through ROS dependent and independent mechanisms, inhibition of cancer proliferation, metastasis and angiogenesis, and modulation of the cell signal transduction pathway and cause lysosomal disruption 223224. Combination of artesunate with lenalinomide, commonly used for the treatment of Multiple Myeloma 225. Hybrid 25 which proved even more potent than clinically used doxorubicin against CEM/ADR5000 cells 226. Significantly enhanced NK-92MI cell (natural killer cells) cytotoxicity against K562 cell line 227.
Clausenalansium(Wampee) Stems Coumarins (8-geranyloxypsolaren) and 2-methoxy-1-(3-methyl-buten-1-yl)-9H-carbazole-3-carbaldehyde Cytotoxicity against K562 cell line 228.
Hericiumerinaceus(Yamabushitake, mushroom) Whole plant polysaccharide Activation of mitochondria-mediated caspase-3 and caspase-9, induce apoptosis through down-regulation of anti-apoptotic proteins (Bcl-2, Bcl-xL(S), XIAP, and cIAPs) in U937 human monocytic leukemia cells 229.
Inonotus obliquus(Chaga mushroom) Whole plant Inonotodiol and inonotsuoxides (lanostan-type triterpenoids) Inotodiol inhibits cell proliferation through apoptosis induction by activating caspase-3 230.
Allium sativum Bulbs Ajoene (Figure 4g) (OSC) Ajoene induced apoptosis in human leukemic cells via stimulation of peroxide production, activation of caspase-3-like and caspase-8 activity 122, 231. The MAPK family member ERK1/2 was also activated by bisPMB (Ajoene Analogue) 232.
Securinega suffruticosa Callus Virosecurinine (Figure 4h) (alkaloid) Inhibits proliferation and induce apoptosis in THP-1 cells by exerting an inhibitory effect on the activation of PI3K/AKT/mTOR signaling pathways 233. Inhibited the growth and proliferation of the K562 cell lines and induced apoptosis in K562 cells by affecting the expression of mTOR, SHIP2, BCR/ABL and PTEN 234.
Cynanchum atratum Root BW18 (a C-21 steroidal glycoside) Potential alternative for CML patients. Regulating MAPK pathway leading to S phase cell cycle arrest and apoptosis, inhibited cell viability and proliferation of K562 cells 235.
Curcuma longa Rhizomes Curcumin(yellow polyphenol compound) Curcumin targets multiple enzymes (eg. NRF2 targeted NQO1) involved in the ROS metabolic pathway to suppress tumor cell growth, increases ROS levels in CML-derived human leukemic cell 236237238. Potentiates the efficacy of vincristine and imatinib, significantly increased the apoptosis degree, decreased the activation of NF-κB and the expression of its regulated genes 239.
Camellia sinensis(Tea) Leaves Epigallocatechin gallate (EGCG) (Catechin) Inhibits growth of human myeloid leukemia cells through the regulation of pRb synthesis and formation of pRb-E2F complexes 240. Causes caspase-independent necrosis-like cell death in CML 241. In early-stage CLL, the use of 2g of EGCG from the green tea extract twice a day was able to reduce the absolute leukocyte count 242243244245246. EGCG was also shown to inhibit DNA replication in leukemia cell lines and to modulate vascular endothelial growth factor leading to apoptosis in leukemic cells 247248.
Vitis vinifera(Grape) Seed Proanthocyanidins, Resveratrol (Figure 4i) (Phenols) Involves sustained JNK activation and Cip1/p21 up-regulation, culminating in caspase activation 249250, apoptotic cell death and cell growth arrest in human promyelocytic leukemia HL-60 cells 251. Effective against the proliferation of both types of acute leukemic lymphocytes of AML and ALL patients 252. Polydatin, a natural precursor of resveratrol (RSV) induces cell cycle arrest and apoptosis in MOLT-4 leukemia cells 253. Combination of chloroquine with RSV and 2 other stilbenes induced significant cell death and toxicity in on RCH-ACV and 697 ALL cells 254. RSV is a molecule without known severe toxicities 255. Proanthocyanidin extract induced mitochondria-associated apoptosis in human AML 14.3D10 cells 256.
Punicagranatum(Pomegranate) Fruit Gallic acid, ellagic acid, caffeic acid, chlorogenic acid, cyanidin, delphinidin, pelargonidin, gallotannins and ellagitannins Induced apoptosis and preferentially alters the cell cycle in leukemia cell lines compared with nontumor control cells 257. Flavonoid-rich fractions had proportional inhibitory effects on HL-60 cell proliferation 258. Peel extract promotes growth inhibition of K562 cells mainly via G2/M phase arrest while still conserving apoptosis induction, but at a lower rate 259. Juice extract significantly induced apoptosis in all leukemic cell lines and also induced cell cycle arrest in vitro 260. The polysaccharide PSP001, isolated from the rind of pomegranate fruit exhibited anti-oxidant activity in addition to growth inhibitory effect on leukemic cell lines 261.
Panax ginseng Root Ginsenoside Ginsenoside Rh1 showed a suppressive effect on the MAPK signaling pathway, resulting inhibition of invasion and migration of THP-1 acute monocytic cells 262. A metabolite of ginseng saponin, compound K induced apoptosis in human leukemia cells and also induced the activation of caspase-3, -8, and -9, and modulation of Bcl-2 families 263. In addition to cell growth inhibition, compound K suppresses cell DNA synthesis and induces cell cycle arrest at G1 phase in pediatric AML 264. It might have antileukemia activity through CD11c+ cell-mediated antitumor immunity 265. Down-regulated the expression of human telomerase reverse transcriptase, with inhibiting the expression of c-Myc in a concentration-dependent manner 266.
Podophyllum emodi(Indian Origin), Podophyllum peltatum(American origin) Roots and rhizomes Podophyllotoxins Podophyllotoxin derivatives showed promising cytotoxicities against a set of human cancer cell lines HL-60 267. Teniposide and etoposide have been reported as inhibitors of MYB transcription factor 268. GMZ-1 suppresses growth and induces apoptosis in adriamycin-resistant K562/A02 cells through modulation of MDR1 expression 269. A398was cytotoxic to the HT-29, MCF-7, MOLT-4 and HL-60 tumor cell lines 270.
Coleus forskohlii Root Forskolin (Diterpene) Forskolin as a GSKJ4 sensitizer/adjuvant in vivo, sensitizes Human AML Cells to H3K27me2/3 eemethylases GSKJ4 Inhibitor via Protein Kinase A 271.
Andrographis paniculate(Green Chirata) Leaves Andrographolide (Figure 4j) (Diterpene) Pretreatment of U937 with andrographolide (AGP) followed by low doses of topotecan showed an enhancement in inducing apoptosis 272. Inhibits growth of human T-ALL Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways 273. AGP was most potent to induce cytotoxicity in NALM-6 cells, effectively induced apoptosis by arresting cell cycle progression and increased the nuclear break down in NALM- 6 leukemic cells 274. Cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells also reported 275. Along with potent derivative NCTU-322, downregulated Bcr-Abl against imatinib-resistant CML cells 276. Inhibits growth of acute promyelocytic leukemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis 277. inhibits MV4-11 cell proliferation and reduces drug resistance by blocking FLT3 signaling in AML 278.

Pterostilbene (Figure 4k) (phytoalexin) isolated from grapevine leaves and blueberries, showing no toxicity in humans up to a dose of 250 mg/day 279, increases Fas expression in T-lymphoblastic leukemia cell lines 280. Blueberry extracts exerted anti-AML efficacy and specifically provoked Erk and Akt regulation within the leukemia stem cell subpopulation 281. Quercetin (Figure 4l) is a polyphenol partially responsible for the anti-AML efficacy of blueberry extracts. It can augment and focus the anti-AML efficacy of nano-liposomal ceramide (Lip-C6) and other ceramide-based therapeutics 282. Plant Homeodomain Finger 6 (PHF6) is frequently mutated in T-cell ALL (T-ALL), or AML 283, are present in about 20% of T-ALL that causes self-renewal and hematopoietic recovery after chemotherapy 284. PHF6 mutations have a significant role in leukemia stem cell activity in the pathogenesis of T-ALL 285. PHF2 low expression was significantly associated with leukemia cell proliferation and several poor prognostic indicators in adult ALL patients. By restoring IKAROS function (zinc finger transcription factor encoded by the IKZF1 gene), PHF2 can be promoted through histone modification 286. Sarkar et.al, 2019 depicted plants of West Bengal (bark of Flacourtiaindica, leaves of Madhucalongifolia (Figure 5b) and Prosopis cineraria) (Figure 5c) showed better cytotoxicity in both AML and CML cell lines (HL-60 and K562) 287. Danışman et.al, 2019 reported combination of flavonoids (apigenin, luteolin, 5-desmethyl sinensetin) and imatinib mesylate were able to enhance the cytotoxic effect on K562 cells in CML 288. Fucoidan (complex polysaccharide from brown seaweeds) inhibited proliferation of the SKM-1 AML cell line via the activation of apoptotic pathways and production of ROS 289 and also induced apoptosis in U937 Cells through activation of p38 MAPK and modulation of Bcl-2 Family 290. In another studies, in vitro and in vivo growth suppression 291 and enhancement of therapeutic potential of arsenic trioxide and all-trans retinoic acid 292 in acute promyelocytic leukemia cells also reported. Fucoxanthin (Figure 4m) induced apoptosis in human promyelocytic leukemia HL-60 cell 293, inhibited growth of leukemia cell lines by ROS generation 294, inhibited phosphorylation of ERK1/2 and histone H3, which are direct downstream signaling targets of lymphokine-activated killer T-cell-originated protein kinase (TOPK) 295, increased cytotoxicity against K562 cells and decreased cell proliferation of K562 and TK6 cells in vitro in imatinib and doxorubicin combination 296. Phlorotannins (algal polyphenols) showed antiproliferative activity in vitro against human leukemia THP-1 and U-937 cells 297. Heteronemin (Figure 4n) (a marine sesterterpenoid) effectively down-regulated cytarabine-induced activation of MAPK, AP-1, NF-κB and c-Myc, the down-stream targets of Ras signaling 298. Cichoriumintybus, Rheum ribes, Alhagipseudalhagi and Glycyrrihza glabra (Figure 5a) (Iranian Traditional plants) also showed notable effects on the leukemia cell lines 299. Juniperus sp. (Figure 5d) can be considered as an alternative source of podophyllotoxin (Figure 4o) and deoxypodophyllotoxin 300.

Plant derived biomolecules studied in leukemias Plants studied in leukemias (a). Glycyrrhiza glabra (Licorice) Madhuca longifolia (Mahua/Madhuca) (Source: Useful Tropical Plants - Ken Fern) Prosopis cineraria (Khejri/Shami tree) (Source: Greensouq.ae) Juniperus communis (Common Juniper) (Source: IUCN Red List) Breast Cell Carcinoma

The most common breast cancer type is the invasive ductal carcinoma accounting for 70-80% of all breast cancers diagnosed 301. It starts in a milk passage (a duct), breaks through the wall of the duct and invades the tissue of the breast 302. In US, 232,000 new cases of breast cancer were diagnosed 303 and claimed the lives of 40,290 women 304 in 2015. First-degree relatives of patients with breast cancer have a 2-fold to 3-fold excess risk for development of the disease 305. BRCA1 and BRCA2 are the 2 most important genes responsible for increased breast cancer susceptibility 306. Early breast cancer detection programs depend for effectiveness on the participation rate, which is affected by risk factor awareness 307. Since 1990, between 384,000 and 614,500 breast cancer deaths have been averted due to increased mammography screening and improved treatment 308. However, more than 25% breast cancer is projected to be increased by 2020 309. Women with breast cancer had a higher risk of developing new comorbidities than women without cancer 306. stressful life 310, urban living, mastectomy 311, lower socioeconomic status 309, 312, genetic predisposition, African-American origin, not having children or breastfeeding, early menstruation/late menopause, obesity, alcohol abuse, HRT after menopause, benign breast conditions or having breast proliferation, using contraceptives and exposure to diethylstilbestrol 313, age between 40-60, late age first pregnancy, smoking 314, abortion history 315 are the associated factors. Distressingly, the 5-year cumulative mortality remains unacceptably high at 50%, primarily due to a late-stage presentation 316. Wearing bra is not associated with breast cancer risk 317 but wearing (tight) bras for many hours and having breast implants 315, 318 may have associations. Around 60% of breast cancer mortality occurs in LMICs 319. The prevalence costs of breast cancer care in the US in 2010 was $16.5 billion 320321, and exceeded $39 billion before 2017 322. Table 3.

Traditional Plants Used in Breast Cell Carcinoma
Plant Plant Parts Used Important Constituents Mode of Action/ Pathway Modulation/ Study Results
Podophyllum peltatum Roots and rhizomes Etoposide (Figure 6e) and teniposide (semisynthetic derivatives of podophyllotoxin) Target topoisomerase II and forms a complex with topoisomerase II and DNA. The complex induces breaks in double-stranded DNA and prevents repair by topoisomerase II binding 93. Etoposide alters the balance between CDC25 splice variants in human breast cancer cell lines both at the mRNA and protein levels 323.
Juniperuscommunis(Juniper Berry) Leaves Deoxypodo-phyllotoxin(aryltetralin lignan or cyclolignan) Induced apoptosis in malignant MB231 breast cancer cells and inhibited MAPK/ERK and NFκB signaling pathways within hours of treatment 324. Antitumor effect of DPT on MDA-MB-231 human breast cancer xenografts in vivo 325 and in vitro 326. Better efficacy to MDR breast cancer than paclitaxel via avoiding efflux transport 327. Crude aqueous extract of J. communis L. significantly decreased the growth of MCF-7/AZ breast cancer cells 328.
Catharanthus roseus Root, stem, bark and flower Vinorelbine, vindesine, vincristine and vinblastine (Vinca alkaloids, microtubule inhibitors) Vinca alkaloids showed Golgi-disrupting activity in 3 different human breast cancer cell lines, BSY-1, MDA-MB-231 and MCF-7 329. Possible involvement of miR-222-3p expression in breast cancer cell apoptosis 330. Quercetin and vincristine are both active against ER breast cancers and exhibit synergism in vitro 331. Vinorelbine-phospholipid complex reduced injection irritation and maintain an antitumor effect in breast cancer in mouse models 332.
Taxus brevifoliaand Taxus baccata Trunk bark Paclitaxel and docetaxel (Taxanes) Taxanes are among the most active chemotherapy agents in the management of metastatic breast cancer, associated less nausea and vomiting compared to non-taxane-containing regimens 333334, disrupt the equilibrium between polymerized and depolymerized forms of microtubules, the cellular structures required for cell division 335. Paclitaxel+ bevacizumab exhibits synergetic effects and anti-tumor efficacy 336. Paclitaxel/cyclophosphamide better tolerated adjuvant regimen for elderly patients than docetaxel combination in elderly patients 337. Intensive paclitaxel NCT has the lowest incidence rate of neutropenia among other available NCTs 338. Docetaxel combined with trastuzumab and Pertuzumab is the standard first-line therapy for HER2-positive metastatic breast cancer 339, regimens containing docetaxel were associated with lower CIPN severity than paclitaxel 340. Adding taxane to an anthracycline-based regimen improves survival in node-positive breast cancer patients 341. Taxane/cyclophosphamide was more effective than taxane/anthracycline in HER2-negative, breast cancer 342.
Syzygiumaromaticum(cloves) Stems and flowers β-caryophyllene (Figure 6a) (Sesquiterpene), Eugenol (Essential oil) Dried flower buds of cloves lowered VEGF-A expressions at high dose and decreased MDA in vivo, induce adoptosis, decrease in CD24 and EpCAM expression in mammary cells 343. β-caryophyllene potentiated the anticancer activity of paclitaxel by facilitating the passage of paclitaxel through the plasma membrane 344. β-caryophyllene induced ionstitutive activation of PI3K/AKT/mTOR/S6K1 signaling and activation of ERK, JNK, and p38 MAPK in tumor cells 345, suppressed constitutive STAT3 activation in breast cancer cell lines and found cytotoxic to MDA-MB-231 346. Eugenol inhibits the cell proliferation and induces the apoptosis in human MCF-7 breast cancer cells 347.
Angelica archangelica Leaves β-phellandrene (Figure 6b) (cyclic monoterpene) Moderate antiproliferative activity against Crl mouse mammary carcinoma cells in vitro 348.
Nigella sativa Seed Thymoquinone (Figure 6c) Sustained inhibition of breast cancer cell proliferation with long-term treatment potential 349.
Viscum Album(European mistletoe, a hemi-parasitic shrub) Leaves Mistletoe lectin Cytotoxic effect breast cancer cells (MFM-223, HCC–1937, KPL-1, MCF-7) 350. Addition to targeted therapy (with mAbs, TKIs, ICIs) significantly reduced adverse effect induced treatment discontinuation 351. Devoid of herb-drug interaction and interference with cytostatic effects of trastuzumab on SK-BR-3 cells in vitro 352. Decreased cell proliferation, increased apoptosis and necrosis reported with human ductal breast carcinoma cell line BT474 353. An increase in the number of neutrophils and the activation of the phagocytic cells also reported with V. Album354. Apoptosis was induced by the activation of its mitochondrial pathway 355.
Camptotheca acuminate(xǐ shù or happy tree) Leaves Camptothecin (Figure 6d)(Insoluble pentacyclic mono-terpene alkaloid) Low dosage camptothecin combined with oncolytic measles virus found to elicit the same therapeutic effect as high doses of camptothecin in breast adenocarcinoma 356.
Plant derived biomolecules studied in breast cancer

Ethanolic extract of Juniperus turbinate was more potent cytotoxic than cisplatin in human breast adenocarcinoma MDA-MB-231 cell lines 357. Juniperusoxycedrus ethanolic extract from needles and berries showed potent cytotoxic effects against two breast cancer cell lines (MDA-MB-468 and MCF-7), with no cytotoxicity towards normal cells (PBMCs) 358. Saturejakhuzistanica (Figure 7a) (Lamiaceae), Casearia Sylvestris (Figure 7b) (Salicaceae), Cedrelopsisgrevei (Rutaceae), Solaniumspirale Roxb. (Solanaceae), carbazole alkaloids, Helichrysumgymnocephalum (Asteraceae), Pituranthostortuosus (Apiaceae), Melaleuca armillaris (Myrtaceae), Rosmarinus officinalis (Lamiaceae), Schinus molle L. and Schinus terebinthifolius Raddi(Anacardiaceae), Erigeron acris L.(Asteraceae), Aquilaria sinensis (Thymelaeaceae), Thymus vulgaris L. (Lamiaceae), Schefflera heptaphylla L. (Araliaceae) showed antiproliferative actions on human MCF-7 breast cancer cells 359. XWL-1-48, a potent orally podophyllotoxin derivative suppress Topo II, induce DNA damage and apoptosis, blocks PI3K/AKT/Mdm2 pathway 360. Alteration of Chk-2 signaling in MCF-7 cells reported with 4'-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum(Figure 7c)361. Genistein (most abundant and active isoflavone in soy), binds to the FIH-1 binding site of HIF-1α protein and downregulates HIF-1α in breast cancer cell line 362. Individuals with the habit of green tea (due to presence of EGCG) were found to have a negative association with the risk of future breast cancer (significantly increases circulating estradiol) 363364365366367368369370371372373. Compared with the US and EU, some Asian countries like China and Japan have lower breast cancer 364, where dietary consumption of soy products is much higher than US and EU 374. Brown seaweed fucoidan inhibited human breast cancer progression by upregulating microRNA (miR)-29c and downregulating miR-17-5p, thereby suppressing their target genes 375. Lophocladia sp (Lophocladines), Fucus sp (fucoidan), Sargassum muticum (7f) (polyphenol), Porphyra dentata (sterol fraction), Cymopoliabarbata (Figure 7e) (CYP1 inhibitors), Gracilariatermistipitata was found to be effective in breast cancer studies 376. High Urokinase-type plasminogen activator receptor (uPAR) expression predicts for more aggressive disease in several cancer types 377, dietary seaweed may help lowering breast cancer incidence by diminishing levels of uPAR 378. The tropical edible red seaweed Eucheuma cottonii L. (Figure 7d) is rich in polyphenols that exhibited strong anticancer effect with enzyme modulating properties 379. Jazzara et.al, 2016 concluded that λ-carrageenan (Figure 6f) (sulfated galactans found in certain red seaweeds) could be a promising bioactive polymer 380, showed a remarkable inhibitory effect on MDA-MB-231(triple negative breast cancer cell line) cell migration 381. Several studies support polyphenols 382383384385386, flavonoids 387388389390391392393394395, fucoidan 396397398399400401402403404405406407, lutein/zeaxanthin 408409410411412, other seaweed alkaloids, peptides, tannins and polysaccharides 413414415416417418419420421422423424425 in breast cancer management.

Plants studied in breast cancer (a). Satureja khuzistanica (Source: Med P Group) Casearia Sylvestris (Source: Árvores do Bioma Cerrado) Podophyllum hexandrum (Source: Wikimedia Commons) Eucheuma cottonii (Source: tradekey.com) Cymopolia barbata (Source: Melev's Reef) Sargassum muticum (Source: Seaweed.ie) Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cause of cancer death 426. It is the second leading cause of death in US, affecting some 135,000 estimated new patients with more than 50000 deaths every year 427428429. In 2015, there were 376,000 new cases and 191,000 deaths in China 430. The overall incidence of CRC is decreasing in many high-income countries, although reported significant increase in Denmark, New Zealand, Australia, UK and Canada, mainly driven by increases in distal (left) tumors of the colon and predominant in 431432433434435436437438. Lifestyle determines around 50% to 60% incident of CRC irrespective of age 439440441442. Physical activity may prevent approximately 15% of the colon cancers 443. Fish, poultry, cheese, fruit, vegetables, tea and coffee were not associated with colorectal-cancer risk 444. Alcohol consumption, red meat/processed meat, junk food, smoking, diabetes and obesity potentiate the same risk 445446447448. In 2018, the estimated national expenditure was $16.6 billion in US, which was $4.5 billion to $9.6 billion in 2009 and projected to be more than $20 in 2020 449450451. There were over 1.8 million new cases in 2018. Hungary, North Korea, Slovakia, Norway, Denmark, Portugal, Japan are in the top-ranking positions 452. 5-year survival for patients with stage IV CRC is less than 10% 453. The overall risk of CRC among patients with ulcerative colitis is about ten times higher than that of the general population 454. A recent study reveals that chili peppers does not increase or decrease the risk of CRC 455. Previous studies say capsaicin has both carcinogenic and anticancer effects. Table 4.

Traditional Plants Used in Colorectal Cancer
Plant Plant Parts Used Important Constituents Mode of Action/ Pathway Modulation/ Study Results
Inula Viscosa Leaves Polyphenols (caffeoylquinic acid (Figure 8a), dicaffeoylquinic acid, flavonoids, terpens, lactones) and sesquiterpens (Tomentosin and Inuvisocolide) Affects the cell cycle progression and induces apoptosis by activation of caspases in colon cancer cells. Moreover, IV extract exhibits anti-tumor activities in an animal model, and it is safe for use 456.
Matricaria chamomilla Flowers Flavonoids Apigenin (4′,5,7-trihydroxyflavone) suppressed the EMT, migration, and invasion of human colon cancer by inhibiting the NF-κB/Snail pathway 457.
Curcuma longa Rhizome Curcumin Inhibit activation of NF-κB, downregulates anti-apoptotic, cell-proliferative, invasive, and angiogenic gene products, suppress activation of STAT3, HIF-1, PPAR and expression of TNF, IL-1, IL-6 458.
Zingiber officinale Rhizome 6-gingerol and 6-paradol, shogaols and zingerone 6-gingerol, regulate the molecules in cellular signal transduction pathways, including NF-κB, AP-1, growth factors, chemokines, MAPK, p53, cyclin D1, VEGF, COX-2 and iNOS pathways. 6-gingerol and 6-paradol have been found to induce cancer cell apoptosis 458.
Alpinia galanga Rhizome 1′-Acetoxychavicol acetate (ACA) (Figure 8b) ACA has been shown to induce apoptosis in CRC cell lines, inhibits DNA synthesis, thereby inhibiting cell proliferation. In rat intestine epithelial cells (IEC6), ACA induced glutathione S-transferase and NAD(P)H: quinone oxidoreductase 1 (NQO1) activities, increased intracellular glutathione levels, and upregulated intranuclear Nrf2 and cytosolic p21. It also has the ability to inhibit azoxymethane-induced colon tumorigenesis in rats 458.
Piper longum(Long pepper or pipli) Dried fruit Piperlongumine (Figure 8c) Piperlongumine targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer 459.
Rhizomacoptidis(Huang Lian) Rhizome Berberine (Figure 8d) Downregulates β-catenin-induced proliferation by binding RXR, cell proliferation by inducing the G2/M phase arrest and down-regulated the expression of the related cyclins 460. Promotes apoptosis of CRC via regulation of the long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2)/AU-binding factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) axis 461.
Punicagranatum(Pomegranate) Fruit Ellagitannins, ellagic acid CDKN1A (p21, Cip1) induction followed by cell-unique downregulation of miR-224 or upregulation of miR-215 462. Pomegranate ellagic acid and their microbiota metabolites urolithins exert anticancer effects in preclinical CRC models, and target normal and malignant colon tissues in CRC patients 463. Consumption of the pomegranate extract was significantly associated with a counterbalance effect in the expression of CD44, CTNNB1, CDKN1A, EGFR and TYMs 464.
Phaseolus vulgaris(Navy bean) Beans Anacardic acid (Figure 8e) and nobiletin Imparts glutathione regulation, and involved cancer control mechanisms such as detoxification of xenobiotics, antioxidant defense, proliferation, and apoptosis. Metabolic pathways involving lysine, and phytochemicals were also modulated by navy bean intake in CRC survivors 465. Anacardic acid efficiently repressed expression of CD44 and MMP14 in HCT116 colon cancer cells, with repression of the SUMO-conjugated TFAP2A isoform and elimination of CD44+/hi/ALDH+/hi cells 466.
Macleaya cordata Leaves Sanguinarine (8f) Sanguinarine decreased the tumor size in a dose-dependent manner in orthotopical colorectal carcinomas through intrinsic apoptosis pathway in BALB/c-nu mice. It dephosphorelates STRAP and MELK and disassociates the interaction between them to trigger intrinsic apoptosis. Overexpression of STRAP and MELK may be markers of CRC and their disassociation may be a determinant of therapeutic efficacy 467.
Betula alba (white birch) Bark Betulinic acid (Pentacyclic triterpenoid) Significantly reduced the expression of matrix metalloproteinase (MMPs) and increased the expression of MMPs inhibitor (TIMP-2), MMP-2+ cells and Ki-67+ cells were reduced and cleaved caspase-3+ cells were increased in tumor tissues of mice. Betulinic acid promoted the apoptosis of CRC cells and also inhibited the metastasis of cancer cells 468. Nano-capsulated analogue (2c) with better therapeutic efficacy than parent molecule to colon carcinoma cells has been reported 469.
Boswellia serrata Oleo-gum-resin 3 acetyl-11-keto-β-boswellic acid (AKBA) AKBA induced upregulation of tumor-suppressive miR-34a and downregulation of miR-27a in CRC cells, inhibited cellular proliferation, induced apoptosis and cell-cycle arrest in CRC cell lines, and these effects were significantly enhanced with combined treatment of AKBA and curcumin 470.
Toxicodendronvernicifluum(formerly known asRhusverniciflua) Stokes Butein* (3,4,2',4'-tetrahydroxychalcone, aromatic ketone) The depletion of securing (onchoprotein) enhances butein-induced apoptosis and tumor inhibition in human CRC. 471472473. Synergistic effects of butein and cisplatin, induce combined inhibition of p38α and MEK specifically induced apoptosis through caspase-3 in CRC cells 474. Butein ameliorated colitis (most important risk factor of CRC) in IL-10(-/-) mice by regulating IL-6/STAT3 and MMP-9 activation 454.
Capsicum annuum(Chili pepper) Fruit E-capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide) Chili peppers can promote digestive juice to secrete and accelerate bowel movements, which may reduce the risk of CRC. Capsaicin can downregulate the expression of COX-2 and B-catenin mRNA, promoting apoptosis through caspase 3 activation and inhibiting the proliferation of cells 455. Capsaicin Mediates Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells via Stabilizing and Activating p53 475476. Low concentration capsaicin promotes CRC cell migration and invasion by triggering production of ROS 477.
Colchicum autumnale (meadow saffron) or Gloriosa superba (glory lily) Seeds and bulbs Colchicine The cellular uptake and apoptotic efficiency of colchicine is correlated with downregulation of MMP-9 mRNA Expression in SW480 CRC cells 478. Colchicine induces apoptosis via MMP loss in HT-29 cells, ROS production, caspase-3 activation, upregulation of pro-apoptotic Bax, downregulation of anti-apoptotic Bcl-2 and phosphorylation of p38, which indicates an involvement of p38-regulated intrinsic apoptosis pathway 479480.
Vitis vinifera(Grape) Seed Resveratrol Resveratrol was found to upregulate miR-96 in a genetically engineered mouse model for sporadic CRC, which caused the downregulation of KRAS, an oncogene associated with tumor aggressiveness and chemoresistance 481. Upregulation of miR-101b and miR-455, which in turn led to decreased levels of IL-6 and TNF-α; these are pro-inflammatory proteins known to be promoters of colon cancer 482483. Additionally, a combination of resveratrol and grape seed extract has been reported to suppress Wnt/β-catenin signaling and increase mitochondria-dependent apoptosis in in vitro and in vivo models 484. Finally, resveratrol has been shown to increase miR-34a levels in DLD-1 and SW480 cells 485.
Allium cepa(Red onion) Bulb Quercetin** Cytotoxic activity of Quercetin on two human colonic cancer cell lines, HT29 and HCT15, depends on COX-2 dependent ROS generation that induces apoptosis and inhibits cell survival 486. In HT-29 colon cancer cells quercetin treatment decreases cell viability, arrests the cell cycle at the G1 phase and induces apoptosis, also Decreases the expression of CSN6, a subunit of the constitutive photomorphogenesis 9 multiprotein complex 487. Additionally, treatment of HT-29 cells with quercetin upregulates AMP-activated protein kinase, a physiological cellular energy sensor, which markedly suppresses cell proliferation 488. Quercetin has also been demonstrated to suppress the Wnt/β-catenin and NF-κB pathways in CRC cells 489490.
Elettaria cardamomum Bark Cardamonin (Figure 8g) Induction of apoptosis, cell cycle arrest, ROS generation, downregulation of MAPK signaling, induction of Bax translocation and loss of mitochondrial integrity were the mechanisms behind the anti-proliferative effect of cardamonin in human CRC cell lines. Also, activation of both p38 and JNK and in presence of ROS scavenger the activation was attenuated 491. Suppression of β-catenin dependent gene expression in human CRC cell lines 492. Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NFκB pathway in vitro 493.
Tripterygium wilfordii Hook F (Mandarin) Root Celastrol (Figure 8h) Inhibit the growth, adhesion, and metastasis of human CRC cells through the inhibition of TGF-β1/Smad signaling 493. Suppression of the expression of key genes (TYMP, CDH5, THBS2, LEP, MMP9, and TNF) and proteins (IL-1b, MMP-9, PDGF, Serpin E1, and TIMP-4) involved in the angiogenesis pathway 495. Reduces the cell size of the SP (side population) increases frequency of apoptosis and binds to Pgp protein in cell membranes inhibiting its transport function 496. Inhibits CRC cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway 497. Effectively inhibited SW480 CRC cell proliferation, down-regulation of Shoc2 expression also significantly inhibited proliferation, colony formation, and migration functions of tumor cells 498.
Mundulea sericea Bark, roots, and leaves Deguelin (Figure 8i) (Rotenoid, flavonoid) Deguelin inhibited CRC cell growth by inducing apoptosis via activation of p38 MAPK pathway 499. Promoted cell cycle arrest at G0/G1 phase in colon cancer cells 500. Deguelin has been found to regulate cell cycle in colon cancer cells by stimulating p27 expression. Cyclin D1 and cyclin E is dramatically downregulated with treatment of deguelin 501. Deguelin exerted anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro 502.
Trigonellafoenum graecum (Fenugreek) Seed Diosgenin (Figure 8j)(phytosteroid sapogenin) Diosgenin induces apoptosis due to HMG (3-hydroxy-3-methylglutaryl) CoA suppression in human colon carcinoma cells 503. Diosgenin induced apoptosis in colorectal cancer cell lines HCT-116 and HT-29 504. HT-29 is sensitized by diosgenin to TRAIL induced apoptosis 505. Acts on colon carcinoma (HCT-15) cells, induces apoptosis via mitochondrial dependent pathway 506.
Darmera peltate (Indian Rhubarb) andRheum palmatum (Chinese Rhubarb) Bark and roots Emodin (Figure 8k) (Trihydroxy-anthraquinone) Inhibited the invasion and migration abilities of RKO cells and decreased the expression of MMP-7, MMP-9, and suppressed the growth of colorectal cancer cells by inhibiting VEGFR2 507508, decreased viability of CoCa cells and induced apoptosis in a time and dose-dependent manner, down regulated Bcl-2 family expression 509. Mitochondrial dysfunction and ROS accumulation in colon cancer cells also reported 510.
Embeliaribes (White-flowered Embelia) Fruit Embelin (Figure 8l) In tumor milieu, embelin increased the infiltration of CD8+ T cells, NK cells and mature dendritic cells whilst depleted the regulatory T cells. Moreover, embelin could directly interfere with the generation and function of MDSCs in vitro 511. In colon cancer cells, embelin diminished both the constitutive and IL-6-induced STAT3 activation by stimulating Src homology domain 2-containing protein tyrosine phosphatase (SHP2) activity 512. Embelin potently inhibited NF-κB signaling in macrophages and decreased the production of key pro-inflammatory cytokines and tumorigenic factors involved in CAC, such as TNFα, IL-6 and COX-2 513.

Aloe-emodin, a natural compound extract from Aloe Vera, has been discovered to suppress cell proliferation and accelerate apoptosis in a variety of tumor cells 514. Camptothecin induces the upregulation of Programmed Death-Ligand 1(PD-L1) and other cytokines that modulate the attraction, migration, and functions of immune cells, primarily T-cells 515. Scutellarin (Figure 8m) is a flavonoid isolated from a medicinal herb Scutellariabarbata(Figure 9a), downregulates the anti-apoptotic protein Bcl-2 and induces apoptosis by activating p53, which upregulates Bax to activate caspase 3 via the mitochondrial pathway 516. Treatment of HT-29 cells with luteolin (flavonoid, exist in fruits, vegetables and medicinal herbs) results in a loss of the mitochondrial membrane potential, an increase in mitochondrial Ca2+ level, upregulation of Bax, downregulation of Bcl-2, release of cytochrome c from the mitochondria to the cytosol and an increase in the levels of the active forms of caspase-9 and caspase-3 517. Treatment of Caco-2 CRC cells with extra virgin olive oil (rich in hydroxytyrosol and oleuropein) miR-23a and miR-301a, which were predicted to target type 1 cannabinoid receptor (CB1) in colon cancer 518, important implications in chemoprevention. Gambogic acid (Figure 8n), a xanthonoid extracted from the resin of Garcinia hanburyi (Figure 9b) inhibits HT-29 proliferation via induction of apoptosis 519. Walnuts (genus Juglans) have been shown to suppress colon cancer in mice models through the decreased expression of miR-1903, miR-467c, and miR-3068, as well as the increased expression of miR-297a in athymic nude mice injected subcutaneously with HT-29 CRC cells 520. Also, Aggarwal et.al, 2013 listed phytochemicals like garcinol, gossypol, gossypin, guggulsterone, indole-3-carbinol, morin, naphthoquinone, nimbolide, noscapine, oleandrin, piperine, piceatannol, pinitol, plumbagin, pomegranate, retnoids, honokiol, sesamin, silymarin, simvastatin, terpenoid, thymoquinone, tocotrienol, triptolide, ursolic acid, withanolides, xanthohumol, and zerumbone 458 having potentials in CRC. Seaweeds like U. pinnatifida175, 401, 521522523524525526527, Saccharina latissimi (9c) 528, Fucusvesiculosus176, 295, 529530, Sargassum hemiphyllum (Figure 9d) 531532533 have proven efficacy in this situation. Also, Algae derived astaxanthin 534535536537538539540, fucoxanthin 541542543544545, lutein and zeaxanthin 546547548549, polyphenols 550551552553554 shown individual excellence.

Plant derived biomolecules studied in colorectal cancer Scutellaria barbata (Source: Strictly Medicinal Seeds) Garcinia hanburyi (Source: Vitamin Supplement Ingredients Information) Saccharina latissimi (Source: Nature Picture Library Print Store) Sargassum hemiphyllum (Source: natural-history.main.jp) Other Bioactive Non-Plant Compounds

Caffeic acid phenethyl ester (Figure 10a) is a central active component of propolis from honeybee hives. Propolis is a well-known health supplement that is extremely popular in Australia and New Zealand. It is constantly marketed in Japan with sales exceeding US$300 million/year 555. It can impart strong antimitogenic activity in lung cancer, breast cancer 556 and apoptosis in colon cancer 557. Peripheral neuropathy is a common side effect of many chemotherapeutic agents including paclitaxel. Poor nutritional status and obesity increase the risk of paclitaxel induced neuropathy 558. PEGylated liposomes of paclitaxel were successfully developed and demonstrated reduced neurotoxicity in-vitro in neuronal cells and prevented development of peripheral neuropathy in-vivo 559. Glutathione 560 and gallic acid 561 may ameliorate paclitaxel-induced neuropathic pain. Di(2-ethylhexyl) phthalate (DEHP) (Figure 10b), estrogen receptor alpha (ERα) agonist due to its ability to interact with ERα and promote the cell proliferation of ERα-positive breast cancer cells, significantly protected MCF-7 cells against the genotoxicity of camptothecin 562. Actinomycin D obtained from various Streptomyces strains decreases Mcl-1 expression in lung cancer cells 563, induces p53-independent cell death in leukemia 564, synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver with soluble TRAIL gene 565. Hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and mitomycin C (Figure 10c) (obtained from Streptomyces caespitosus) is the only protocol to demonstrate an adjuvant HIPEC benefit in colorectal cancer patients at high risk for peritoneal failure and an alternative to high-dose and short-term oxaliplatin 566. 5-FU plus mitomycin remains the preferred chemotherapy in most patients with anal cancer 567. Bleomycin (Figure 10e) is an antibiotic complex of several glycopeptides derived from Streptomyces verticillus, gained FDA approval in July 1973. The extract from Streptomyces sp. MUM265- represents a valuable bioresource of bioactive compounds for the future development of chemo-preventive agents, with particular promise suggested for treatment of colon cancer 568. Bleomycin is an indispensable antineoplastic agent for the treatment of germ cell tumors and lymphomas. Pirfenidone (Figure 10d) (novel orally available antifibrotic drug approved by the FDA in 2014) is currently the only approved therapy for idiopathic pulmonary fibrosis (IPF), considered as a salvage drug for refractory cases of bleomycin-induced lung injury 569. In a similar study, Yu et.al, 2019 reported EZY-1 (16-amino-acid peptide was isolated from Eucheuma) can inhibit the IPF induced by bleomycin 570.

Biomolecules from non-plant origin studied or used in different types cancers Alternative Therapies and Mind-Body Interventions

According to the Global Health Observatory Report from the WHO, insufficient physical activity is the 4th leading risk factor for mortality. Participation in 150 minutes of moderate physical activity a week or its equivalent is estimated to reduce risk of breast and colon cancer by 21%–25% 571. Approximately 50% of all leukemia, lymphoma, colorectal- and breast cancer patients are affected by CIPN. Sensorimotor training (SMT) or whole-body vibration (WBV) can reduce the symptoms of CIPN and attenuate motor and sensory deficits 572. Hypnosis, music (Figure 11) and relaxing video reduced anxiety and pain associated with colonoscopy and need for sedation during colon cancer screening 573574575576577578579580581. Impaired cognitive function, change in brain metabolism and change in brain structure are associated with cancer treatment. CBT moderately improved anxiety and depression in patients with early-stage breast cancer 582, significantly improved tumor associated fatigue levels after 8 weeks 583, improved QoL 584, improved cognitive function 585, improved insomnia 586587, reduced fear of cancer recurrence 588 and most importantly, reduced pain and distress 589. Mindfulness-based approaches and hypnosis reduced demonstrated efficacy in reducing anxiety and depressive symptoms. 40% to 50% CRC patients reported fear of cancer recurrence, tends to increase around the time of scans or other testing for recurrence 590. Also, CRC patients have unique psychosocial needs (e.g., isolation, embarrassment) related to altered eating and bowel habits and sexual dysfunction that warrant clinical attention 591. Acceptance and commitment therapy, meta-cognitive therapy, and mindfulness-based therapies emphasize mindfulness, acceptance, cognitive flexibility, and patient values changes in self-efficacy or confidence in using coping skills targeted by the intervention, acceptance of unwanted thoughts and feelings, or enhanced social support as well as physiological mechanisms (e.g., decreased arousal to negative thoughts and feelings about cancer) 592. Combined CBT/GET improves fatigue and functional outcomes for a subset of patients with post-cancer fatigue in breast or colon cancer 593. CBT intervention has the potential to ease acute anxiety during the often-challenging re-entry phase and to prevent the development of chronic, debilitating, and costly anxiety 594. Physical activity interventions also reduce depressive and anxiety symptoms in breast cancer survivors 595. Telehealth approaches may improve access to mental health resources especially for those with limited online access or lack of online skill 596. Yoga has a solid effect on cancer-related fatigue in patients with breast cancer 597. It is one of the most prevalent complementary therapies used in breast cancer care, seems to be as effective as other exercise modalities for improving the QoL of women with breast cancer 598. Wei et.al, 2019 reported significant improvement in lymphedema status, range of shoulder motion and spinal mobility after an 8-week yoga intervention 599. Although, yoga could not improve HRQoL in patients with colorectal cancer 600 but research supports that yoga is a promising intervention for reducing fatigue and sleep disturbances in this patient group 601.

Music Therapy: Pain or Distress Management 619. In the UK, music therapists are trained to master’s level and are registered with Health and Care Professions Council as allied health professionals. Aristotle recognized the innate ability of melodies to surpass “feelings such as pity and fear, or enthusiasm,” and thus “heal and purify the soul.” The Greeks identified Apollo as the father of both healing and music, alongside his many other accolades (as God of light, sun, truth, prophecy, plague and poetry).

Dyadic yoga may offer effective relaxation techniques for lung cancer patients and their caregivers who were undergoing an extreme stressor in addition to the cancer experience 602, feasible and beneficial for patients having toxic thoracic radiography 603. Approximately 20% of breast cancer survivors develop breast cancer-related lymphedema (BCRL) 604. Acupuncture is safe and effective at reducing breast cancer-related lymphoedema in patients after breast cancer treatment 605 and managing joint stiffness. Acupuncture use among breast cancer patients in the US is currently as high as 16% to 63% 606. At the current time breast cancer related lymphedema is incurable but well manageable by a number of physical therapy modalities, especially complete decongestive therapy (CDT) 607. Obesity is a factor that deteriorates the CDT efficacy. Early treatment, before developing fat accumulation and fibrosis, must be primary goal in the treatment of BCRL 608. The first “intensive treatment” phase aims to decongest the swollen arm through two or more weeks of daily therapist-delivered treatment including multi-layer compression bandaging and manual lymph drainage (MLD). This is followed by a “maintenance” phase of patient self-treatment, with compression usually in the form of hosiery 609. The mindfulness component may enhance the positive impact of exercise on cognitive function in breast cancer 610611. Tai Chi is accessible to most people and does not require special facilities or expensive equipment 612. Healthier dietary choices were the most frequently reported change already made by people affected by CRC, followed by increased physical activity, stress management, quitting smoking and alcohol and therapies including meditation, tai chi, and naturopathy 613. Greater shoulder muscular strength was significantly associated with better functional well-being in breast cancer survivors with TC Qigong training 614. Massage with or without aromatherapy have been suggested by a few studies in breast cancer to ameliorate anxiety and other symptom relief 615 and immunologic state 616 that needs further investigation. TENS was found valuable in lung cancer patient underwent standard posterolateral thoracotomy 617. Animal-assisted activities (Figure 12) has potential benefit children with cancer because pediatric oncology patients often suffer from distress due to physical examinations, venipuncture, chemotherapy infusions, spinal taps, surgery, hospitalization, pain, fear of medical procedures, unpleasant physical symptoms, uncertainty, and worry about death 618.

Hospitalized kid on animal visit 620. Understanding whether AAA is safe and effective for pediatric cancer patients is critical, especially because of concern about infection in immunosuppressed persons. Conducting AAA research in pediatric oncology requires understanding current regulations and variations in practice. Knowledge of regulations helps us understand elements required for intervention protocols (e.g., hand-cleaning), whereas knowledge of practice variation can help us identify research opportunities. Conclusion

The journey from diagnosis to treatment of cancer affects the patients' lives in a variety of ways. Debilitating symptoms arising both due to disease and its treatments consistently hamper their QoLs. CAM treatment aims to restore body’s ability to protect, regulate and heal itself. Since almost 50% of existing medicine is derived from plants, it is clear that natural sources, especially plants can be investigated for effective medicines in cancer treatment. These data can equip providers and patients with the information they need to have informed conversations regarding non-drug approaches for treatment of specific cancer conditions. The use of CAM by cancer patients is becoming widespread. This is a reflection of the many needs and concerns that are currently not being met by conventional medical practice. Significant proportions of cancer patients in developed countries use complementary therapies as adjuncts to conventional symptom management to improve their QoL. India’s indigenous systems of medicine, such as Ayurveda, Siddha, and Unani, are more than 5,000 years old, and in rural areas, the Indian population has relied heavily on these practices, particularly Ayurveda. In addition, CAM has the potential for the primary and secondary prevention of cancer through counselling on healthy lifestyle, nutrition and supporting the human power of ‘salutogenesis’ throughout life. The lack of communication about CAM use may be due to fear of a negative response, physicians being perceived as not supportive nor helpful, or physicians and patients having differing views about CAM. Discussions of CAM therapies may have additional benefits for the patient-provider relationship, as studies have shown it indicates use of participatory decision-making, patient-centered communication, and thus greater patient satisfaction, not only in cancer care but also in other arenas of healthcare.

 Financial Disclosure or Funding

N/A

 Informed Consent

N/A

 Author contributions

N/A

I’m thankful to Dr. Alexandra McCarthy, The University of Auckland, New Zealand for her valuable time to audit my paper and for her thoughtful suggestions. I’m also grateful to seminar library of Faculty of Pharmacy, University of Dhaka and BANSDOC Library, Bangladesh for providing me books, journal and newsletters.

Abbreviations American Institute for Cancer Research (AICR)

Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Nicotine Replacement Therapy (NRT)

Carbohydrate (CHO)

Prostaglandin E2 (PGE2)

Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB)

Phosphatidylinositol 3-Kinase/Protein Kinase B (PI3K/Akt)

Mitogen-Activated Protein Kinases (MAPK)

Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2)

Lewis Lung Carcinoma (LLC)

Vascular Endothelial Growth Factor (VEGF)

Matrix Metalloproteinase-2 (MMP)-2

Reactive Oxygen Species (ROS)

European Medicines Agency (EMA)

Aldo‐Keto Reductase 1B10 (AKR1B10)

National Cancer Institute (NCI)

small interfering RNA (siRNA)

Organo-Sulfur Compounds (OSCs)

Tumor-Associated Macrophages (TAM)

Non-Small-Cell Lung Cancer (NSCLC)

Chinese Herbal Medicines (CHM)

Primary Care Physicians (PCPs)

Cognitive Behavioral Therapy (CBT)

Low and/or Middle Income Countries (LMICs)

Global Cancer Incidence

Mortality and Prevalence (GLOBOCAN)

 Chronic Myeloid Leukemia (CML)

Leukemia & Lymphoma Society (LLS)

cleaved Poly (ADP-ribose) Polymerase (c-PARP)

Immunogenic Cell Death (ICD)

Tyrosine Kinase Inhibitors (TKI)

Bruton Tyrosine Kinase (BTK)

Glycogen Synthase Kinase-3β (GSK3β)

Myeloid cell leukemia-1 (Mcl-1)

'Tamm-Horsfall Protein 1' (THP-1)

mammalian target of rapamycin (mTOR)

Src-Homology 2-Containing Inositol-5-Phosphatase 2 (SHIP2)

Phosphatase and Tensin homolog (PTEN)

Plant Homeodomain Finger 6 (PHF6)

T-cell acute lymphoblastic leukemia (T-ALL)

NADPH Quinone Dehydrogenase 1 (NQO1)

Nuclear factor erythroid 2-related factor 2 (Nrf2)

Rb tumor suppressor protein (pRb)

c-Jun NH2-terminal kinase (JNK)

Human Leukocyte Antigen (HLA)

Epigallocatechin Gallate (EGCG)

BReast CAncer gene-1 (BRCA-1)

Chemotherapy-induced peripheral neuropathy (CIPN)

Sensorimotor Training (SMT)

Whole Body Vibration (WBV)

Neoadjuvant Chemotherapy (NCT)

Di(2-ethylhexyl)phthalate (DEHP)

Programmed Death-Ligand 1(PD-L1)

cyclin-dependent kinase inhibitor 1A gene (CDKN1A)

Transcription Factor AP-2α (TFAP2A)

Serine-threonine kinase receptor-associated protein (STRAP)

Maternal embryonic leucine zipper kinase (MELK)

COP9 signalosome subunit 6 (CSN6)

TNF-related apoptosis-inducing ligand (TRAIL)

Idiopathic Pulmonary Fibrosis (IPF)

Graded Exercise Therapy (GET)

Manual Lymph Drainage (MLD)

Transcutaneous electrical nerve stimulation (TENS)

Animal-Assisted Activities (AAA)

Ducharme J A Third of People with Cancer Use Alternative Medicine. Here&apos;s Why That Could Be Dangerous. Time Magazine 2019 IntegrativePDQAlternative, and Complementary Therapies Editorial Board. Topics in Integrative, Alternative, and Complementary Therapies (PDQ®): Patient Version2018PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); Available from: https://www.ncbi.nlm.nih.gov/books/NBK131880/ Siegel R L Miller K D statistics Jemal A Cancer 2019 CA Cancer Jan;69(1): 7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8. PubMed PMID: 30620402 10.3322/caac.21551 30620402 Shah S C Kayamba V Peek RM Jr Heimburger D Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? J Glob Oncol 2019 Mar;5: 1-8. doi: 10.1200/JGO.18.00200. PubMed PMID: 30908147; PubMed Central PMCID: PMC6452918 10.1200/JGO.18.00200 30908147 Ferlay J Colombet M Soerjomataram I Mathers C Parkin D M Piñeros M Znaor A Bray F Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods 2019 Int 10.1002/ijc.31937. Epub 2018 Dec 6. PubMed PMID: 144 8 1941 1953 10.1002/ijc.31937 30350310 Feng R M Zong Y N Cao S M Xu R H Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond) 2019 PubMed PMID: 31030667; PubMed Central PMCID: PMC6487510 39 1 22 10 10.1186/s40880-019-0368-6 31030667 WHOLatest global cancer data: Cancer burden rises to 18. 1 million new cases and 9. 6 million cancer deaths in 2018. Presse Release2018 Available From: https://www.who.int/cancer/PRGlobocanFinal.pdf Li M Chen Z Liu Z Zhang N Liu J Wang H Wang W Liang Y Chen J Liu Z Li Y Zhai S Twelve Chinese herbal preparations for the treatment of depression or depressive symptoms in cancer patients: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Altern Med 2019 PubMed PMID: 30674300; PubMed Central PMCID: PMC6345004 19 28 1 16 10.1186/s12906-019-2441-8 30674300 Schüz J Espina C Wild C P Primary prevention: a need for concerted action. Mol Oncol 2019 18. Review. PubMed PMID: 30582778; PubMed Central PMCID: PMC6396360 13 3 567 578 10.1002/1878-0261.12432 30582778 CancerAmericanSociety. Cancer Facts & Figures2018 Available From:https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf Fitzmaurice C Allen C Barber R M Barregard L Bhutta Z A Brenner H Dicker D J Chimed-Orchir O Dandona R Dandona L Fleming T Forouzanfar M H Hancock J Hay R J Hunter-Merrill R Huynh C Hosgood H D Johnson C O Jonas J B Khubchandani J Kumar G A Kutz M Lan Q Larson H J Liang X Lim S S Lopez A D MacIntyre M F Marczak L Marquez N Mokdad A H Pinho C Pourmalek F Salomon J A Sanabria J R Sandar L Sartorius B Schwartz S M Shackelford K A Shibuya K Stanaway J Steiner C Sun J Takahashi K Vollset S E Vos T Wagner J A Wang H Westerman R Zeeb H Zoeckler L Abd-Allah F Ahmed M B Alabed S Alam N K Aldhahri S F Alem G Alemayohu M A Ali R Al-Raddadi R Amare A Amoako Y Artaman A Asayesh H Atnafu N Awasthi A Saleem H B Barac A Bedi N Bensenor I Berhane A Bernabé E Betsu B Binagwaho A Boneya D Campos-Nonato I Castañeda-Orjuela C Catalá-López F Chiang P Chibueze C Chitheer A Choi J Y Cowie B Damtew S das Neves J Dey S Dharmaratne S Dhillon P Ding E Driscoll T Ekwueme D Endries A Y Farvid M Farzadfar F Fernandes J Fischer F GHiwot T T Gebru A Gopalani S Hailu A Horino M Horita N Husseini A Huybrechts I Inoue M Islami F Jakovljevic M James S Javanbakht M Jee S H Kasaeian A Kedir M S Khader Y S Khang Y H Kim D Leigh J Linn S Lunevicius R El Razek HMA Malekzadeh R Malta D C Marcenes W Markos D Melaku Y A Meles K G Mendoza W Mengiste D T Meretoja T J Miller T R Mohammad K A Mohammadi A Mohammed S Moradi-Lakeh M Nagel G Nand D Q Le Nguyen Nolte S Ogbo F A Oladimeji K E Oren E Pa M Park E K Pereira D M Plass D Qorbani M Radfar A Rafay A Rahman M Rana S M Søreide K Satpathy M Sawhney M Sepanlou S G Shaikh M A She J Shiue I Shore H R Shrime M G So S Soneji S Stathopoulou V Stroumpoulis K Sufiyan M B Sykes B L Tabarés-Seisdedos R Tadese F Tedla B A Tessema G A Thakur J S Tran B X Ukwaja K N BSC Uzochukwu Vlassov Weiderpass E Wubshet Terefe M Yebyo H G Yimam H H Yonemoto N Younis M Z Yu C Zaidi Z MES Zaki Zenebe Z M CJL Murray Naghavi M Global Burden of Disease Cancer Collaboration, Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups 2017 3 4 524 548 10.1001/jamaoncol.2016.5688 27918777 CancerWHO2018Health Topics12 Available from: https://www.who.int/news-room/fact-sheets/detail/cancer Mohiuddin A K Non-drug pain management: opportunities to explore. BiomedGrid LLC,USA 2019 Bray F Ferlay J Soerjomataram I Siegel R L Torre L A Jemal A Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries 2018 CA Cancer Nov;68(6): 394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. PubMed PMID: 30207593 10.3322/caac.21492 30207593 Rawla P Barsouk A Epidemiology of gastric cancer: global trends, risk factors and prevention Prz Gastroenterol Epub 2018 Nov 28. Review. PubMed PMID: 30944675; PubMed Central PMCID: PMC6444111 14 1 26 38 10.5114/pg.2018.80001 30944675 Rawla P Sunkara T Gaduputi V Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors 2019 Feb;10(1): 10-27. doi: 10.14740/wjon1166. Epub 2019 Feb 26. Review. PubMed PMID: 30834048; PubMed Central PMCID: PMC6396775 World 10.14740/wjon1166 30834048 Moradi A Zamani M Moudi E A systematic review and meta-analysis on incidence of prostate cancer in Iran. Health Promot Perspect 2019 10.15171/hpp.2019.13. eCollection 2019. Review. PubMed PMID: 31249795; PubMed Central PMCID: PMC6588804 9 2 92 98 10.15171/hpp.2019.13 31249795 Rawla P Epidemiology of Prostate Cancer 2019 Apr;10(2): 63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20. Review. PubMed PMID: 31068988; PubMed Central PMCID: PMC6497009 World 10.14740/wjon1191 31068988 Waks A G Winer E P Breast Cancer Treatment: A Review 2019 10.1001/jama.2018.19323. Review. PubMed PMID: 321 3 288 300 JAMA 10.1001/jama.2018.19323 30667505 Malvezzi M Carioli G Bertuccio P Boffetta P Levi F La Vecchia C Negri E European cancer mortality predictions for the year 2019 with focus on breast cancer. Ann Oncol 2019 10.1093/annonc/mdz051. PubMed PMID: 30 5 781 787 10.1093/annonc/mdz051 30887043 Miller K D Nogueira L Mariotto A B Rowland J H Yabroff K R Alfano C M Jemal A Kramer J L Siegel R L Cancer treatment and survivorship statistics 2019 CA Cancer 31184787 10.3322/caac.21565 31184787 DeSantis C E Miller K D Goding Sauer A Jemal A Siegel R L Cancer statistics for African Americans 2019 CA Cancer May;69(3): 211-233. doi: 10.3322/caac.21555. Epub 2019 Feb 14. PubMed PMID: 30762872 10.3322/caac.21555 30762872 Layne T M Graubard B I Ma X Mayne S T Albanes D Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study. Prostate Cancer Prostatic Dis 2019 22 1 91 100 10.1038/s41391-018-0070-9 30108373 Ghose S Radhakrishnan V Bhattacharya S Ethics of cancer care: beyond biology and medicine Ecancermedicalscience. 2019 Mar 28;13: 911. doi: 10.3332/ecancer.2019.911. eCollection 2019. Review. PubMed PMID: 31123494; PubMed Central PMCID: PMC6467456 10.3332/ecancer.2019.911 31123494 AllcottNDunhamLLevyDCarrJStitzenbergKFinancial burden amongst cancer patients treated with curative intent surgery alone2019Am2183452456 doi: 10.1016/j.amjsurg.2019.01.033. (Epub ahead of print) PubMed PMID: 10.1016/j.amjsurg.2019.01.03330771864 Coumoundouros C Ould Brahim L Lambert S D McCusker J The direct and indirect financial costs of informal cancer care: A scoping review. Health Soc Care Community 2019 31293013 10.1111/hsc.12808 31293013 WHO46 billion in productivity lost to cancer in major emerging economies.Presse Release201831 Available From: https://www.iarc.fr/wp-content/uploads/2018/07/pr255_E.pdf WorldCancer Day Available From: https://www.worldcancerday.org/financial-and-economic-impact ScreeningPDQPreventionEditorial BoardCancer Prevention Overview (PDQ®): Health Professional Version2019PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); Available from: https://www.ncbi.nlm.nih.gov/books/NBK66016/ Sung H Siegel R L Rosenberg P S Jemal A Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health 2019 Epub 2019 Feb 4. PubMed PMID: 4 3 137 147 10.1016/S2468-2667(18)30267-6 30733056 Park B You S WCS Cho Choi J Y Lee M S A systematic review of herbal medicines for the treatment of cancer cachexia in animal models 2019 J Zhejiang Univ Sci Jan.;20(1): 9-22. doi: 10.1631/jzus.B1800171. Review. PubMed PMID: 30614226; PubMed Central PMCID: PMC6331334 10.1631/jzus.B1800171 30614226 ZhangQTraditional and Complementary Medicine in Primary Health Care2015Health For All:The Journey of Universal Health Coverage. Hyderabad (IN): Orient Blackswan. Chapter 12. Available from: https://www.ncbi.nlm.nih.gov/books/NBK316267/ In: Medcalf A, Bhattacharya S, Momen H, et al, editors Mawoza T Nhachi C Magwali T Prevalence of Traditional Medicine Use during Pregnancy, at Labour and for Postpartum Care in a Rural Area in Zimbabwe. Clinics in mother and child health 2019 16 2 321 10 10.24105/2090-7214.16.321 Krupa J Sureshkumar J Silambarasan R Priyadarshini K Ayyanar M Integration of traditional herbal medicines among the indigenous communities in Thiruvarur District of Tamil Nadu 2019 India. Journal of Ayurveda and integrative medicine 10 1 32 37 10.1016/j.jaim.2017.07.013 Wode K Henriksson R Sharp L Stoltenberg A Hök Nordberg J Cancer patients&apos; use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med 2019 PubMed PMID: 30866916; PubMed Central PMCID: PMC6417272 19 1 62 10 10.1186/s12906-019-2452-5 30866916 Jermini M Dubois J Rodondi P Y Zaman K Buclin T Csajka C Orcurto A E Rothuizen L Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci Rep 2019 PubMed PMID: 30911084; PubMed Central PMCID: PMC6434040 9 1 1 11 10.1038/s41598-019-41532-3 30911084 Kwon J H Lee S C Lee M A Kim Y J Kang J H Kim J Y Lee H J Bae W K Kim M J Chie E K Kim J Kim Y H Chung H C Rha S Y Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients. Cancer Res Treat. 2019 Jul;51(3): 851-860. doi: 10.4143/crt.2019.137. Epub 2019 Jun 7. PubMed PMID: 31208165; PubMed Central PMCID: PMC6639220 10.4143/crt.2019.137 31208165 Jones E Nissen L McCarthy A Steadman K Windsor C Exploring the Use of Complementary and Alternative Medicine in Cancer Patients. Integr Cancer Ther 2019 Jan-Dec;18: 1534735419854134. doi: 10.1177/1534735419854134. PubMed PMID: 31170844; PubMed Central PMCID: PMC6557018 10.1177/1534735419854134 31170844 Chotipanich A Sooksrisawat C Jittiworapan B Association between complementary and alternative medicine use and prolonged time to conventional treatment among Thai cancer patients in a tertiary-care hospital. PeerJ 2019 14;7:e7159. doi: 10.7717/peerj.7159. eCollection 2019. PubMed PMID: 31231600; PubMed Central PMCID: PMC6573806 10.7717/peerj.7159 31231600 Ekor M The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014 10;4: 177. doi: 10.3389/fphar.2013.00177. eCollection 2014 Jan 10. Review. PubMed PMID: 24454289; PubMed Central PMCID: PMC3887317 10.3389/fphar.2013.00177 24454289 Haefeli W E Carls A Drug interactions with phytotherapeutics in oncology. Expert Opin Drug Metab Toxicol 2014 Epub 2014 Jan 6. Review. PubMed PMID: 10 3 359 77 10.1517/17425255.2014.873786 24387348 Kabat G Why Resorting to Alternative Medicine To Treat Cancer Is A Bad Idea 2018 Forbes Caraceni A Shkodra M Cancer Pain Assessment and Classification. Cancers 2019 E510. doi: 10.3390/cancers11040510. Review. PubMed PMID: 30974857; PubMed Central PMCID: PMC6521068 11 4 (Basel) 10.3390/cancers11040510 30974857 E510 Derry S Wiffen P J Moore R A McNicol E D Bell R F Carr D B McIntyre M Wee B Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults Cochrane Database Syst Rev. 2017 Jul 12;7: CD012638. doi: 10.1002/14651858.CD012638.pub2. Review. PubMed PMID: 28700091; PubMed Central PMCID: PMC6369931 10.1002/14651858.CD012638.pub2 28700091 BennettM IKaasaSBarkeAKorwisiBRiefWTreede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic cancer-related2019 Review. PubMed PMID: 30586069 1601384410.1097/j.pain.000000000000136330586069 Asthana R Goodall S Lau J Zimmermann C Diaz P L Wan A B Chow E De Angelis C. Framing of the opioid problem in cancer pain management in Canada. Curr Oncol 2019 Jun;26(3):e410-e413. doi: 10.3747/co.26.4517. Epub 2019 Jun 1. PubMed PMID: 31285686; PubMed Central PMCID: PMC6588080 10.3747/co.26.4517 31285686 Johnson M Collett B Castro-Lopes J M The challenges of pain management in primary care: a pan-European survey. J Pain Res 2013 22;6: 393-401. doi: 10.2147/JPR.S41883. Print 2013. PubMed PMID: 23723719; PubMed Central PMCID: PMC3666876 10.2147/JPR.S41883 23723719 Jones M R Viswanath O Peck J Kaye A D Gill J S Simopoulos T T A Brief History of the Opioid Epidemic and Strategies for Pain Medicine 2018 Pain Ther 7 1 13 21 10.1007/s40122-018-0097-6 29691801 OelhafR CAzadfardMToxicityKum B OpioidIn:StatPearls Internet. Treasure Island (FL):StatPearls Publishing;2019 Available from: https://www.ncbi.nlm.nih.gov/books/NBK431077/ Gallagher R New category of opioid-related death. Can Fam Physician 2018 Feb;64(2): 95-96. PubMed PMID: 29449232; PubMed Central PMCID: PMC5964377 29449232 Roland C L Ye X Stevens V Oderda G M The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning. J Manag Care Spec Pharm 2019 Jan;25(1): 18-27. doi: 10.18553/jmcp.2019.25.1.018. PubMed PMID: 30589633 10.18553/jmcp.2019.25.1.018 30589633 ShahMHueckerM ROpioid Withdrawal In: StatPearls [Internet]. Treasure Island (FL):2019StatPearls Publishing; Available from:https://www.ncbi.nlm.nih.gov/books/NBK526012/ Magee D J Jhanji S Poulogiannis G Farquhar-Smith P MRD Brown Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence 2019 Br Aug;123(2):e412-e423. doi: 10.1016/j.bja.2019.02.028. Epub 6676054 10.1016/j.bja.2019.02.028 31122736 RSY Wong Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Adv Pharmacol Sci 2019 eCollection 2019. Review. PubMed PMID: 30838040; PubMed Central PMCID: PMC6374867 31 3418975 10 10.1155/2019/3418975 30838040 Cuomo A Bimonte S Forte C A Botti G Cascella M Multimodal approaches and tailored therapies for pain management: the trolley analgesic model. J Pain Res 2019 19 711 714 10.2147/JPR.S178910 30863143 Nair A S Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain. Indian J Palliat Care 2019 Jan-Mar;25(1): 164-165. doi: 10.4103/IJPC.IJPC_143_18. PubMed PMID: 30820123; PubMed Central PMCID: PMC6388596 10.4103/IJPC.IJPC_143_18 30820123 Wongrakpanich S Wongrakpanich A Melhado K Rangaswami J A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis 2018 10.14336/AD.2017.0306. eCollection 2018 Feb. Review. PubMed PMID: 29392089; PubMed Central PMCID: PMC5772852 9 1 143 150 10.14336/AD.2017.0306 29392089 Brasky T M Bonner M R Moysich K B Ambrosone C B Nie J Tao M H Edge S B Kallakury B V Marian C Goerlitz D S Trevisan M Shields P G Freudenheim J L Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 2011 22 7 965 75 10.1007/s10552-011-9769-9 21516318 Choueiri T K Je Y Cho E Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies 2014 Int 10.1002/ijc.28093. Epub 2013 Sep 23. PubMed PMID: 23400756; PubMed Central PMCID: PMC3815746 134 2 384 96 10.1002/ijc.28093 23400756 Byars T Theisen E Bolton D L Using Cannabis to Treat Cancer-Related Pain. Semin Oncol Nurs 2019 Jun;35(3): 300-309. doi: 10.1016/j.soncn.2019.04.012. Epub 2019 Apr 30. Review. PubMed PMID: 31053395 10.1016/j.soncn.2019.04.012 31053395 Dzierżanowski T Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence. Cancers 2019 pii: E129. doi: 10.3390/cancers11020129. Review. PubMed PMID: 30678303; PubMed Central PMCID: PMC6406915 11 2 (Basel) 10.3390/cancers11020129 30678303 E129 Carr Daniel Schatman Michael Cannabis for Chronic Pain: Not Ready for Prime Time.” 2019 American Journal of Public Health 109 1 50 51 10.2105/AJPH.2018.304593 Sharafi G He H Nikfarjam M Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer. J Pancreat Cancer 2019 10.1089/pancan.2018.0019. eCollection 2019. Review. PubMed PMID: 30706048; PubMed Central PMCID: PMC6352507 5 1 1 7 10.1089/pancan.2018.0019 30706048 CampbellGStockingsENielsenSUnderstanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. Eur Arch Psychiatry Clin Neurosci2019 11. Review. PubMed PMID: 269113514410.1007/s00406-018-0960-930635715 Stockings E Campbell G Hall W D Nielsen S Zagic D Rahman R Murnion B Farrell M Weier M Degenhardt L Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies Pain. 2018 Oct;159(10): 1932-1954. doi: 10.1097/j.pain.0000000000001293. PubMed PMID: 29847469 10.1097/j.pain.0000000000001293 29847469 Wang J Wang Y Tong M Pan H Li D New Prospect for Cancer Cachexia: Medical 2019 10.7150/jca.28246. eCollection 2019. Review. PubMed PMID: 30719170; PubMed Central PMCID: PMC6360413 10 3 716 720 10.7150/jca.28246 30719170 Turgeman I Bar-Sela G Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opin Investig Drugs 2019 Epub 2018 Dec 29. Review. PubMed PMID: 28 3 285 296 10.1080/13543784.2019.1561859 30572744 Urits I Borchart M Hasegawa M Kochanski J Orhurhu V Viswanath O An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. Pain Ther 2019 Epub 2019 Feb 5. Review. PubMed PMID: 30721403; PubMed Central PMCID: PMC6514017 8 1 41 51 10.1007/s40122-019-0114-4 30721403 Lossignol D Cannabinoids: a new approach for pain control? Curr Opin Oncol 2019 Jul;31(4): 275-279. doi: 10.1097/CCO.0000000000000523. PubMed PMID: 30789867 10.1097/CCO.0000000000000523 30789867 SteeleGArnesonTZyllaDA Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. Curr Oncol Rep2019 Review. PubMed PMID: 30707319 21111010.1007/s11912-019-0757-730707319 Mead A Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States. Front Plant Sci 2019 14;10: 697. doi: 10.3389/fpls.2019.00697. eCollection 2019. Review. PubMed PMID: 31263468; PubMed Central PMCID: PMC6590107 10.3389/fpls.2019.00697 31263468 Shi S Brant A R Sabolch A Pollom E False News of a Cannabis Cancer Cure. Cureus 2019 doi: 10.7759/cureus.3918. PubMed PMID: 30931189; PubMed Central PMCID: PMC6426557 10.7759/cureus.3918 30931189 Wilkinson S T Medical and recreational marijuana: commentary and review of the literature. Mo Med 2013 Nov-Dec;110(6): 524-8. Review. PubMed PMID: 24564006; PubMed Central PMCID: PMC6179811 24564006 Boehnke K F Gangopadhyay S Clauw D J Haffajee R L Qualifying Conditions Of Medical Cannabis License Holders In The United States. Health Aff (Millwood) 2019 Feb;38(2): 295-302. doi: 10.1377/hlthaff.2018.05266. Erratum in: Health Aff (Millwood). 2019 Mar;38(3): 511. PubMed PMID: 30715980; PubMed Central PMCID: PMC6398594 10.1377/hlthaff.2018.05266 30715980 Stuyt E The Problem with the Current High Potency THC Marijuana from the Perspective of an Addiction Psychiatrist. Mo Med 2018 Nov-Dec;115(6): 482-486. PubMed PMID: 30643324; PubMed Central PMCID: PMC6312155 30643324 KansagaraDO&apos;NeilMNugentSBenefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review [Internet]. Washington (DC): Department of Veterans Affairs (US);2017 RESULTS. Available from:https://www.ncbi.nlm.nih.gov/books/NBK476452/ Pacula R L Smart R Medical Marijuana and Marijuana Legalization. Annu Rev Clin Psychol 2017 Review. PubMed PMID: 28482686; PubMed Central PMCID: PMC6358421 8 397 419 10.1146/annurev-clinpsy-032816-045128 28482686 Dariš B Tancer Verboten M Knez Ž Ferk P Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci 2019 10.17305/bjbms.2018.3532. Review. PubMed PMID: 30172249; PubMed Central PMCID: PMC6387667 19 1 14 23 10.17305/bjbms.2018.3532 30172249 Gonçalves J Rosado T Soares S Simão A Y Caramelo D Luís  Fernández N Barroso M Gallardo E Duarte A P Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. Medicines (Basel) 2019 10.3390/medicines6010031. Review. PubMed PMID: 30813390; PubMed Central PMCID: PMC6473697. 6(1) 31 10.3390/medicines6010031 30813390 E31 Cooke A C Knight K R Miaskowski C Patients&apos; and clinicians&apos; perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care Int J Drug Policy. 2019 Jan;63: 23-28. doi: 10.1016/j.drugpo.2018.09.002. Epub 2018 Nov 23. PubMed PMID: 30472467; PubMed Central PMCID: PMC6353665 10.1016/j.drugpo.2018.09.002 30472467 Huang M Y Zhang L L Ding J Lu J J Anticancer drug discovery from Chinese medicinal herbs. Chin Med.13(35): 1-9. eCollection Review. PubMed PMID: 29997684; PubMed Central PMCID: 2018 6031194 10 10.1186/s13020-018-0192-y 29997684 Li K Giustini D Seely D A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy. Curr Oncol 2019 Apr;26(2):e147-e154. doi: 10.3747/co.26.4261. Epub 2019 Apr 1. PubMed PMID: 31043820; PubMed Central PMCID: PMC6476456 10.3747/co.26.4261 31043820 Chou H L Chao T Y Chen T C Chu C M Hsieh C H Lin L I Yao C T Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients 2019 Eur J Pharmacol 10.1016/j.ejphar.2019.01.011. Epub 846 38 48 10.1016/j.ejphar.2019.01.011 30658113 Bonhof C S LV van de Poll-Franse PAJ Vissers Wasowicz D K Wegdam J A Révész D Vreugdenhil G Mols F Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry. Psychooncology 2019 31293046 10.1002/pon.5176 31293046 Chui P L Cancer and Chemotherapy-Related Symptoms and the Use of Complementary and Alternative Medicine 2019 Asia Pac J Oncol Nurs. Jan-Mar; 10.4103/apjon.apjon_51_18. PubMed PMID: 30599008; PubMed Central PMCID: PMC6287385 6 1 4 6 10.4103/apjon.apjon_51_18 30599008 Munzone E Bagnardi V Campennì G Mazzocco K Pagan E Tramacere A Masiero M Iorfida M Mazza M Montagna E Cancello G Bianco N Palazzo A Cardillo A Dellapasqua S Sangalli C Pettini G Pravettoni G Colleoni M Veronesi P Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 2019 Br 121 4 325 331 10.1038/s41416-019-0520-8 31303642 Hain B A Xu H Wilcox J R Mutua D Waning D L Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia JCSM Rapid Commun. 2019 Jan-Jun;2(1). pii: e00075. PubMed PMID: 31032492; PubMed Central PMCID: PMC6481302 31032492 e00075 Dy S M Isenberg S R Al Hamayel NA Palliative Care for Cancer Survivors. Med Clin North Am 2017 Nov;101(6): 1181-1196. doi: 10.1016/j.mcna.2017.06.009. Review. PubMed PMID: 28992862; PubMed Central PMCID: PMC6467511 10.1016/j.mcna.2017.06.009 28992862 Lee Y H Spiritual Care for Cancer Patients. Asia Pac J Oncol Nurs 2019 Apr-Jun;6(2): 101-103. doi: 10.4103/apjon.apjon_65_18. PubMed PMID: 30931352; PubMed Central PMCID: PMC6371666 10.4103/apjon.apjon_65_18 30931352 Karim L Palliative Care: the new healthcare frontier. The daily Star 2019 Mohiuddin A K Community and Clinical Pharmacists in Transition Care Glob J Pharmaceu Sci 7 2 555706 10 10.19080/GJPPS.2019.06.555706 Khan H Saeedi M Nabavi S M Mubarak M S Bishayee A Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs 2019 Curr Med Chem Review. PubMed PMID: 26 13 2389 2406 10.2174/0929867325666180403145137 29611474 Kuruppu A I Paranagama P Goonasekara C L Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka. Saudi Pharm J 2019 May;27(4): 565-573. doi: 10.1016/j.jsps.2019.02.004. Epub 2019 Feb 7. Review. PubMed PMID: 31061626; PubMed Central PMCID: PMC6488922 10.1016/j.jsps.2019.02.004 31061626 Tuama A A Mohammed A A Phytochemical screening and in vitro antibacterial and anticancer activities of the aqueous extract of Cucumis sativus 2019 Saudi J Biol Sci Mar;26(3): 600-604. doi: 10.1016/j.sjbs.2018.07.012. Epub 2018 Jul 31. PubMed PMID: 30899178; PubMed Central PMCID: PMC6408718 10.1016/j.sjbs.2018.07.012 30899178 AML Seca DCGA Pinto Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int J Mol Sci 2018 pii: E263. doi: 10.3390/ijms19010263. Review. PubMed PMID: 29337925; PubMed Central PMCID: PMC5796209 19 1 10.3390/ijms19010263 29337925 E263 Alves-Silva J M Romane A Efferth T Salgueiro L North African Medicinal Plants Traditionally Used in Cancer Therapy. Front Pharmacol 2017 26;8: 383. doi: 10.3389/fphar.2017.00383. eCollection 2017. Review. PubMed PMID: 28694778; PubMed Central PMCID: PMC5483438 10.3389/fphar.2017.00383 28694778 Tariq A Sadia S Pan K Ullah I Mussarat S Sun F Abiodun O O Batbaatar A Li Z Song D Xiong Q Ullah R Khan S Basnet B B Kumar B Islam R Adnan M A systematic review on ethnomedicines of anti-cancer plants. Phytother Res 2017 Feb;31(2): 202-264. doi: 10.1002/ptr.5751. Epub 2017 Jan 17. Review. PubMed PMID: 28093828 10.1002/ptr.5751 28093828 Gezici S Şekeroğlu N Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents. Anticancer Agents Med Chem PubMed PMID: 19 1 101 111 10.2174/1871520619666181224121004 30582485 Lichota A Gwozdzinski K Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int J Mol Sci 2018 9;19(11). pii: E3533. doi: 10.3390/ijms19113533. Review. PubMed PMID: 30423952; PubMed Central PMCID: PMC6275022 10.3390/ijms19113533 30423952 E3533 Mushtaq S Abbasi B H Uzair B Abbasi R Natural products as reservoirs of novel therapeutic agents. EXCLI J 2018 Review. PubMed PMID: 29805348; PubMed Central PMCID: PMC5962900 4 420 451 10.17179/excli2018-1174 29805348 Dutt R Garg V Khatri N Madan A K Phytochemicals in Anticancer Drug Development Anticancer Agents Med Chem PubMed PMID: 19 2 172 183 10.2174/1871520618666181106115802 30398123 Qi F Zhao L Zhou A Zhang B Li A Wang Z Han J The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends 2015 Feb;9(1): 16-34. doi: 10.5582/bst.2015.01019. Review. PubMed PMID: 25787906 10.5582/bst.2015.01019 25787906 Wong W Chen B Z AKY Lee AHC Chan JCY Wu Lin Z Chinese Herbal Medicine Effectively Prolongs the Overall Survival of Pancreatic Cancer Patients: A Case Series 2019 Integr Cancer Ther PubMed PMID: 30791742; PubMed Central PMCID: PMC6432679 18 1 1 8 10.1177/1534735419828836 30791742 Jiao L Xu J Sun J Chen Z Gong Y Bi L Lu Y Yao J Zhu W Hou A Feng G Jia Y Shen W Li Y Zhang Z Chen P Xu L Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Front Pharmacol. 2019 Jul 2;10: 732. doi: 10.3389/fphar.2019.00732. eCollection 2019. PubMed PMID: 31333456; PubMed Central PMCID: PMC6614728 10.3389/fphar.2019.00732 31333456 Shen S Jiang S Chinese herbal medicines of supplementing Qi and nourishing Yin combined with chemotherapy for non-small cell lung cancer: A meta-analysis and systematic review. J Cell Biochem 2019 Jun;120(6): 8841-8848. doi: 10.1002/jcb.28192. Epub 2019 Feb 7. PubMed PMID: 30730073 10.1002/jcb.28192 30730073 Wu J Liu Y Fang C Zhao L Lin L Lu L Traditional Chinese Medicine Preparation Combined Therapy May Improve Chemotherapy Efficacy: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2019 1 8 10.1155/2019/5015824 31320914 Ma Z Fan Y Wu Y Kebebe D Zhang B Lu P Pi J Liu Z Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment 2019 Int J Nanomedicine. Mar22; 14 2029 2053 10.2147/IJN.S197889 30962686 So T H Chan S K Lee V H Chen B Z Kong F M Lao L X Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West? Clin Oncol (R Coll Radiol) 2019 Aug;31(8): 578-588. doi: 10.1016/j.clon.2019.05.016. Epub 2019 Jun 6. PubMed PMID: 31178347 10.1016/j.clon.2019.05.016 31178347 Gong Y Xu Z Jin C Deng H Wang Z Zhou W Zhang M Zhao X Wang L Treatment of Advanced Non-small-Cell Lung Cancer with Qi-Nourishing Essence-Replenishing Chinese Herbal Medicine Combined with Chemotherapy. Biol Proced Online 2018 20 9 1 7 10.1186/s12575-018-0074-9 29618954 Jiao L Bi L Lu Y Wang Q Gong Y Shi J Xu L Cancer chemoprevention and therapy using chinese herbal medicine. Biol Proced Online 2018 Jan8 Review. PubMed PMID: 29321719; PubMed Central PMCID: PMC5757296 20 1 1 14 10.1186/s12575-017-0066-1 29321719 Yue G G Lee J K Chan B C Kwok H F Hoi S W Sze D M Fung K P Leung P C Lau C B An innovative anti-cancer Chinese herbal formula exhibited multi-targeted efficacies in metastatic breast cancer mouse model. Chin Med 2018 Dec22 13 64 1 12 10.1186/s13020-018-0222-9 30598693 Aghajanpour M Nazer M R Obeidavi Z Akbari M Ezati P Kor N M Functional foods and their role in cancer prevention and health promotion: a comprehensive review. Am J Cancer Res 2017 Review. PubMed PMID: 28469951; PubMed Central PMCID: PMC5411786 7 4 740 769 28469951 Volpato M Hull M A Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer. Cancer Metastasis Rev 2018 Review. PubMed PMID: 29971573; PubMed Central PMCID: PMC6133177 37 23 545 555 10.1007/s10555-018-9744-y 29971573 Liu J Abdelmagid S A Pinelli C J Monk J M Liddle D M Hillyer L M Hucik B Silva A Subedi S Wood G A Robinson L E Muller W J DWL Ma Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumors. J Nutr Biochem 2018 May;55: 41-52. doi: 10.1016/j.jnutbio.2017.12.011. Epub 2017 Dec 27. PubMed PMID: 29413488 10.1016/j.jnutbio.2017.12.011 29413488 Pacheco B S Dos Santos MAZ Schultze E Martins R M Lund R G Seixas F K Colepicolo P Collares T Paula F R De Pereira CMP. Cytotoxic Activity of Fatty Acids From Antarctic Macroalgae on the Growth of Human Breast Cancer Cells. Front Bioeng Biotechnol 2018 Dec3 6 1 10 10.3389/fbioe.2018.00185 30560124 Teas J Vena S Cone D L Irhimeh M The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle 2013 J Appl Phycol Jun;25(3): 771-779. Epub 2012 Nov 10. PubMed PMID: 23678231; PubMed Central PMCID: PMC3651528 23678231 DHA Rocha AML Seca DCGA Pinto Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity. Mar Drugs 2018 pii: E410. doi: 10.3390/md16110410. Review. PubMed PMID: 30373208; PubMed Central PMCID: PMC6266495 16 11 10.3390/md16110410 30373208 E410 Shreadah M A El Moneam NMA Al-Assar S A Nabil-Adam A Phytochemical and pharmacological screening of Sargassium vulgare from Suez Canal, Egypt. Food Sci Biotechnol 2018 27 4 963 979 10.1007/s10068-018-0323-3 30263825 Shin S A Moon S Y Kim W Y Paek S M Park H H Lee C S Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites Int J Mol Sci. 2018 Sep 6;19(9). pii: E2651. doi: 10.3390/ijms19092651. Review. PubMed PMID: 30200668; PubMed Central PMCID: PMC6163735 10.3390/ijms19092651 30200668 E2651 Bernardini G Minetti M Polizzotto G Biazzo M Santucci A Pro-Apoptotic Activity of French Polynesian Padina pavonica Extract on Human Osteosarcoma Cells. Mar Drugs 2018 13;16(12). pii: E504. doi: 10.3390/md16120504. PubMed PMID: 30551628; PubMed Central PMCID: PMC6316765 10.3390/md16120504 30551628 E504 Stonik V A Fedorov S N Marine low molecular weight natural products as potential cancer preventive compounds. Mar Drugs 2014 10.3390/md12020636. Review. PubMed PMID: 24473167; PubMed Central PMCID: PMC3944507 12 2 636 71 10.3390/md12020636 24473167 Kooti W Servatyari K Behzadifar M Asadi-Samani M Sadeghi F Nouri B Zare Marzouni H Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study 2017 J Evid Based Complementary Altern Med Epub 2017 Mar 31. Review. PubMed PMID: 28359161; PubMed Central PMCID: PMC5871268 22 4 982 995 10.1177/2156587217696927 28359161 A F Wali Majid S Rasool S Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer Saudi Pharmaceutical Journal,https://doi.org/10.1016/j.jsps.2019.04.013 Shree T J Poompavai S SMFM Begum Gowrisree V Hemalatha S Cancer-Fighting Phytochemicals: Another Look 2019 J Nanomedine Biotherapeutic Discov 9 1 1 7 10.4172/2155-983X.1000162 Smith R A Andrews K S Brooks D Fedewa S A Manassaram-Baptiste D Saslow D Brawley O W Wender R C Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening 2017 CA Cancer Mar;67(2): 100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7. PubMed PMID: 28170086 10.3322/caac.21392 28170086 Kim S-K Kalimuthu S Chapter 1. Introduction to Anti-cancer Drugs from Marine Origine. In: Se-Kwon Kim 2014 ISBN Handbook of Anticancer Drugs from Marine Origin 3319071459 9783319071459 Publisher: Springer Sun L Yim W S Fahey P Wang S Zhu X Qiao J Lai H Lin L Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data. Evid Based Complement Alternat Med 2019 Jan2, doi: 10.1155/2019/1898345. eCollection 2019. PubMed PMID: 30719055; PubMed Central PMCID: PMC6334362 10.1155/2019/1898345 30719055 Abdelaziz H M Elzoghby A O Helmy M W Samaha M W Fang J Y Freag M S Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells Int J Nanomedicine. 2019 Jan11; 14 499 517 10.2147/IJN.S188335 30666110 Blandin Knight S Crosbie P A Balata H Chudziak J Hussell T Dive C Progress and prospects of early detection in lung cancer. Open Biol 2017 Sep;7(9). pii: 170070. doi: 10.1098/rsob.170070. Review. PubMed PMID: 28878044; PubMed Central PMCID: PMC5627048 10.1098/rsob.170070 28878044 170070 Zappa C Mousa S A Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res 2016 Jun;5(3): 288-300. doi: 10.21037/tlcr.2016.06.07. Review. PubMed PMID: 27413711; PubMed Central PMCID: PMC4931124 10.21037/tlcr.2016.06.07 27413711 Lin C K Lin R T Chen T Zigler C Wei Y Christiani D C A global perspective on coal-fired power plants and burden of lung cancer. Environ Health 2019 Jan28 PubMed PMID: 30691464; PubMed Central PMCID: PMC6350330 18 9 1 11 10.1186/s12940-019-0448-8 30691464 Alberg A J Brock M V Ford J G Samet J M Spivack S D Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2013 May;143(5 Suppl):e1S-e29S. doi: 10.1378/chest.12-2345. Review. PubMed PMID: 23649439; PubMed Central PMCID: PMC4694610 10.1378/chest.12-2345 23649439 Sulé-Suso J Watson N A van Pittius DG Jegannathen A Striking lung cancer response to self-administration of cannabidiol: A case report and literature review SAGE Open Med Case Rep. 2019 Feb 21;7: 2050313X19832160. doi: 10.1177/2050313X19832160. eCollection 2019. PubMed PMID: 30815264; PubMed Central PMCID: PMC6385325 10.1177/2050313X19832160 30815264 Myneni A A Chang S C Niu R Liu L Swanson M K Li J Su J Giovino G A Yu S Zhang Z F Mu L Raw Garlic Consumption and Lung Cancer in a Chinese Population. Cancer Epidemiol Biomarkers Prev 2016 25 4 624 33 10.1158/1055-9965.EPI-15-0760 26809277 Jin Z Y Wu M Han R Q Zhang X F Wang X S Liu A M Zhou J Y Lu Q Y Zhang Z F Zhao J K Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population. Cancer Prev Res (Phila) 2013 6 7 711 8 10.1158/1940-6207.CAPR-13-0015 23658367 Lin Y Cai L Environmental and dietary factors and lung cancer risk among Chinese women: a case-control study in southeast China. Nutr Cancer 2012 Epub 2012 Apr 10. PubMed PMID: 64 4 508 14 10.1080/01635581.2012.668743 22489989 MohammadPNosratollahZMohammadRAbbasAJavadRThe inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line2017Afr J Biotechnol96 http://www.ajol.info/index.php/ajb/article/view/78098. Accessed Valiahdi S M Iranshahi M Sahebkar A Cytotoxic activities of phytochemicals from Ferula species 2013 May23 PubMed PMID: 23701832; PubMed Central PMCID: PMC3671137 21 39 1 7 Daru 10.1186/2008-2231-21-39 23701832 Wu C Y Ke Y Zeng Y F Zhang Y W Yu H J Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells. Cancer Cell Int 2017 Dec4 PubMed PMID: 29225515; PubMed Central PMCID: PMC5716001 17 115 1 9 10.1186/s12935-017-0487-6 29225515 Guo L Bai S P Zhao L Wang X H Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival. Med Oncol 2012 29 3 1656 62 10.1007/s12032-011-0068-9 21928106 McCullochMSeeCShuX JBroffmanMKramerAFanW YGaoJLiebWShiehKColfordJM JrAstragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol200624341930 PubMed PMID: 16421421 Li H Hung A Li M AWH Yang Fritillariae Thunbergii Bulbus: Traditional Uses, Phytochemistry, Pharmacodynamics, Pharmacokinetics and Toxicity Int J Mol Sci. 2019 Apr 3;20(7). pii: E1667. doi: 10.3390/ijms20071667. Review. PubMed PMID: 30987173; PubMed Central PMCID: PMC6479889 10.3390/ijms20071667 30987173 E1667 Li T Chen X Chen X Ma D L Leung C H Lu J J Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells. Sci Rep 2016 29;6: 37997. doi: 10.1038/srep37997. PubMed PMID: 27897231; PubMed Central PMCID: PMC5126555 10.1038/srep37997 27897231 Yim N H Hwang Y H Liang C Ma J Y A platycoside-rich fraction from the root of Platycodon grandiflorum enhances cell death in A549 human lung carcinoma cells via mainly AMPK/mTOR/AKT signal-mediated autophagy induction J Ethnopharmacol. 2016 Dec 24;194: 1060-1068. doi: 10.1016/j.jep.2016.10.078. Epub 2016 Oct 27. PubMed PMID: 27989873 10.1016/j.jep.2016.10.078 27989873 Platycodin D a bioactive component of Platycodon grandiflorum, induces cancer cell death associated with extreme vacuolation. Anim Cells Syst (Seoul) 2019 23 2 118 127 10.1080/19768354.2019.1588163 30949399 Huang M Y Jiang X M Xu Y L Yuan L W Chen Y C Cui G Huang R Y Liu B Wang Y Chen X Lu J J Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells. Food Chem Toxicol 2019 Sep;131: 110537. doi: 10.1016/j.fct.2019.05.045. Epub 31150782 10.1016/j.fct.2019.05.045 31150782 Lee C T Huang Y W Yang C H Huang K S Drug delivery systems and combination therapy by using vinca alkaloids Curr Top Med Chem Review. PubMed PMID: 25877096; PubMed Central PMCID: PMC4997956 15 15 1491 500 25877096 Zhang Y Yang S H Guo X L New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer. Biomed Pharmacother 2017 Dec;96: 659-666. doi: 10.1016/j.biopha.2017.10.041. Epub 2017 Nov 6. Review. PubMed PMID: 29035832 10.1016/j.biopha.2017.10.041 29035832 Tagliamento M Genova C Rossi G Coco S Rijavec E Dal Bello MG Boccardo S Grossi F Alama A Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. Expert Opin Investig Drugs 2019 Epub 2019 Jun 7. Review. PubMed PMID: 28 6 513 523 10.1080/13543784.2019.1627326 31159588 Gusella M Pasini F Caruso D Barile C Modena Y Fraccon A P Bertolaso L Menon D Crepaldi G Bononi A Spezzano R Telatin G A Corona G Padrini R Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms. Cancer Chemother Pharmacol 2019 83 3 493 500 10.1007/s00280-018-3751-0 30542768 Jung Y J Lee E H Lee C G Rhee K J Jung W S Choi Y Pan C H Kang K AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo 2017 J Ethnopharmacol. 202: 78 - 84, doi: 10.1016/j.jep.2017.03.010. Epub 2017 Mar 9. PubMed PMID: 28286104 10.1016/j.jep.2017.03.010 28286104 YangS FChuS CLiuS JChenY CChangY ZHsiehY SAntimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in200711034839 PubMed PMID: 17113737 MH Do TT Le Hoang T H Chau V M Nguyen T D Toxicity and anticancer effects of an extract from Selaginella tamariscina on a mice model. Nat Prod Res 2012 Epub 2011 Oct 14. PubMed PMID: 26 12 1130 4 10.1080/14786419.2011.560847 21995305 Magesh V DurgaBhavani K Senthilnathan P Rajendran P Sakthisekaran D In vivo protective effect of crocetin on benzo(a)pyrene-induced lung cancer in Swiss albino mice. Phytother Res 2009 Apr;23(4): 533-9. doi: 10.1002/ptr.2666. PubMed PMID: 19067387 10.1002/ptr.2666 19067387 Samarghandian S Borji A Farahmand S K Afshari R Davoodi S Crocus sativus L. (saffron) stigma aqueous extract induces apoptosis in alveolar human lung cancer cells through caspase-dependent pathways activation. Biomed Res Int 2013 Epub 2013 Oct 29. PubMed PMID: 24288678; PubMed Central PMCID: PMC3830877 1 13 10.1155/2013/417928 24288678 Samarghandian S Tavakkol Afshari J Davoodi S Suppression of pulmonary tumor promotion and induction of apoptosis by Crocus sativus L. extraction. Appl Biochem Biotechnol 2011 164 2 238 47 10.1007/s12010-010-9130-x 21153568 Zhong Y J Shi F Zheng X L Wang Q Yang L Sun H He F Zhang L Lin Y Qin Y Liao L C Wang X Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms. Acta Pharmacol Sin 2011 Dec;32(12): 1529-36. doi: 10.1038/aps.2011.109. Epub 2011 Oct 10. PubMed PMID: 21986580; PubMed Central PMCID: PMC4010206 10.1038/aps.2011.109 21986580 Bhandari P R Crocus sativus L. (saffron) for cancer chemoprevention: A mini review. J Tradit Complement Med 2015 10.1016/j.jtcme.2014.10.009. eCollection 2015 Apr. Review. PubMed PMID: 26151016; PubMed Central PMCID: PMC4488115 5 2 81 7 10.1016/j.jtcme.2014.10.009 26151016 Lin Y J Liang W M Chen C J Tsang H Chiou J S Liu X Cheng C F Lin T H Liao C C Huang S M Chen J Tsai F J Li T M Network analysis and mechanisms of action of Chinese herb-related natural compounds in lung cancer cells Phytomedicine. 2019 May;58: 152893. doi: 10.1016/j.phymed.2019.152893. Epub 2019 Mar 13. PubMed PMID: 30901663 10.1016/j.phymed.2019.152893 30901663 Pajaniradje S Mohankumar K Pamidimukkala R Subramanian S Rajagopalan R Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells. Biomed Res Int 2014 Epub 1 12 10.1155/2014/474953 24949454 Yang C J Huang Y J Wang C Y Wang C S Wang P H Hung J Y Wang T H Hsu H K Huang H W Kumar S P Huang M S Weng C F Antiproliferative and antitumorigenic activity of Toona sinensis leaf extracts in lung adenocarcinoma. J Med Food 2010 Feb;13(1): 54-61. doi: 10.1089/jmf.2009.1166. PubMed PMID: 20136436 10.1089/jmf.2009.1166 20136436 Pinmai K Chunlaratthanabhorn S Ngamkitidechakul C Soonthornchareon N Hahnvajanawong C Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells 2008 PubMed PMID: 18330936; PubMed Central PMCID: PMC2693740 14 10 1491 7 World 18330936 Zhao T Sun Q Marques M Witcher M Anticancer Properties of Phyllanthus emblica (Indian Gooseberry). Oxid Med Cell Longev 2015 Epub 2015 Jun 9. Review. PubMed PMID: 26180601; PubMed Central PMCID: PMC4477227 1 10 1155 10.1155/2015/950890 26180601 Basu T Panja S Ghate N B Chaudhuri D Mandal N Antioxidant and antiproliferative effects of different solvent fractions from Terminalia belerica Roxb. fruit on various cancer cells. Cytotechnology 2017 69 2 201 216 10.1007/s10616-016-0051-6 28004224 Hung J Y Wen C W Hsu Y L Lin E S Huang M S Chen C Y Kuo P L Subamolide a induces mitotic catastrophe accompanied by apoptosis in human lung cancer cells. Evid Based Complement Alternat Med 2013 Epub 1 15 10.1155/2013/828143 23533526 Li G X Chen Y K Hou Z Xiao H Jin H Lu G Lee M J Liu B Guan F Yang Z Yu A Yang C S Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 2010 May;31(5): 902-10. doi: 10.1093/carcin/bgq039. Epub 2010 Feb 16. PubMed PMID: 20159951; PubMed Central PMCID: PMC2864413 10.1093/carcin/bgq039 20159951 Metwaly A M Lianlian Z Luqi H Deqiang D Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects. Molecules 2019 pii: E1856. doi: 10.3390/molecules24101856. Review. PubMed PMID: 31091790; PubMed Central PMCID: PMC6572638 24 10 10.3390/molecules24101856 31091790 E1856 Rosière R Berghmans T P De Vuyst Amighi K Wauthoz N The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses. Cancers (Basel) 2019 7;11(3). pii: E329. doi: 10.3390/cancers11030329. Review. PubMed PMID: 30866545; PubMed Central PMCID: PMC6468657 10.3390/cancers11030329 30866545 E329 Verco J Johnston W Baltezor M Kuehl P J Gigliotti A Belinsky S A Lopez A Wolff R Hylle L diZerega G Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac(®)) in a Rodent Model. J Aerosol Med Pulm Drug Deliv 2019 Apr;32(2): 99-109. doi: 10.1089/jamp.2018.1467. Epub 2018 Oct 25. PubMed PMID: 30359162; PubMed Central PMCID: PMC6477588 10.1089/jamp.2018.1467 30359162 Tan B L Norhaizan M E Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer. Molecules 2019 E2527. doi: 10.3390/molecules24142527. Review. PubMed PMID: 31295906; PubMed Central PMCID: PMC6680685 24 14 10.3390/molecules24142527 31295906 E2527 Lwin Z Riess J W Gandara D The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era. J Thorac Dis 2013 Oct;5 Suppl 5:S556-64. doi: 10.3978/j.issn.2072-1439.2013.08.47. Review. PubMed PMID: 24163748; PubMed Central PMCID: PMC3804876 10.3978/j.issn.2072-1439.2013.08.47 24163748 Europa Scitech Inhaled chemotherapy: a promising solution to treat lung cancer 2018 Health Research News 11 Sapalidis K Zarogoulidis P Huang H Bai C Wen Y Wang L Boniou K Karapantzos I Karapantzou C Karanikas M Thomaidis V Kosmidis C Sardeli C Benhassen N Man Y G Florou M C Mantalovas S Laskou S Giannakidis D Koulouris C Amaniti A Kesisoglou I Hohenforst-Schmidt W Inhaled Immunotherapy Administration for Lung Cancer; Efficient? CertainlyPossible.JCancer. Mar2; 9(6): 1121-1126. doi: 10.7150/jca.24397. eCollection 2018. PubMed PMID: 29581792; PubMed Central PMCID: 2018 5868180 10.7150/jca.24397 29581792 ThafeniM ASayedYMotadiL REuphorbia mauritanica and Kedrostis hirtella extracts can induce anti-proliferative activities in lung cancer cells. Mol Biol Rep201239121078594 PubMed PMID: 10.1007/s11033-012-1972-623086267 Hsu H Y Hwang P A Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy. Clin Transl Med 2019 Review. PubMed PMID: 31041568; PubMed Central PMCID: PMC6491526 8 15 1 18 10.1186/s40169-019-0234-9 31041568 G van Weelden Bobiński M Okła K van Weelden WJ Romano A JMA Pijnenborg Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms. Mar Drugs 2019 pii: E32. doi: 10.3390/md17010032. Review. PubMed PMID: 30621045; PubMed Central PMCID: PMC6356449 17 1 10.3390/md17010032 30621045 E32 Wang Y Xing M Cao Q Ji A Liang H Song S Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies. Mar Drugs 2019 20; 17(3). pii: E183. doi: 10.3390/md17030183. Review. PubMed PMID: 30897733; PubMed Central PMCID: PMC6471298 10.3390/md17030183 30897733 E183 Misra P Singh S Role of cytokines in combinatorial immunotherapeutics of non-small cell lung cancer through systems perspective. Cancer Med 2019 May;8(5): 1976-1995. doi: 10.1002/cam4.2112. Epub 2019 Apr 17. Review. PubMed PMID: 30997737; PubMed Central PMCID: PMC6536974 10.1002/cam4.2112 30997737 Ercolano G P De Cicco Ianaro A New Drugs from the Sea: Pro-Apoptotic Activity of Sponges and Algae Derived Compounds. Mar Drugs 2019 pii: E31. doi: 10.3390/md17010031. Review. PubMed PMID: 30621025; PubMed Central PMCID: PMC6356258 17 1 10.3390/md17010031 30621025 E31 Song J Su H Wang B L Zhou Y Y Guo L L Fish consumption and lung cancer risk: systematic review and meta-analysis Nutr Cancer Epub 2014 Apr 7. Review. PubMed PMID: 66 4 539 49 10.1080/01635581.2014.894102 24707954 Siu F M Ma D L Cheung Y W Lok C N Yan K Yang Z Yang M Xu S Ko B C He Q Y Che C M Proteomic and transcriptomic study on the action of a cytotoxic saponin (Polyphyllin D): induction of endoplasmic reticulum stress and mitochondria-mediated apoptotic pathways. Proteomics 2008 Aug;8(15): 3105-17. doi: 10.1002/pmic.200700829. PubMed PMID: 18615425 10.1002/pmic.200700829 18615425 TakezakiTInoueMKataokaHIkedaSYoshidaMOhashiYTajimaKTominagaSDiet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption2003Nutr Cancer4521607 PubMed PMID: 12881009 Yang P Cartwright C Chan D Ding J Felix E Pan Y Pang J Rhea P Block K Fischer S M Newman R A Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Mol Carcinog. 2014 Jul;53(7): 566-77. doi: 10.1002/mc.22008. Epub 2013 Jan 31. PubMed PMID: 23371504; PubMed Central PMCID: PMC4395033 10.1002/mc.22008 23371504 Daniel C R Cross A J Graubard B I Hollenbeck A R Park Y Sinha R Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila) 2011 4 11 1903 11 10.1158/1940-6207.CAPR-11-0241 21803982 Sun Y Li Z Li J Li Z Han J A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis. Nutrients 2016 4;8(3): 134. doi: 10.3390/nu8030134. Review. PubMed PMID: 26959051; PubMed Central PMCID: PMC4808863 10.3390/nu8030134 26959051 ElisiaIChoBHayMLiM YHofsELamVDyerR ALumJKrystalGThe effect of diet and exercise on tobacco carcinogen-induced lung cancer. Carcinogenesis2019403448460 PubMed PMID: 10.1093/carcin/bgz06030874285 Alsharairi N A The Effects of Dietary Supplements on Asthma and Lung Cancer Risk in Smokers and Non-Smokers: A Review of the Literature 2019 pii: E725. doi: 10.3390/nu11040725. Review. PubMed PMID: 30925812; PubMed Central PMCID: PMC6521315 11 4 Nutrients 10.3390/nu11040725 30925812 E725 Middha P Weinstein S J Männistö S Albanes D Mondul A M β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine. Nicotine Tob Res 2019 10.1093/ntr/nty115. PubMed PMID: 29889248; PubMed Central PMCID: PMC6636175 21 8 1045 1050 10.1093/ntr/nty115 29889248 Narita S Saito E Sawada N Shimazu T Yamaji T Iwasaki M Ishihara J Takachi R Shibuya K Inoue M Tsugane S; JPHC Study Group. Dietary consumption of antioxidant vitamins and subsequent lung cancer risk: The Japan Public Health Center-based prospective study 2018 Int Epub 2018 Jan 31. PubMed PMID: 142 12 2441 2460 10.1002/ijc.31268 29355932 SealockTSharmaSSmoking Cessation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2019 Available from:https://www.ncbi.nlm.nih.gov/books/NBK482442/ Steliga M A Yang P Integration of smoking cessation and lung cancer screening. Transl Lung Cancer Res 2019 May;8(Suppl 1):S88-S94. doi: 10.21037/tlcr.2019.04.02. Review. PubMed PMID: 31211109; PubMed Central PMCID: PMC6546623 10.21037/tlcr.2019.04.02 31211109 Taylor K L Deros D E Fallon S Stephens J Kim E Lobo T Davis K M Luta G Jayasekera J Meza R Stanton C A Niaura R S Abrams D B McKee B Howell J Ramsaier M Batlle J Dornelas E Parikh V Anderson E Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial. Contemp Clin Trials 2019 Jul;82: 25-35. doi: 10.1016/j.cct.2019.05.006. Epub 6657688 10.1016/j.cct.2019.05.006 31129371 Robbins S L Kumar V Cotran R S Robbins and Cotran Pathologic Basis of Disease 2010 Philadelphia, PA:Elsevier VakitiAMewawallaP CancerAcute Myeloid Leukemia (AML, Erythroid Leukemia, Myelodysplasia-Related Leukemia2019BCR-ABL Chronic Leukemia) [Updated Available from:https://www.ncbi.nlm.nih.gov/books/NBK507875/ Naik J Themeli M R de Jong-Korlaar RWJ Ruiter Poddighe P J Yuan H de Bruijn JD Ossenkoppele G J Zweegman S Smit L Mutis T ACM Martens NWCJ van de Donk RWJ Groen CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia Haematologica. 2019 Mar;104(3):e100-e103. doi: 10.3324/haematol.2018.192757. Epub 2018 Sep 6. PubMed PMID: 30190344; PubMed Central PMCID: PMC6395314 10.3324/haematol.2018.192757 30190344 Bawazir A Al-Zamel N Amen A Akiel M A Alhawiti N M Alshehri A The burden of leukemia in the Kingdom of Saudi Arabia: 15 period (1999-2013). BMC Cancer 2019 PubMed PMID: 31315607; PubMed Central PMCID: PMC6637507 19 703 1 10 10.1186/s12885-019-5897-5 31315607 Dhall A Zee B M Yan F Blanco M A Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia. Front Oncol 2019 22;9: 432. doi: 10.3389/fonc.2019.00432. eCollection 2019. Review. PubMed PMID: 31192132; PubMed Central PMCID: PMC6540842 10.3389/fonc.2019.00432 31192132 Medeiros B C Chan S M Daver N G Jonas B A Pollyea D A Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia 2019 Am Jul;94(7): 803-811. doi: 10.1002/ajh.25484. Epub 2019 May 1. Review. PubMed PMID: 30945331; PubMed Central PMCID: PMC6593671 10.1002/ajh.25484 30945331 Murphy B R Roth M Kolb E A Alonzo T Gerbing R Wells R J Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children&apos;s Oncology Group acute myeloid leukemia trials. Pediatr Blood Cancer 2019 Aug;66(8):e27700. doi: 10.1002/pbc.27700. Epub 2019 Mar 25. Review. PubMed PMID: 30908863 10.1002/pbc.27700 30908863 PuckettYChanOCancer, Acute Lymphocytic Leukemia (ALL), In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2019 Available from: https://www.ncbi.nlm.nih.gov/books/NBK459149/ BranfordSDDHKimApperleyJ FEideC AMustjokiSOngS TNteliopoulosGErnstTChuahCGambacorti-PasseriniCMauroM JDrukerB JKimD WMahonF XCortesJRadichJ PHochhaus A, Hughes TP; International CML Foundation Genomics Alliance. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia. Leukemia2019 Review. PubMed PMID: 3381835185010.1038/s41375-019-0512-y31209280 Franki R Report details financial burden of blood cancers. MDedge 2018 Rahimi Babasheikhali S Rahgozar S Mohammadi M Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells 2019 J Cancer Res Clin Oncol 145 8 1987 1998 10.1007/s00432-019-02949-5 31214760 Hwang D Kim M Park H Jeong M I Jung W Kim B Natural Products and Acute Myeloid Leukemia: A Review Highlighting Mechanisms of Action. Nutrients 2019 3;11(5). pii: E1010. doi: 10.3390/nu11051010. Review. PubMed PMID: 31058874; PubMed Central PMCID: PMC6567155 10.3390/nu11051010 31058874 E1010 Bhargava S Malhotra H Rathore O S Malhotra B Sharma P Batra A Sharma A Chiplunkar SV. Anti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants 2015 Leuk Lymphoma Epub 56 11 3168 82 10.3109/10428194.2015.1026813 25772975 Yang C Cai H Meng X Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells. Int Immunopharmacol 2016 Jul;36: 17-22. doi: 10.1016/j.intimp.2016.04.011. Epub 2016 Apr 19. PubMed PMID: 27104314 10.1016/j.intimp.2016.04.011 27104314 Wu L Li Q Liu Y Polyphyllin D induces apoptosis in K562/A02 cells through G2/M phase arrest 2014 J Pharm Pharmacol May;66(5): 713-21. doi: 10.1111/jphp.12188. Epub 2013 Dec 11. PubMed PMID: 24325805 10.1111/jphp.12188 24325805 Turrini E Calcabrini C Sestili P Catanzaro E E de Gianni Diaz A R Hrelia P Tacchini M Guerrini A Canonico B Papa S Valdrè G Fimognari C Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells. Toxins (Basel) 2016 12;8(5). pii: E147. doi: 10.3390/toxins8050147. PubMed PMID: 27187469; PubMed Central PMCID: PMC4885062 10.3390/toxins8050147 27187469 E147 PiresNGotaVGuliaAHingoraniLAgarwalMPuriASafety and Pharmacokinetics of Withaferin-A in advanced stage high grade Osteosarcoma: A phase I trial. J Ayurveda Integr Med201930904387 pii: S0975-9476(18)30789-7. doi: 10.1016/j.jaim.2018.12.008. [Epub ahead of print] PubMed PMID: 10.1016/j.jaim.2018.12.00830904387S0975-9476(18)30789-7 Kim S Yu J S Lee J Y Choi S U Lee J Kim K H Cytotoxic Withanolides from the Roots of Indian Ginseng (Withania somnifera) J Nat Prod. 2019 Apr 10.1021/acs.jnatprod.8b00665. Epub 2019 Feb 18. PubMed PMID: 82 4 765 773 10.1021/acs.jnatprod.8b00665 30776236 Li C Dong L Su R Bi Y Qing Y Deng X Zhou Y Hu C Yu M Huang H Jiang X Li X He X Zou D Shen C Han L Sun M Skibbe J Ferchen K Qin X Weng H Huang H Song C Chen J Jin J Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC. Haematologica. 2019 Apr 11. pii: haematol.2018.208835. doi: 10.3324/haematol.2018.208835. [Epub ahead of print] PubMed PMID: 30975912 10.3324/haematol.2018.208835 30975912 haematol.2018.208835 Zhang J Geng H Liu L Zhang H Synergistic cytotoxicity of homoharringtonine and etoposide in acute myeloid leukemia cells involves disrupted antioxidant defense. Cancer Manag Res 2019 Jan22; 11 1023 1032 10.2147/CMAR.S187597 30774430 Wu Z Zhuang H Yu Q Zhang X Jiang X Lu X Xu Y Yang L Wu B Ma A Zhang L Xiao X Liang Y Gao R Shen J Xu R Homoharringtonine Combined with the Heat Shock Protein 90 Inhibitor IPI504 in the Treatment of FLT3-ITD Acute Myeloid Leukemia. Transl Oncol. 2019 Jun;12(6): 801-809. doi: 10.1016/j.tranon.2019.02.016. Epub 2019 Apr 4. PubMed PMID: 30953928; PubMed Central PMCID: PMC6449739 10.1016/j.tranon.2019.02.016 30953928 Yakhni M Briat A A El Guerrab Furtado L Kwiatkowski F Miot-Noirault E Cachin F Penault-Llorca F Radosevic-Robin N Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance. Am J Cancer Res 2019 9 5 1043 1060 31218111 Huang S Pan J Jin J Li C Li X Huang J Huang X Yan X Li F Yu M Hu C Jin J Xu Y Ling Q Ye W Wang Y Jin J Abivertinib a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. Cancer Lett 2019 Oct1; 461: 132-143. doi: 10.1016/j.canlet.2019.07.008. Epub 2019 Jul 13. PubMed PMID: 31310800 10.1016/j.canlet.2019.07.008 31310800 Tan M Zhang Q Yuan X Chen Y Wu Y Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. J Exp Clin Cancer Res 2019 Jul15; PubMed PMID: 31307525; PubMed Central PMCID: PMC6631946 38 308 1 8 10.1186/s13046-019-1295-8 31307525 Chen P Zhan W Wang B You P Jin Q Hou D Wang X You R Zou H Chen Y Huang H Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. Exp Cell Res 2019 Mar15; 376(2): 114-123. doi: 10.1016/j.yexcr.2019.02.008. Epub 2019 Feb 11. PubMed PMID: 30763586 10.1016/j.yexcr.2019.02.008 30763586 Chen X J Zhang W N Chen B Xi W D Lu Y Huang J Y Wang Y Y Long J Wu S F Zhang Y X Wang S Li S X Yin T Lu M Xi X D Li J M Wang K K Chen Z Chen S J Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor 2019 Proc Natl Acad Sci U S A. 2019 Feb 5;116(6): 2220-2225. doi: 10.1073/pnas.1818539116. Epub 6369765 10.1073/pnas.1818539116 30659143 Lien le Q Linh T M Giang V H Mai N C Nhiem N X Tai B H Cuc N T Anh Hle T Ban N K Minh C V Kiem P V New naphthalene derivatives and isoquinoline alkaloids from Ancistrocladus cochinchinensis with their anti-proliferative activity on human cancer cells. Bioorg Med Chem Lett 2016 Epub 2016 Jul 5. PubMed PMID: 26 16 3913 7 10.1016/j.bmcl.2016.07.014 27423477 DantasB BFaheina-MartinsG VCoulidiatiT HBomfimC CCda Silva DiasBarbosa-FilhoJ MAraújoD AEffects of curine in HL-60 leukemic cells: cell cycle arrest and apoptosis induction2015J Nat Med. 2015 Apr;69(2):21823 PubMed PMID: 10.1007/s11418-014-0881-525616501 Chen L G Su P J Tsai P W Yang L L Wang C C Intermedin A, a New Labdane Diterpene Isolated from Alpinia intermedia 2016 Prolonged the Survival Time of P-388D1 Tumor-Bearing CDF1 Mice. Planta Med. 2017 Jan;83(1-02): 151 157 10.1055/s-0042-109779 27352383 Li D H Li J Y Xue C M Han T Sai C M Wang K B Lu J C Jing Y K Hua H M Li Z L Antiproliferative Dimeric Aporphinoid Alkaloids from the Roots of Thalictrum cultratum 2017 J 10.1021/acs.jnatprod.7b00387. Epub 2017 Nov 13. PubMed PMID: 80 11 2893 2904 10.1021/acs.jnatprod.7b00387 29131616 Lam N S Long X Wong J W Griffin R C JCG Doery Artemisinin and its derivatives: a potential treatment for leukemia. Anticancer Drugs 2019 Jan;30(1): 1-18. doi: 10.1097/CAD.0000000000000697. PubMed PMID: 30540593 10.1097/CAD.0000000000000697 30540593 Beck J Schwarzer A Gläser D Mügge L O Uhlig J Heyn S Kragl B Mohren M Hoffmann F A Lange T Schliwa T Zehrfeld T Becker C Kreibich U Winkelmann C Edelmann T Andrea M Bill M Jentzsch M Schwind S Niederwieser D Pönisch W Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077). J Cancer Res Clin Oncol 2017 143 12 2545 2553 10.1007/s00432-017-2504-5 28828689 Drenberg C D Buaboonnam J Orwick S J Hu S Li L Fan Y Shelat A A Guy R K Rubnitz J Baker S D Evaluation of artemisinins for the treatment of acute myeloid leukemia. Cancer Chemother Pharmacol 2016 77 6 1231 43 10.1007/s00280-016-3038-2 27125973 Letis A S Seo E J Nikolaropoulos S S Efferth T Giannis A Fousteris M A Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells. Bioorg Med Chem 2017 10.1016/j.bmc.2017.04.021. Epub 2017 Apr 20. PubMed PMID: 25 13 3357 3367 10.1016/j.bmc.2017.04.021 28456567 Houh Y K Kim K E Park S Hur D Y Kim S Kim D Bang S I Yang Y Park H J Cho D The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells. Int J Mol Sci. 2017 Jul 24;18(7). pii: E1600. doi: 10.3390/ijms18071600. PubMed PMID: 28737711; PubMed Central PMCID: PMC5536087 10.3390/ijms18071600 28737711 E1600 Jiang H Y Wang C F Fan L Yang K Feng J B Geng Z F Xu J Deng Z W Du S S Yin H B Cytotoxic constituents from the stems of Clausena lansium (Lour.) Skeels. Molecules 2013 10.3390/molecules180910768. PubMed PMID: 24005969; PubMed Central PMCID: PMC6270150 18 9 10768 75 10.3390/molecules180910768 24005969 Kim S P Kang M Y Choi Y H Kim J H Nam S H Friedman M Mechanism of Hericium erinaceus (Yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells. Food Funct 2011 Jun;2(6): 348-56. doi: 10.1039/c1fo10030k. Epub 2011 Jun 8. PubMed PMID: 21779573 10.1039/c1fo10030k 21779573 Nomura M Takahashi T Uesugi A Tanaka R Kobayashi S Inotodiol a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis. Anticancer Res 2008 Sep-Oct;28(5A): 2691-6. PubMed PMID: 19035296 19035296 Bayan L Koulivand P H Gorji A Garlic: a review of potential therapeutic effects. Avicenna 2014 Jan;4(1): 1-14. Review. PubMed PMID: 25050296; PubMed Central PMCID: PMC4103721 25050296 Antlsperger D S Dirsch V M Ferreira D Su J L Kuo M L Vollmar A M Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERK. Oncogene 2003 Jan30; 22 4 582 9 12555071 Zhang G Gao X Zeng H Li Y Guo X Virosecurinine induces apoptosis in human leukemia THP-1 cells and other underlying molecular mechanisms. Oncol Lett 2018 Jan;15(1): 849-854. doi: 10.3892/ol.2017.7437. Epub 5772865 10.3892/ol.2017.7437 29399150 Zhang G Li M Han S Chen D Wang Y Ye W Ji Z Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism. Mol Med Rep 2014 Nov;10(5): 2365-71. doi: 10.3892/mmr.2014.2531. Epub 2014 Sep 3. PubMed PMID: 25189629; PubMed Central PMCID: PMC4214351 10.3892/mmr.2014.2531 25189629 Yang J Chen L Yan Y Qiu J Chen J Song J Rao Q Ben-David Y Li Y Hao X BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells. Biomed Pharmacother 2019 Apr;112: 108603. doi: 10.1016/j.biopha.2019.108603. Epub 2019 Feb 20. PubMed PMID: 30784914 10.1016/j.biopha.2019.108603 30784914 Larasati Y A Yoneda-Kato N Nakamae I Yokoyama T Meiyanto E Kato J Y Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep 2018 Feb1; 8(1): 2039. doi: 10.1038/s41598-018-20179-6. PubMed PMID: 29391517; PubMed Central PMCID: PMC5794879 10.1038/s41598-018-20179-6 29391517 Kouhpeikar H Butler A E Bamian F Barreto G E Majeed M Sahebkar A Curcumin as a therapeutic agent in leukemia 2019 J Cell Physiol Aug;234(8): 12404-12414. doi: 10.1002/jcp.28072. Epub 2019 Jan 4. Review. PubMed PMID: 30609023 10.1002/jcp.28072 30609023 Kujundžić R N Stepanić V Milković L AČ Gašparović Tomljanović M Trošelj K G Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer. Int J Mol Sci. 2019 Mar 8;20(5). pii: E1180. doi: 10.3390/ijms20051180. Review. PubMed PMID: 30857125; PubMed Central PMCID: PMC6429141 10.3390/ijms20051180 30857125 E1180 Santana-Bejarano U F Bobadilla-Morales L Mendoza-Maldonado L Torres-Anguiano E Brukman-Jiménez S A Barba-Barba C C Corona-Rivera J R Corona-Rivera A In vitro effect of curcumin in combination with chemotherapy drugs in Ph(+) acute lymphoblastic leukemia cells. Oncol Lett 2019 Jun;17(6): 5224-5240. doi: 10.3892/ol.2019.10204. Epub 2019 Apr 2. PubMed PMID: 31186739; PubMed Central PMCID: PMC6507345 10.3892/ol.2019.10204 31186739 Henry D Brumaire S Hu X Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells. Leuk Res 2019 Feb;77: 34-41. doi: 10.1016/j.leukres.2018.12.014. Epub 2019 Jan 2. PubMed PMID: 30641474 10.1016/j.leukres.2018.12.014 30641474 IwasakiRItoKIshidaTHamanoueMAdachiSWatanabeTSatoYCatechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci2009100234956 PubMed PMID: 10.1111/j.1349-7006.2008.01046.x19200260 Marjanovic G The use of inexpensive broad spectrum lower toxicity therapeutics in chronic lymphocytic leukemia J BUON. 2017 Mar-Apr;22(2): 288-294. Review. PubMed PMID: 28534346 28534346 Yang C S Wang H Cancer therapy combination: green tea and a phosphodiesterase 5 inhibitor? J Clin Invest 2013 Feb;123(2): 556-8. doi: 10.1172/JCI67589. Epub 2013 Jan 25. PubMed PMID: 23348734; PubMed Central PMCID: PMC3561839 10.1172/JCI67589 23348734 Yang C S Wang H Cancer Preventive Activities of Tea Catechins. Molecules 2016 9;21(12). pii: E1679. Review. PubMed PMID: 27941682; PubMed Central PMCID: PMC6273642 27941682 E1679 Angelo L S Kurzrock R Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia. Clin Cancer Res 2009 PubMed PMID: 19228716; PubMed Central PMCID: PMC2646173 15 4 1123 5 10.1158/1078-0432.CCR-08-2791 19228716 Shanafelt T D Call T G Zent C S Leis J F LaPlant B Bowen D A Roos M Laumann K Ghosh A K Lesnick C Lee M J Yang C S Jelinek D F Erlichman C Kay N E Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 2013 Jan15; 119(2): 363-70. doi: 10.1002/cncr.27719. Epub 2012 Jul 3. PubMed PMID: 22760587; PubMed Central PMCID: PMC3902473 10.1002/cncr.27719 22760587 Smith D M Dou Q P Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Int J Mol Med 2001 Jun;7(6): 645-52. PubMed PMID: 11351279 11351279 Lee Y K Bone N D Strege A K Shanafelt T D Jelinek D F Kay N E VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG) 2004 in B-cell chronic lymphocytic leukemia. Blood 104 3 788 94 14996703 Gao N Budhraja A Cheng S Yao H Zhang Z Shi X Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res 2009 PubMed PMID: 19118041; PubMed Central PMCID: PMC2760842 15 1 140 9 10.1158/1078-0432.CCR-08-1447 19118041 Saedi T A Noor S Ismail P Othman F The effects of herbs and fruits on leukaemia. Evid Based Complement Alternat Med 2014 Epub 2014 Aug 27. Review. PubMed PMID: 25250054; PubMed Central PMCID: PMC4163312 1 8 10.1155/2014/494136 25250054 Espino J González-Gómez D Moreno D Fernández-León M F Rodríguez A B Pariente J A Delgado-Adámez J Tempranillo-derived grape seed extract induces apoptotic cell death and cell growth arrest in human promyelocytic leukemia HL-60 cells. Food Funct 2013 Dec;4(12): 1759-66. doi: 10.1039/c3fo60267b. Epub 2013 Oct 16. PubMed PMID: 24129601 10.1039/c3fo60267b 24129601 AAB Al-Asady HMS Algarmavy SKM Salih Antileukemic Effect of Polyphenol of Local Grape Seeds Extract from Duhok/Kurdistan of Iraq: in vitro Study. Research in Cell Biology 2017 3 1 1 6 10.5923/j.cellbiology.20170301.01 Cao W J Wu K Wang C Wan D M Polydatin-induced cell apoptosis and cell cycle arrest are potentiated by Janus kinase 2 inhibition in leukemia cells. Mol Med Rep 2016 Apr;13(4): 3297-302. doi: 10.3892/mmr.2016.4909. Epub 2016 Feb 18. PubMed PMID: 26934953 10.3892/mmr.2016.4909 26934953 Papandreou I Verras M McNeil B Koong A C Denko N C Plant stilbenes induce endoplasmic reticulum stress and their anti-cancer activity can be enhanced by inhibitors of autophagy. Exp Cell Res 2015 10.1016/j.yexcr.2015.10.014. Epub 2015 Oct 17. PubMed PMID: 26477823; PubMed Central PMCID: PMC4822495 339 1 147 53 10.1016/j.yexcr.2015.10.014 26477823 Frazzi R Guardi M Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells. Molecules 2017 pii: E885. doi: 10.3390/molecules22060885. Review. PubMed PMID: 28555002; PubMed Central PMCID: PMC6152792 22 6 10.3390/molecules22060885 28555002 E885 HuHQinY MGrape seed proanthocyanidin extract induced mitochondria-associated apoptosis in human acute myeloid leukaemia 14.3D10 cells2006Chin Med119541721 PubMed PMID: 16542587 Dahlawi H Jordan-Mahy N Clench M McDougall G J Maitre C L Polyphenols are responsible for the proapoptotic properties of pomegranate juice on leukemia cell lines. Food Sci Nutr 2013 Mar;1(2): 196-208. doi: 10.1002/fsn3.26. Epub 2013 Feb 20. PubMed PMID: 24804028; PubMed Central PMCID: PMC3967757 10.1002/fsn3.26 24804028 Kawaii S Lansky E P Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Med Food 2004 Spring;7(1): 13-8. PubMed PMID: 15117547 15117547 Asmaa M J Ali A J Farid J M Azman S Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells Int J Appl Basic Med Res. 2015 May-Aug;5(2): PubMed PMID: 26097816; PubMed Central PMCID: 100 5 10.4103/2229-516X.157154 26097816 Dahlawi H Jordan-Mahy N Clench M R Le Maitre CL Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia Nutr Cancer Epub 2011 Nov 18. PubMed PMID: 64 1 100 10 10.1080/01635581.2012.630155 22098126 Joseph M M Aravind S R Varghese S Mini S Sreelekha T T Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum. Mol Med Rep 2012 Feb;5(2): 489-96. doi: 10.3892/mmr.2011.638. Epub 2011 Oct 18. PubMed PMID: 22012001 10.3892/mmr.2011.638 22012001 Choi Y J Yoon J H Cha S W Lee S G Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway Fitoterapia. 2011 Sep;82(6): 911-9. doi: 10.1016/j.fitote.2011.05.005. Epub 2011 May 14. PubMed PMID: 21605636 10.1016/j.fitote.2011.05.005 21605636 Compound K a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells 2009 BMC Cancer. Dec18; PubMed PMID: 20017956; PubMed Central PMCID: PMC2806409 9 449 10 10.1186/1471-2407-9-449 20017956 Chen Y Xu Y Zhu Y Li X Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells. Cancer Cell Int 2013 PubMed PMID: 23497352; PubMed Central PMCID: PMC3602037 13 1 24 10 10.1186/1475-2867-13-24 23497352 Park J G Son Y J Aravinthan A Kim J H Cho J Y Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells. J Ginseng Res 2016 Oct;40(4): 431-436. Epub 2016 Aug 4. PubMed PMID: 27746697; PubMed Central PMCID: PMC5052435 27746697 Park S E Park C Kim S H Hossain M A Kim M Y Chung H Y Son W S Kim G Y Choi Y H Kim N D Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol 2009 121 2 304 12 Epub 10.1016/j.jep.2008.10.038 19041934 Ardalani H Avan A Ghayour-Mobarhan M Podophyllotoxin: a novel potential natural anticancer agent. Avicenna 2017 Jul-Aug;7(4): 285-294. Review. PubMed PMID: 28884079; PubMed Central PMCID: PMC5580867 28884079 Yusenko M Jakobs A Klempnauer K H A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity. Sci Rep 2018 PubMed PMID: 30177851; PubMed Central PMCID: PMC6120916 8 1 1 11 10.1038/s41598-018-31620-1 30177851 Cao B Yang S Li W Chen H Chen Y Liu Y Liu B GMZ-1 is a podophyllotoxin derivative that suppresses growth and induces apoptosis in adriamycin-resistant K562/A02 cells through modulation of MDR1 expression. Mol Med Rep 2018 Jan;17(1): 474-478. doi: 10.3892/mmr.2017.7862. Epub 2017 Oct 25. PubMed PMID: 29115592 10.3892/mmr.2017.7862 29115592 Silveira A L Faheina-Martins G V Maia R C Araújo D A Compound A398, a novel podophyllotoxin analogue: cytotoxicity and induction of apoptosis in human leukemia cells. PLoS One 2014 doi: 10.1371/journal.pone.0107404. eCollection 2014. PubMed PMID: 25221997; PubMed Central PMCID: PMC4164611 9 9 107404 10.1371/journal.pone.0107404 25221997 Illiano M Conte M Sapio L Nebbioso A Spina A Altucci L Naviglio S Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A. Front Pharmacol. 2018 Jul 20;9: 792. doi: 10.3389/fphar.2018.00792. eCollection 2018. PubMed PMID: 30079022; PubMed Central PMCID: PMC6063003 10.3389/fphar.2018.00792 30079022 Hodroj M H Jardaly A Abi Raad S Zouein A Rizk S Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway. Cancer Manag Res 2018 10 1079 1088 10.2147/CMAR.S160924 29785137 Yang T Yao S Zhang X Guo Y Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation 2016 of p38 MAPK pathways. Drug Des Devel Ther. Apr11; 10: 1389-1397. doi: 10.2147/DDDT.S94983. eCollection 2016. PubMed PMID: 27114702; PubMed Central PMCID: PMC4833376 10.2147/DDDT.S94983 27114702 Sarkar S Gopal P K Paul S Andrographolide Induced Apoptosis in NALM-6 Cells Mediated Through the Cell Cycle Arrest and Nuclear Fragmentation Pharmacog J DOI: 10.5530/pj.2018.2.36. Available from:http://www.phcogj.com/sites/default/files/PharmacognJ-10_2_210.pdf 10 2 210 4 10.5530/pj.2018.2.36 Cheung H Y Cheung S H Li J Cheung C S Lai W P Fong W F Leung F M Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med 2005 Dec;71(12): 1106-11. PubMed PMID: 16395645 16395645 Liao H C Chou Y J Lin C C Liu S H Oswita A Huang Y L Wang Y L Syu J L Sun C M Leu C M Lin C H Fu S L Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein. Biochem Pharmacol 2019 May;163: 308-320. doi: 10.1016/j.bcp.2019.02.028. Epub 2019 Feb 26. PubMed PMID: 30822403 10.1016/j.bcp.2019.02.028 30822403 Manikam S D Stanslas J Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis. J Pharm Pharmacol 2009 Jan;61(1): 69-78. doi: 10.1211/jpp/61.01.0010. Erratum in: J Pharm Pharmacol. 2009 May;61(5): 687. Manikam, Shiamala T [corrected to Manikam, Shiamala T]. PubMed PMID: 19126299 10.1211/jpp/61.01.0010 19126299 Chen X Zhang J Yuan L Lay Y Wong Y K Lim T K Ong C S Lin Q Wang J Hua Z Andrographolide Suppresses MV4-11 Cell Proliferation through the Inhibition of FLT3 Signaling, Fatty Acid Synthesis and Cellular Iron Uptake. Molecules. 2017 Aug 31;22(9). pii: E1444. doi: 10.3390/molecules22091444. PubMed PMID: 28858244; PubMed Central PMCID: PMC6151431 10.3390/molecules22091444 28858244 E1444 Chatterjee K AlSharif D Mazza C Syar P Al Sharif M Fata J E Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells. Nutrients. 2018 Feb 21;10(2). pii: E243. doi: 10.3390/nu10020243. PubMed PMID: 29485619; PubMed Central PMCID: PMC5852819 10.3390/nu10020243 29485619 E243 Ramezani G Pourgheysari B Shirzad H Sourani Z Pterostilbene increases Fas expression in T-lymphoblastic leukemia cell lines. Res Pharm Sci 2019 PubMed PMID: 30936933; PubMed Central PMCID: PMC6407337 14 1 55 63 10.4103/1735-5362.251853 30936933 McGill C M Brown T J Cheng Y Y Fisher L N Shanmugavelandy S S Gustafson S J Dunlap K L Lila M A Kester M Toran P T Claxton D F Barth B M Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia. Int J Biopharm Sci 2018 Jan;1(1). pii: 102. Epub 2018 Jan 2. PubMed PMID: 29607443; PubMed Central PMCID: PMC5875929 29607443 102 McGill C M Brown T J Fisher L N Gustafson S J Dunlap K L Beck A J Toran P T Claxton D F Barth B M Combinatorial Efficacy of Quercitin and Nanoliposomal Ceramide for Acute Myeloid Leukemia 2018 Int J Biopharm Sci pii: 106. doi: 10.31021/ijbs.20181106. Epub 1 1 6349237 10.31021/ijbs.20181106 30701264 106 Liu Z Li F Zhang B Li S Wu J Shi Y Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex 2015 J Biol Chem. 2015 Mar 290 10 6630 8 10.1074/jbc.M114.610196 25601084 P Van Vlierberghe Patel J Abdel-Wahab O Lobry C Hedvat C V Balbin M Nicolas C Payer A R Fernandez H F Tallman M S Paietta E Melnick A Vandenberghe P Speleman F Aifantis I Cools J Levine R Ferrando A 29. PubMed PMID: 21030981; PubMed Central PMCID: 2010 PHF6 mutations in adult acute myeloid leukemia. Leukemia. 2011 Jan;25(1): 130-4. doi: 10.1038/leu.2010.247. Epub 3878659 10.1038/leu.2010.247 21030981 Ge Z Gu Y Han Q Sloane J Ge Q Gao G Ma J Song H Hu J Chen B Dovat S Song C Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia. Epigenomics 2018 10 1 59 69 10.2217/epi-2017-0092 28994305 Wendorff A A Quinn S A Rashkovan M Madubata C J Ambesi-Impiombato A Litzow M R Tallman M S Paietta E Paganin M Basso G Gastier-Foster J M Loh M L Rabadan R P Van Vlierberghe Ferrando A A 19. PubMed PMID: 30567843; PubMed Central PMCID: 2018 Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL. Cancer Discov. 2019 Mar;9(3): 436 451 10.1158/2159-8290.CD-18-1005 30567843 Sarkar M K Vadivel V MRC Raja Kar Mahapatra S Investigation of phytochemical constituents of anti-leukemic herbal drugs used by the traditional healers of Purulia, Birbhum and Bankura districts of West Bengal. Nat Prod Res 2019 [Epub ahead of print] PubMed PMID: 15 1 6 10.1080/14786419.2019.1566818 30764661 Danışman Kalındemirtaş F Birman H Candöken E Bilgiş Gazioğlu S Melikoğlu G Kuruca S Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method. Balkan Med J 2019 Epub 2018 Nov 5. PubMed PMID: 30396879; PubMed Central PMCID: PMC6409953 36 2 96 105 10.4274/balkanmedj.galenos.2018.2017.1244 30396879 Wei C Xiao Q Kuang X Zhang T Yang Z Wang L Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species. Mol Med Rep 2015 Nov;12(5): 6649-55. doi: 10.3892/mmr.2015.4252. Epub 2015 Aug 25. PubMed PMID: 26324225; PubMed Central PMCID: PMC4626197 10.3892/mmr.2015.4252 26324225 Park H S Hwang H J Kim G Y Cha H J Kim W J Kim N D Yoo Y H Choi Y H Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family. Mar Drugs. 2013 Jul 4;11(7): 2347-64. doi: 10.3390/md11072347. PubMed PMID: 23880928; PubMed Central PMCID: PMC3736427 10.3390/md11072347 23880928 Atashrazm F Lowenthal R M Woods G M Holloway A F Karpiniec S S Dickinson J L Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo. J Cell Physiol. 2016 Mar;231(3): 688-97. doi: 10.1002/jcp.25119. PubMed PMID: 26241708 10.1002/jcp.25119 26241708 AtashrazmFLowenthalR MDickinsonJ LHollowayA FWoodsG MFucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia201610.18632/oncotarget.10016. PubMed PMID: 27329592; PubMed Central PMCID: PMC52167797294602846041 in vitro and in 10.18632/oncotarget.1001627329592 Rengarajan T Rajendran P Nandakumar N Balasubramanian M P Nishigaki I Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis. Nutrients 2013 10.3390/nu5124978. Review. PubMed PMID: 24322524; PubMed Central PMCID: PMC3875925 5 12 4978 89 10.3390/nu5124978 24322524 Kumar S R Hosokawa M Miyashita K Fucoxanthin: a marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms. Mar Drugs 2013 10.3390/md11125130. Review. PubMed PMID: 24351910; PubMed Central PMCID: PMC3877908 11 12 5130 47 10.3390/md11125130 24351910 Catarino M D AMS Silva Cardoso S M Phycochemical Constituents and Biological Activities of Fucus spp. Mar Drugs 2018 pii: E249. doi: 10.3390/md16080249. Review. PubMed PMID: 30060505; PubMed Central PMCID: PMC6117670 16 8 10.3390/md16080249 30060505 E249 Almeida T P Ferreira J Vettorazzi A Azqueta A Rocha E Ramos A A Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines. Environ Toxicol Pharmacol 2018 Apr;59: 24-33. doi: 10.1016/j.etap.2018.02.006. Epub 2018 Feb 16. PubMed PMID: 29518678 10.1016/j.etap.2018.02.006 29518678 Almeida T P Ramos A A Ferreira J Azqueta A Rocha E Bioactive Compounds from Seaweed with Anti-Leukemic Activity: A Mini-Review on Carotenoids and Phlorotannins. Mini Rev Med Chem. doi: 10.2174/1389557519666190311095655. [Epub ahead of print] PubMed PMID: 2019 30854962 10.2174/1389557519666190311095655 30854962 Saikia M Retnakumari A P Anwar S Anto N P Mittal R Shah S Pillai K S Balachandran V S Peter V Thomas R Anto R J Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras 2018 Oncotarget. Apr 10.18632/oncotarget.24771. eCollection 2018 Apr 6. PubMed PMID: 29719594; PubMed Central PMCID: PMC5915061 9 26 18115 18127 10.18632/oncotarget.24771 29719594 Esmaeilbeig M Kouhpayeh S A Amirghofran Z An Investigation of the Growth Inhibitory Capacity of Several Medicinal Plants From Iran on Tumor Cell Lines. Iran J Cancer Prev 2015 Oct;8(5):e4032. doi: 10.17795/ijcp-4032. Epub 2015 Oct 27. PubMed PMID: 26634 10.17795/ijcp-4032 26634 Och M Och A Cieśla Ł Kubrak T Pecio Ł Stochmal A Kocki J Bogucka-Kocka A Study of cytotoxic activity, podophyllotoxin, and deoxypodophyllotoxin content in selected Juniperus species cultivated in Poland. Pharm Biol 2015 Epub 2015 Feb 27. PubMed PMID: 53 6 831 7 10.3109/13880209.2014.943246 25720974 Erfani N Nazemosadat Z Moein M Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy Res 2015 PubMed PMID: 25829786; PubMed Central PMCID: PMC4357963 7 2 133 7 10.4103/0974-8490.150539 25829786 Joseph O A The prospects of medicinal plants in the treatment of breast cancer 2016 European Pharmaceutical Review 13 Azubuike S O Muirhead C Hayes L McNally R Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol 2018 Review. PubMed PMID: 29566711; PubMed Central PMCID: PMC5863808 16 63 1 13 10.1186/s12957-018-1345-2 29566711 Blumen H Fitch K Polkus V Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. Am Health Drug Benefits 2016 Feb;9(1): 23-32. PubMed PMID: 27066193; PubMed Central PMCID: PMC4822976 27066193 AlkabbanF MFergusonT CancerBreastIn: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2019 Available from:https://www.ncbi.nlm.nih.gov/books/NBK482286/ Mehrgou A Akouchekian M The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.Med J Islam Repub Iran.May 15; 30: 369. eCollection 2016.Review.PubMed PMID: 27493913; PubMed Central PMCID: 2016 4972064 27493913 Poehls U G Hack C C Wunderle M Renner S P Lux M P Beckmann M W Fasching P A Nabieva N Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 years. Eur J Cancer Prev 2019 30681416 10.1097/CEJ.0000000000000500 30681416 Hendrick R E Baker J A Helvie M A Breast cancer deaths averted over 3 decades. Cancer 2019 10.1002/cncr.31954. Epub 2019 Feb 11. PubMed PMID: 125 9 1482 1488 10.1002/cncr.31954 30740647 Vishwakarma G Ndetan H Das D N Gupta G Suryavanshi M Mehta A Singh K P Reproductive factors and breast cancer risk: A meta-analysis of case-control studies in Indian women 2019 South Asian Apr-Jun;8(2): 80-84. doi: 10.4103/sajc.sajc_317_18. PubMed PMID: 31069183; PubMed Central PMCID: PMC6498720 10.4103/sajc.sajc_317_18 31069183 Ng H S Vitry A Koczwara B Roder D McBride M L Patterns of comorbidities in women with breast cancer: a Canadian population-based study. Cancer Causes Control 2019 Epub 2019 Jul 6. PubMed PMID: 30 9 931 941 10.1007/s10552-019-01203-0 31280456 BahriNFathiNajafi THomaeiShandiz FTohidinikH RKhajaviAThe relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies. Breast Cancer Res Treat2019 Review. PubMed PMID: 1761536110.1007/s10549-019-05231-x31004298 Ho-Huynh A Tran A Bray G Abbot S Elston T Gunnarsson R A de Costa Factors influencing breast cancer outcomes in Australia: A systematic review 2019 Eur J Cancer Care Jul;28(4):e13038. doi: 10.1111/ecc.13038. Epub 2019 Mar 27. Review. PubMed PMID: 30919536 10.1111/ecc.13038 30919536 Feng Y Spezia M Huang S Yuan C Zeng Z Zhang L Ji X Liu W Huang B Luo W Liu B Lei Y Du S Vuppalapati A Luu H H Haydon R C He T C Ren G Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 2018 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun. Review. PubMed PMID: 30258937; PubMed Central PMCID: PMC6147049 5 2 77 106 10.1016/j.gendis.2018.05.001 30258937 Sun Y S Zhao Z Yang Z N Xu F Lu H J Zhu Z Y Shi W Jiang J Yao P P Zhu H P Risk Factors and Preventions of Breast Cancer 2017 Int J Biol Sci 13 11 1387 1397 10.7150/ijbs.21635 29209143 InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); Risk factors for breast cancer2006 Available from: https://www.ncbi.nlm.nih.gov/books/NBK447103/ Alexander A Kaluve R Prabhu J S Korlimarla A Srinath B S Manjunath S Patil S Gopinath K S Sridhar T S The Impact of Breast Cancer on the Patient and the Family in Indian Perspective. Indian J Palliat Care. 2019 Jan-Mar;25(1): 66-72. doi: 10.4103/IJPC.IJPC_158_18. PubMed PMID: 30820105; PubMed Central PMCID: PMC6388591 10.4103/IJPC.IJPC_158_18 30820105 Chen L Malone K E Li C I Bra wearing not associated with breast cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2014 Epub 2014 Sep 5. PubMed PMID: 25192706; PubMed Central PMCID: PMC4184992 23 10 2181 5 10.1158/1055-9965.EPI-14-0414 25192706 SSD Rios ACR Chen Chen J R Wearing a Tight Bra for many hours a day is associated with increased risk of breast cancer. Adv Oncol Res Treat 2016 1 1 5 Virani S Chindaprasirt J Wirasorn K Sookprasert A Somintara O Vachirodom D Koonmee S Srinakarin J Kamsa-Ard S Suwanrungruang K Rozek L S Sriplung H Wiangnon S 12. PubMed PMID: 29760320; PubMed Central PMCID: 2018 Breast Cancer Incidence Trends and Projections in Northeastern Thailand. J Epidemiol. 2018 Jul 5;28(7): 323-330. doi: 10.2188/jea.JE20170045. Epub 6004364 10.2188/jea.JE20170045 29760320 Yabroff K R Lund J Kepka D Mariotto A Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev 2011 PubMed PMID: 21980008; PubMed Central PMCID: PMC3191884 20 10 2006 14 10.1158/1055-9965.EPI-11-0650 21980008 Mariotto A B Yabroff K R Shao Y Feuer E J Brown M L Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011 J Natl Cancer Inst. 2011 Apr 20;103(8): 699. PubMed PMID: 21228314; PubMed Central PMCID: PMC3107566 103 2 117 28 Epub 10.1093/jnci/djq495 21228314 Iadeluca L Mardekian J Chander P Hopps M Makinson G T The burden of selected cancers in the US: health behaviors and health care resource utilization. Cancer Manag Res 2017 Nov28; 9: 721 - 730. doi: 10.2147/CMAR.S143148. eCollection 2017. PubMed PMID: 29238222; PubMed Central PMCID: PMC5713681 10.2147/CMAR.S143148 29238222 Montecucco A Zanetta F Biamonti G Molecular mechanisms of etoposide 2015 EXCLI J. 2015 Jan19; Review. PubMed PMID: 26600742; PubMed Central PMCID: PMC4652635 14 95 108 10.17179/excli2015-561 26600742 BenzinaSHarquailJJeanSBeauregardA PColquhounC DCarrollMBosAGrayC ARobichaudG ADeoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells. Anticancer Agents Med Chem1517988 PubMed PMID: 24913660 Khaled M Belaaloui G Jiang Z Z Zhu X Zhang L Y Antitumor effect of Deoxypodophyllotoxin on human breast cancer xenograft transplanted in BALB/c nude mice model. J Infect Chemother 2016 Oct;22(10): 692-6. doi: 10.1016/j.jiac.2016.07.017. Epub 2016 Aug 28. PubMed PMID: 27578026 10.1016/j.jiac.2016.07.017 27578026 Guerram M Jiang Z Z Sun L Zhu X Zhang L Y Antineoplastic effects of deoxypodophyllotoxin, a potent cytotoxic agent of plant origin on glioblastoma U-87 MG and SF126 cells. Pharmacol Rep. 2015 Apr;67(2): 245-52. doi: 10.1016/j.pharep.2014.10.003. Epub 2014 Oct 19. PubMed PMID: 25712646 10.1016/j.pharep.2014.10.003 25712646 Zang X Wang G Cai Q Zheng X Zhang J Chen Q Wu B Zhu X Hao H Zhou F A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport. Drug Metab Dispos 2018 May;46(5): 542-551. doi: 10.1124/dmd.117.079442. Epub 2018 Mar 9. PubMed PMID: 29523600 10.1124/dmd.117.079442 29523600 SVanDanielsA LHootenC JBrockS LJenkinsA ROgasawaraM ABakerJ MAdkinsGEliasE MAgustinV JConstantineS RPullinM JShorsS TKornienkoASteelantW FEffects of crude aqueous medicinal plant extracts on growth and invasion of breast cancer cells. Oncol Rep2007176148792 PubMed PMID: 17487409 Kamata H Sadahiro S Yamori T Discovery of Inhibitors of Membrane Traffic from a Panel of Clinically Effective Anticancer Drugs. Biol Pharm Bull 2019 Epub 2019 Feb 21. PubMed PMID: 42 5 814 818 10.1248/bpb.b18-01026 30787205 Mavrogiannis A V Kokkinopoulou I Kontos C K Sideris D C Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell Lines Curr Pharm Biotechnol PubMed PMID: 19 13 1076 1086 10.2174/1389201019666181112103204 30417784 Wong M Y Chiu G N Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. Anticancer Drugs 2010 Apr;21(4): 401-10. doi: 10.1097/CAD.0b013e328336e940. PubMed PMID: 20110806 10.1097/CAD.0b013e328336e940 20110806 Su M Zhao M Luo Y Lin X Xu L He H Xu H Tang X Evaluation of the efficacy, toxicity and safety of vinorelbine incorporated in a lipid emulsion 2011 Int doi: 10.1016/j.ijpharm.2011.03.028. Epub 2011 Mar 21. PubMed PMID: 21421039 10.1016/j.ijpharm.2011.03.028 21421039 Ghersi D Willson M L Chan M M Simes J Donoghue E Wilcken N Taxane-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2015 10;(6):CD003366. doi: 10.1002/14651858.CD003366.pub3. Review. PubMed PMID: 26058962; PubMed Central PMCID: PMC6464903 10.1002/14651858.CD003366.pub3 26058962 Bachegowda L S Makower D F Sparano J A Taxanes: impact on breast cancer therapy. Anticancer Drugs 2014 May;25(5): 512-21. doi: 10.1097/CAD.0000000000000090. PubMed PMID: 24552749 10.1097/CAD.0000000000000090 24552749 Alken S Kelly C M Benefit risk assessment and update on the use of docetaxel in the management of breast cancer. Cancer Manag Res 2013 14;5: 357-65. doi: 10.2147/CMAR.S49321. Review. PubMed PMID: 24143122; PubMed Central PMCID: PMC3798099 10.2147/CMAR.S49321 24143122 Habib S Delourme J Dhalluin X Petyt G Tacelli N Scherpereel A Lafitte J J Cortot A B Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: a retrospective study. Lung Cancer 2013 May;80(2): 197-202. doi: 10.1016/j.lungcan.2013.01.015. Epub 2013 Feb 14. PubMed PMID: 23414642 10.1016/j.lungcan.2013.01.015 23414642 Joris S Fontaine C Decoster L Vanacker L Schallier D J De Grève Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer 2019 Breast Jul;25(4): 663-666. doi: 10.1111/tbj.13306. Epub 2019 May 9. PubMed PMID: 31074007 10.1111/tbj.13306 31074007 Liu Y Xu Z Zhang Z Wen G Sun J Han F Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer. Oncol Lett 2019 Jan;17(1): 907-912. doi: 10.3892/ol.2018.9658. Epub 2018 Nov 1. PubMed PMID: 30655846; PubMed Central PMCID: PMC6312931 10.3892/ol.2018.9658 30655846 Bachelot T Ciruelos E Schneeweiss A Puglisi F Peretz-Yablonski T Bondarenko I Paluch-Shimon S Wardley A Merot J L du Toit Y Easton V Lindegger N Miles D PERUSE investigators . Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). Ann Oncol 2019 10.1093/annonc/mdz061. PubMed PMID: 30 5 766 773 10.1093/annonc/mdz061 30796821 Nyrop K A Deal A M Reeder-Hayes K E Shachar S S Reeve B B Basch E Choi S K Lee J T Wood W A Anders C K Carey L A Dees E C Jolly T A Kimmick G G Karuturi M S Reinbolt R E Speca J C Muss H B Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice 2019 125 17 2945 2954 Epub Cancer 10.1002/cncr.32175 31090930 Hojo T Masuda N Iwamoto T Niikura N Anan K Aogi K Ohnishi T Yamauchi C Yoshida M Kinoshita T Masuoka H Sagara Y Sakatani T Kojima Y Tsuda H Kumamaru H Miyata H Nakamura S Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on data from the Breast Cancer Registry of the Japanese Breast Cancer Society. Breast Cancer 2019 31327134 31327134 Ntellas P Spathas N Agelaki S Zintzaras E Saloustros E Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology. Oncotarget 2019 10.18632/oncotarget.26632. eCollection 2019 Feb 5. PubMed PMID: 30838092; PubMed Central PMCID: PMC6383821 10 11 1209 1216 10.18632/oncotarget.26632 30838092 Kubatka P Uramova S Kello M Kajo K Kruzliak P Mojzis J Vybohova D Adamkov M Jasek K Lasabova Z Zubor P Fialova S Dokupilova S Solar P Pec M Adamicova K Danko J Adamek M Busselberg D Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. J Cell Mol Med 2017 Nov;21(11): 2837-2851. doi: 10.1111/jcmm.13197. Epub 5661249 10.1111/jcmm.13197 28524540 Legault J Pichette A Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol 2007 Dec;59(12): 1643-7. PubMed PMID: 18053325 18053325 Park K R Nam D Yun H M Lee S G Jang H J Sethi G Cho S K Ahn K S β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 2011 10.1016/j.canlet.2011.08.001. Epub 2011 Aug 26. PubMed PMID: 312 2 178 88 10.1016/j.canlet.2011.08.001 21924548 Kim C Cho S K Kapoor S Kumar A Vali S Abbasi T Kim S H Sethi G Ahn K S β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. Mol Carcinog 2014 Oct;53(10): 793-806. doi: 10.1002/mc.22035. Epub 2013 Jun 13. PubMed PMID: 23765383 10.1002/mc.22035 23765383 Vidhya N Devaraj S N Induction of apoptosis by eugenol in human breast cancer cells 2011 Indian J Exp Biol Nov;49(11): 871-8. PubMed PMID: 22126019 22126019 Sigurdsson S Ogmundsdottir H M Hallgrimsson J Gudbjarnason S Antitumour activity of Angelica archangelica leaf extract In Vivo. 2005 Jan-Feb;19(1): 191-4. PubMed PMID: 15796173 15796173 Motaghed M Al-Hassan F M Hamid S S Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7. Pharmacognosy Res 2013 PubMed PMID: 23900121; PubMed Central PMCID: PMC3719263 10 4103 10.4103/0974-8490.112428 23900121 Eggenschwiler J L von Balthazar Stritt B Pruntsch D Ramos M Urech K Rist L Simões-Wüst A P Viviani A Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata). BMC Complement Altern Med 2007 1878504 17493268 Thronicke A Oei S L Merkle A Matthes H Schad F Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients. Medicines 2018 6;5(3). pii: E100. doi: 10.3390/medicines5030100. PubMed PMID: 30200590; PubMed Central PMCID: PMC6164814 (Basel) 10.3390/medicines5030100 30200590 E100 Weissenstein U Kunz M Urech K Regueiro U Baumgartner S Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro. BMC Complement Altern Med. 2016 Aug 4;16: 271. doi: 10.1186/s12906-016-1246-2. PubMed PMID: 27491866; PubMed Central PMCID: PMC4973521 10.1186/s12906-016-1246-2 27491866 Beuth J Ko H L Schneider H Tawadros S Kasper H U Zimst H Schierholz J M Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model. Anticancer Res 2006 Nov-Dec;26(6B): 4451-6. PubMed PMID: 17201168 17201168 Kienle G S Glockmann A Schink M Kiene H Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res 2009 Review. PubMed PMID: 19519890; PubMed Central PMCID: PMC2711058 28 79 1 33 10.1186/1756-9966-28-79 19519890 Harmsma M Grommé M Ummelen M Dignef W Tusenius K J Ramaekers F C Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells 2004 Int Dec;25(6): 1521-9. PubMed PMID: 15547686 15547686 Tai C J Liu C H Pan Y C Wong S H Tai C J Richardson C D Lin L T Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells. Sci Rep 2019 PubMed PMID: 31043633; PubMed Central PMCID: PMC6494908 9 1 6767 10 10.1038/s41598-019-43047-3 31043633 Venditti A Maggi F Quassinti L Bramucci M Lupidi G Ornano L Ballero M Sanna C Bruno M Rosselli S Bianco A Bioactive Constituents of Juniperus turbinata Guss. from La Maddalena Archipelago. Chem Biodivers 2018 Aug;15(8):e1800148. doi: 10.1002/cbdv.201800148. Epub 2018 Jun 28. PubMed PMID: 29790302 10.1002/cbdv.201800148 29790302 Ben Mrid R Bouchmaa N Bouargalne Y Ramdan B Karrouchi K Kabach I M El Karbane Idir A Zyad A Nhiri M Phytochemical Characterization, Antioxidant and In Vitro Cytotoxic Activity Evaluation of Juniperus oxycedrus Subsp. oxycedrus Needles and Berries. Molecules. 2019 Jan 30;24(3). pii: E502. doi: 10.3390/molecules24030502. PubMed PMID: 30704127; PubMed Central PMCID: PMC6384603 10.3390/molecules24030502 30704127 E502 Bayala B Bassole I H Scifo R Gnoula C Morel L Lobaccaro J M Simpore J Anticancer activity of essential oils and their chemical components - a review. Am J Cancer Res 2014 4 6 591 607 25520854 Wang Y Sun H Xiao Z Zhang G Zhang D Bao X Li F Wu S Gao Y Wei N DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer. Cell Commun Signal 2018 PubMed PMID: 30176902; PubMed Central PMCID: PMC6122736 16 52 1 13 10.1186/s12964-018-0263-9 30176902 Zilla M K Nayak D Amin H Nalli Y Rah B Chakraborty S Kitchlu S Goswami A Ali A 4&apos;-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells. Chem Biol Interact. 2014 Dec 5;224: 100-7. doi: 10.1016/j.cbi.2014.09.022. Epub 2014 Oct 18. PubMed PMID: 25446499 10.1016/j.cbi.2014.09.022 25446499 Mukund V Saddala M S Farran B Mannavarapu M Alam A Nagaraju G P Molecular docking studies of angiogenesis target protein HIF-1α and genistein in breast 2019 Epub 2019 Mar 28. PubMed PMID: 15 169 172 10.1016/j.gene.2019.03.062 30930227 Yu S Zhu L Wang K Yan Y He J Ren Y Green tea consumption and risk of breast cancer: A systematic review and updated meta-analysis of case-control studies. Medicine (Baltimore) 2019 Jul;98(27):e16147. doi: 10.1097/MD.0000000000016147. PubMed PMID: 31277115; PubMed Central PMCID: PMC6635178 10.1097/MD.0000000000016147 31277115 Stuart E C Scandlyn M J Rosengren R J Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci 2006 Epub 2006 Aug 5. Review. PubMed PMID: 79 25 2329 36 16945390 Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast 2019 PubMed PMID: 30926986; PubMed Central PMCID: PMC6461722 149 4 619 627 10.1093/jn/nxy316 30926986 Khan N Mukhtar H Tea Polyphenols in Promotion of Human Health. Nutrients 2018 E39. doi: 10.3390/nu11010039. Review. PubMed PMID: 30585192; PubMed Central PMCID: PMC6356332 11 1 10.3390/nu11010039 30585192 E39 Schröder L Marahrens P Koch J G Heidegger H Vilsmeier T Phan-Brehm T Hofmann S Mahner S Jeschke U Richter D U Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF7 and MDA-MB-231 breast carcinoma cells. Oncol Rep 2019 Jan;41(1): 387-396. doi: 10.3892/or.2018.6789. Epub 2018 Oct 12. PubMed PMID: 30320348 10.3892/or.2018.6789 30320348 Zhang J Y Liao Y H Lin Y Liu Q Xie X M Tang L Y Ren Z F Effects of tea consumption and the interactions with lipids on breast cancer survival. Breast Cancer Res Treat 2019 176 3 679 686 10.1007/s10549-019-05253-5 31098780 Najaf Salehi M Ghazanfarpour M Hoseini Z S Khadem-Rezaiyan M The association between green tea consumption and breast cancer risk: A systematic review and meta-analysis. Phytother Res 2018 Oct;32(10): 1855-1864. doi: 10.1002/ptr.6124. Epub 2018 Jun 7. Review. PubMed PMID: 29876987 10.1002/ptr.6124 29876987 Gianfredi V Nucci D Abalsamo A Acito M Villarini M Moretti M Realdon S Green Tea Consumption and Risk of Breast Cancer and Recurrence-A Systematic Review and Meta-Analysis of Observational Studies 2018 3;10(12). pii: E1886. doi: 10.3390/nu10121886. PubMed PMID: 30513889; PubMed Central PMCID: PMC6316745 Nutrients 10.3390/nu10121886 30513889 E1886 Cai Z Y Li X M Liang J P Xiang L P Wang K R Shi Y L Yang R Shi M Ye J H Lu J L Zheng X Q Liang Y R Bioavailability of Tea Catechins and Its Improvement. Molecules. 2018 Sep 13;23(9). pii: E2346. doi: 10.3390/molecules23092346. Review. PubMed PMID: 30217074; PubMed Central PMCID: PMC6225109 10.3390/molecules23092346 30217074 E2346 Iwasaki M Mizusawa J Kasuga Y Yokoyama S Onuma H Nishimura H Kusama R Tsugane S Green tea consumption and breast cancer risk in Japanese women: a case-control study Nutr Cancer Epub 2013 Nov 25. PubMed PMID: 66 1 57 67 10.1080/01635581.2014.847963 24274352 Shirakami Y Shimizu M Possible Mechanisms of Green Tea and Its Constituents against Cancer. Molecules 2018 E2284. doi: 10.3390/molecules23092284. Review. PubMed PMID: 30205425; PubMed Central PMCID: PMC6225266 23 9 10.3390/molecules23092284 30205425 E2284 Sahin I Bilir B Ali S Sahin K Kucuk O Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy. Integr Cancer Ther 2019 Jan-Dec; PubMed PMID: 30897972; PubMed Central PMCID: PMC6431760 18 1534735419835310 10 10.1177/1534735419835310 30897972 Wu S Y Wu A T Yuan K S Liu S H Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells. J Cancer.7(15): 2408-2419.eCollection 2016. PubMed PMID: 27994679; PubMed Central PMCID: 2016 5166552 27994679 Moussavou G Kwak D H Obiang-Obonou B W Maranguy C A Dinzouna-Boutamba S D Lee D H Pissibanganga O G Ko K Seo J I Choo Y K Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs 2014 10.3390/md12094898. Review. PubMed PMID: 25255129; PubMed Central PMCID: PMC4178489 12 9 4898 911 10.3390/md12094898 25255129 Montuori N Pesapane A Rossi F W Giudice V Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer 2016 De Transl Med UniSa. 15-21. eCollection 2016 Nov. PubMed PMID: 27896223; PubMed Central PMCID: PMC5120746 27896223 Teas J Vena S Cone D L Irhimeh M The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle 2013 J Appl Phycol Jun;25(3): 771-779. Epub 2012 Nov 10. PubMed PMID: 23678231; PubMed Central PMCID: PMC3651528 23678231 Shamsabadi F T Khoddami A Fard S G Abdullah R Othman H H Mohamed S Comparison of tamoxifen with edible seaweed (Eucheuma cottonii L.) extract in suppressing breast tumor Nutr Cancer PubMed PMID: 65 2 255 62 10.1080/01635581.2013.756528 23441613 Jazzara M Ghannam A Soukkarieh C Murad H Anti-Proliferative Activity of λ-Carrageenan Through the Induction of Apoptosis in Human Breast Cancer Cells Int J Cancer Manag 9 4 1 8 10.17795/ijcp-3836 Groult H Cousin R Chot-Plassot C Maura M Bridiau N Piot J M Maugard T Fruitier-Arnaudin I λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration. Mar Drugs. 2019 Feb 27;17(3). pii: E140. doi: 10.3390/md17030140. PubMed PMID: 30818840; PubMed Central PMCID: PMC6471403 10.3390/md17030140 30818840 E140 Losada-Echeberría M Herranz-López M Micol V Barrajón-Catalán E Polyphenols as Promising Drugs against Main Breast Cancer Signatures. Antioxidants 2017 pii: E88. doi: 10.3390/antiox6040088. Review. PubMed PMID: 29112149; PubMed Central PMCID: PMC5745498 6 4 (Basel) 10.3390/antiox6040088 29112149 E88 Antioxidant antiproliferative and antiangiogenesis effects of polyphenol-rich seaweed (Sargassum muticum). Biomed Res Int 2013 Epub 2013 Sep 4. PubMed PMID: 24078922; PubMed Central PMCID: PMC3776361 10 1155 10.1155/2013/604787 24078922 Niedzwiecki A Roomi M W Kalinovsky T Rath M Anticancer Efficacy of Polyphenols and Their Combinations. Nutrients 2016 9;8(9). pii: E552. doi: 10.3390/nu8090552. Review. PubMed PMID: 27618095; PubMed Central PMCID: PMC5037537 10.3390/nu8090552 27618095 E552 Kapinova A Kubatka P Golubnitschaja O Kello M Zubor P Solar P Pec M Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med 2018 Review. PubMed PMID: 30092754; PubMed Central PMCID: PMC6085646 23 36 1 18 10.1186/s12199-018-0724-1 30092754 Keating E Martel F Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism. Front Nutr 2018 16;5: 25. doi: 10.3389/fnut.2018.00025. eCollection 2018. Review. PubMed PMID: 29713632; PubMed Central PMCID: PMC5911477 10.3389/fnut.2018.00025 29713632 Sudhakaran M Sardesai S Doseff A I Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control. Antioxidants (Basel) 2019 pii: E103. doi: 10.3390/antiox8040103. Review. PubMed PMID: 30995775; PubMed Central PMCID: PMC6523469 8 4 10.3390/antiox8040103 30995775 E103 Hui C Qi X Qianyong Z Xiaoli P Jundong Z Mantian M Flavonoids flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies PLoS One 10.1371/journal.pone.0054318. Epub 2013 Jan 18. PubMed PMID: 23349849; PubMed Central PMCID: PMC3548848 8 1 10.1371/journal.pone.0054318 23349849 Sak K Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative Review. Asian Pac J Cancer Prev 2017 PubMed PMID: 28950673; PubMed Central PMCID: PMC5720631 18 9 2309 2328 28950673 TakemuraHSakakibaraHYamazakiSShimoiKBreast cancer and flavonoids - a role in preventionCurr Pharm Des Review. PubMed PMID: 193461253223448447 Batra P Sharma A K Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech 2013 3 6 439 459 10.1007/s13205-013-0117-5 28324424 MagneNde CBZingueSWinterECreczynski-PasaT BMichelTFernandezXNjamenDClyneC FlavonoidsBreast Cancer Chemopreventive and/or Chemotherapeutic AgentsCurr Med Chem Review. PubMed PMID: 223034344626502949 Abotaleb M Samuel S M Varghese E Varghese S Kubatka P Liskova A Büsselberg D Flavonoids in Cancer and Apoptosis. Cancers 2018 pii: E28. doi: 10.3390/cancers11010028. Review. PubMed PMID: 30597838; PubMed Central PMCID: PMC6357032 11 1 (Basel) 10.3390/cancers11010028 30597838 E28 Pang B B Chu Y K Yang H [Anti-breast cancer mechanism of flavonoids]. Zhongguo Zhong Yao Za Zhi 2018 Mar;43(5): 913-920. doi: 10.19540/j.cnki.cjcmm.20171211.005. Review. Chinese. PubMed PMID: 29676087 10.19540/j.cnki.cjcmm.20171211.005 29676087 Zhang H W Hu J J Fu R Q Liu X Zhang Y H Li J Liu L Li Y N Deng Q Luo Q S Ouyang Q Gao N Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci Rep 2018 PubMed PMID: 30050147; PubMed Central PMCID: PMC6062549 8 1 13 10.1038/s41598-018-29308-7 30050147 Rodríguez-García C Sánchez-Quesada C J Gaforio Dietary Flavonoids as Cancer Chemopreventive Agents: An Updated Review of Human Studies. Antioxidants 2019 pii: E137. doi: 10.3390/antiox8050137. Review. PubMed PMID: 31109072; PubMed Central PMCID: PMC6562590 8 5 (Basel) 10.3390/antiox8050137 31109072 E137 Abudabbus A Badmus J A Shalaweh S Bauer R Hiss D Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines. Curr Pharm Biotechnol 18 9 748 757 10.2174/1389201018666171115115112 29141543 Zhang J Riby J E Conde L Grizzle W E Cui X Skibola C F A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines. BMC Complement Altern Med 2016 PubMed PMID: 27234961; PubMed Central PMCID: PMC4884380 16 151 1 9 10.1186/s12906-016-1129-6 27234961 Moussavou G Kwak D H Obiang-Obonou B W Maranguy C A Dinzouna-Boutamba S D Lee D H Pissibanganga O G Ko K Seo J I Choo Y K Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs 2014 10.3390/md12094898. Review. PubMed PMID: 25255129; PubMed Central PMCID: PMC4178489 12 9 4898 911 10.3390/md12094898 25255129 Atashrazm F Lowenthal R M Woods G M Holloway A F Dickinson J L Fucoidan and cancer: a multifunctional molecule with anti-tumor potential. Mar Drugs 2015 10.3390/md13042327. Review. PubMed PMID: 25874926; PubMed Central PMCID: PMC4413214 13 4 2327 46 10.3390/md13042327 25874926 Lu J Shi K K Chen S Wang J Hassouna A White L N Merien F Xie M Kong Q Li J Ying T White W L Nie S Fucoidan Extracted from the New Zealand Undaria pinnatifida-Physicochemical Comparison against Five Other Fucoidans: Unique Low Molecular Weight Fraction Bioactivity in Breast Cancer Cell Lines. Mar Drugs 2018 pii: E461. doi: 10.3390/md16120461. PubMed PMID: 30469516; PubMed Central PMCID: PMC6316445 16 12 10.3390/md16120461 30469516 E461 Zorofchian Moghadamtousi S Karimian H Khanabdali R Razavi M Firoozinia M Zandi K Abdul Kadir H Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae ScientificWorldJournal. 2014 Jan 2;2014: 768323. doi: 10.1155/2014/768323. eCollection 2014. Review. PubMed PMID: 24526922; PubMed Central PMCID: PMC3910333 10.1155/2014/768323 24526922 Xue M Ge Y Zhang J Wang Q Hou L Liu Y Sun L Li Q Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo PLoS One. 2012;7(8):e43483. doi: 10.1371/journal.pone.0043483. Epub 2012 Aug 20. PubMed PMID: 22916270; PubMed Central PMCID: PMC3423341 10.1371/journal.pone.0043483 22916270 Pawar V K Singh Y Sharma K Shrivastav A Sharma A Singh A Meher J G Singh P Raval K Kumar A Bora H K Datta D Lal J Chourasia M K Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin 2019 Int J Biol Macromol 10.1016/j.ijbiomac.2018.09.059. Epub 2018 Sep 13. PubMed PMID: 122 1 1100 1114 10.1016/j.ijbiomac.2018.09.059 30219515 HeXXueMJiangSLiWYuJXiangSFucoidan Promotes Apoptosis and InhibitsEMT of Breast Cancer Cells. Biol Pharm Bull423442447 PubMed PMID: 10.1248/bpb.b18-0077730828076 Xue M Ge Y Zhang J Liu Y Wang Q Hou L Zheng Z Fucoidan inhibited 4T1 mouse breast cancer cell growth in vivo and in vitro via downregulation of Wnt/β-catenin signaling Nutr Cancer PubMed PMID: 65 3 460 8 10.1080/01635581.2013.757628 23530646 XueMJiXLiangHLiuYWangBSunLLiWThe effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer. Food Funct20189212141223 PubMed PMID: 10.1039/c7fo01677h29384543 Oliveira C Neves N M Reis R L Martins A Silva T H Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells. Nanomedicine (Lond) 2018 Epub 2018 Sep 7. PubMed PMID: 13 16 2037 2050 10.2217/nnm-2018-0004 30189774 Gong X Smith J R Swanson H M Rubin L P Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms. Molecules 2018 14;23(4). pii: E905. doi: 10.3390/molecules23040905. PubMed PMID: 29662002; PubMed Central PMCID: PMC6017803 10.3390/molecules23040905 29662002 E905 ChangJZhangYLiYLuKShenYGuoYQiQWangMZhangSNrF2/ARE and NF-κB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell. Future Oncol2018148719726 PubMed PMID: 10.2217/fon-2017-058429336610 Mignone L I Giovannucci E Newcomb P A Titus-Ernstoff L Trentham-Dietz A Hampton J M Willett W C Egan K M Dietary carotenoids and the risk of invasive breast cancer 2009 Int 10.1002/ijc.24334. PubMed PMID: 19330841; PubMed Central PMCID: PMC3564658 124 12 2929 37 10.1002/ijc.24334 19330841 Li Y Zhang Y Liu X Wang M Wang P Yang J Zhang S Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1 2018 Int Jun;52(6): 2119-2129. doi: 10.3892/ijo.2018.4332. Epub 2018 Mar 23. PubMed PMID: 29620169 10.3892/ijo.2018.4332 29620169 Yan B Lu M S Wang L Mo X F Luo W P Du Y F Zhang C X Specific serum carotenoids are inversely associated with breast cancer risk among Chinese women: a case-control study 2016 Br 10.1017/S000711451500416X. Epub 2015 Oct 20. PubMed PMID: 115 1 129 37 10.1017/S000711451500416X 26482064 DHA Rocha AML Seca DCGA Pinto Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity. Mar Drugs 2018 pii: E410. doi: 10.3390/md16110410. Review. PubMed PMID: 30373208; PubMed Central PMCID: PMC6266495 16 11 10.3390/md16110410 30373208 E410 Erfani N Nazemosadat Z Moein M Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy Res 2015 PubMed PMID: 25829786; PubMed Central PMCID: PMC4357963 7 2 133 7 10.4103/0974-8490.150539 25829786 Li Y X Himaya S W Dewapriya P Zhang C Kim S K Fumigaclavine C from a marine-derived fungus Aspergillus fumigatus induces apoptosis in MCF-7 breast cancer cells. Mar Drugs 2013 10.3390/md11125063. PubMed PMID: 24351905; PubMed Central PMCID: PMC3877903 11 12 5063 86 10.3390/md11125063 24351905 Dyshlovoy S A Honecker F Marine Compounds and Cancer: Where Do We Stand? Mar Drugs 2015 Sep;13(9): 5657-65. Epub 2015 Sep 2. PubMed PMID: 26540740; PubMed Central PMCID: PMC4584346 26540740 Vaikundamoorthy R Krishnamoorthy V Vilwanathan R Rajendran R Structural characterization and anticancer activity (MCF7 and MDA-MB-231) of polysaccharides fractionated from brown seaweed Sargassum wightii 2018 Int J Biol Macromol May;111: 1229-1237. doi: 10.1016/j.ijbiomac.2018.01.125. Epub 2018 Feb 19. PubMed PMID: 29415413 10.1016/j.ijbiomac.2018.01.125 29415413 Sithranga Boopathy N Kathiresan K Anticancer drugs from marine flora: an overview. J Oncol 2010 Epub 2011 Feb 27. PubMed PMID: 21461373; PubMed Central PMCID: PMC3065217 21 41 86 10.1155/2010/214186 21461373 Abd-Ellatef G F Ahmed O M Abdel-Reheim E S Abdel-Hamid A Z Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis through the augmentation of apoptosis, enhancement of antioxidant defense system, and suppression of inflammation 2017 Breast Cancer (Dove Med Press); 9 67 83 10.2147/BCTT.S125165 28280387 Fedorov S N Ermakova S P Zvyagintseva T N Stonik V A Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects. Mar Drugs 2013 10.3390/md11124876. PubMed PMID: 24317475; PubMed Central PMCID: PMC3877892 11 12 4876 901 10.3390/md11124876 24317475 Isolation Structural characterization, and antiproliferative activity of phycocolloids from the red seaweed Laurencia papillosa on MCF-7 human breast cancer cells 2018 Int J Biol Macromol Mar;108: 916-926. doi: 10.1016/j.ijbiomac.2017.11.001. Epub 2017 Nov 4. PubMed PMID: 29113895 10.1016/j.ijbiomac.2017.11.001 29113895 Vishchuk O S Ermakova S P Zvyagintseva T N Sulfated polysaccharides from brown seaweeds Saccharina japonica and Undaria pinnatifida: isolation, structural characteristics, and antitumor activity. Carbohydr Res 2011 10.1016/j.carres.2011.09.034. Epub 2011 Oct 5. PubMed PMID: 346 17 2769 76 10.1016/j.carres.2011.09.034 22024567 Vaseghi G Sharifi M Dana N Ghasemi A Yegdaneh A Cytotoxicity of Sargassum angustifolium Partitions against Breast and Cervical Cancer Cell Lines. Adv Biomed Res 2018 27;7: 43. doi: 10.4103/abr.abr_259_16. eCollection 2018. PubMed PMID: 29657928; PubMed Central PMCID: PMC5887695 10.4103/abr.abr_259_16 29657928 Kim E K Tang Y Kim Y S Hwang J W Choi E J Lee J H Lee S H Jeon Y J Park P J First evidence that Ecklonia cava-derived dieckol attenuates MCF-7 human breast carcinoma cell migration. Mar Drugs 2015 10.3390/md13041785. PubMed PMID: 25830682; PubMed Central PMCID: PMC4413187 13 4 1785 97 10.3390/md13041785 25830682 Araghi M Soerjomataram I Jenkins M Brierley J Morris E Bray F Arnold M Global trends in colorectal cancer mortality: projections to the year 2035. Int 2019 10.1002/ijc.32055. Epub 2019 Jan 8. PubMed PMID: 144 12 2992 3000 10.1002/ijc.32055 30536395 Recio-Boiles A Waheed A Cagir B Cancer Colon In: StatPearls [Internet]. Treasure Island (FL): StatPearls, Available from:https://www.ncbi.nlm.nih.gov/books/NBK470380/ 2019 Virk G S Jafri M Ashley C Colonoscopy and colorectal cancer rates among octogenarians and nonagenarians: nationwide study of US veterans 2019 Clin Interv Aging.; 14 609 614 10.2147/CIA.S192497 30988602 ScreeningPDQPreventionEditorial BoardColorectal Cancer Prevention (PDQ®): Health Professional Version2019PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); Available from: https://www.ncbi.nlm.nih.gov/books/NBK65779/ ChenWZhengRBaadeP DZhangSZengHBrayFJemalAYuX QHeJCancer statistics in China2015CA Cancer66211532 PubMed PMID: 10.3322/caac.2133826808342 Araghi M Soerjomataram I Bardot A Ferlay J Cabasag C J Morrison D S P Tervonen H De Walsh P M Bucher O Engholm G Jackson C McClure C Woods R R Saint-Jacques N Morgan E Ransom D Thursfield V Møller B Leonfellner S Guren M G Bray F Arnold M Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol 2019 Aug;4(8):e8. PubMed PMID: 4 7 511 518 10.1016/S2468-1253(19)30147-5 31105047 AJD Wray Minaker L M Is cancer prevention influenced by the built environment? A multidisciplinary scoping review 2019 31287585 Cancer 10.1002/cncr.32376 31287585 Poirier A E Ruan Y Walter S D Franco E L Villeneuve P J King W D Volesky K D O&apos;Sullivan D E Friedenreich C M Brenner DR; ComPARe Study Team. The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042. Cancer Epidemiol 2019 Apr;59: 199-207. doi: 10.1016/j.canep.2019.02.011. Epub 2019 Mar 1. PubMed PMID: 30831552 10.1016/j.canep.2019.02.011 30831552 Poirier A E Ruan Y Hebert L A Grevers X Walter S D Villeneuve P J Brenner D R Friedenreich CM; ComPARe Study Team. Estimates of the current and future burden of cancer attributable to low fruit and vegetable consumption in Canada. Prev Med 2019 May;122: 20-30. doi: 10.1016/j.ypmed.2019.03.013. Erratum in: Prev Med. 2019 Aug;125: 79. PubMed PMID: 31078169 10.1016/j.ypmed.2019.03.013 31078169 Feletto E Yu X Q Lew J B St John DJB Jenkins M A Macrae F A Mahady S E Canfell K Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases. Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1): 83 90 10.1158/1055-9965.EPI-18-0523 30530848 Jenkins M A Ait Ouakrim D Boussioutas A Hopper J L Ee H C Emery J D Macrae F A Chetcuti A Wuellner L St John DJB Revised Australian national guidelines for colorectal cancer screening: family history 2018 Med 209 10 455 460 30359558 GloverMMansoorEPanhwarMParasaSCooperG S2019Epidemiology of Colorectal Cancer in Average Risk Adults 20-39 Years of Age: A Population-Based National Study. Dig Dis Sci18 [Epub ahead of print] PubMed PMID: 10.1007/s10620-019-05690-831175493 Siegel R L Medhanie G A Fedewa S A Jemal A State variation in early-onset colorectal cancer in the United States 1995 J Natl Cancer Inst 29. pii: djz098. doi: 10.1093/jnci/djz098. [Epub ahead of print] PubMed PMID: 31141602 10.1093/jnci/djz098 31141602 djz098 Mannucci A Zuppardo R A Rosati R Leo M D Perea J Cavestro G M Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis 2019 10.3748/wjg.v25.i21.2565. Review. PubMed PMID: 31210710; PubMed Central PMCID: PMC6558439 25 21 2565 2580 World 10.3748/wjg.v25.i21.2565 31210710 Erdrich J Zhang X Giovannucci E Willett W Proportion of colon cancer attributable to lifestyle in a cohort of US women. Cancer Causes Control 2015 26 9 1271 1279 10.1007/s10552-015-0619-z 26092381 Aleksandrova K Pischon T Jenab M Bueno-de-Mesquita H B Fedirko V Norat T Romaguera D Knüppel S Boutron-Ruault M C Dossus L Dartois L Kaaks R Li K Tjønneland A Overvad K Quirós J R Buckland G Sánchez M J Dorronsoro M Chirlaque M D Barricarte A Khaw K T Wareham N J Bradbury K E Trichopoulou A Lagiou P Trichopoulos D Palli D Krogh V Tumino R Naccarati A Panico S Siersema P D Peeters P H Ljuslinder I Johansson I Ericson U Ohlsson B Weiderpass E Skeie G Borch K B Rinaldi S Romieu I Kong J Gunter M J Ward H A Riboli E Boeing H Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med 2014 PubMed PMID: 25319089; PubMed Central PMCID: PMC4192278 12 168 1 15 10.1186/s12916-014-0168-4 25319089 Jeon J Du M Schoen R E Hoffmeister M Newcomb P A Berndt S I Caan B Campbell P T Chan A T Chang-Claude J Giles G G Gong J Harrison T A Huyghe J R Jacobs E J Li L Lin Y L Potter J D Qu C Bien S A Zubair N Macinnis R J Buchanan D D Hopper J L Cao Y Nishihara R Rennert G Slattery M L Thomas D C Woods M O Prentice R L Gruber S B Zheng Y Brenner H Hayes R B White E Peters U Hsu L Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. 2018 Jun;154(8): 2152-2164.e19. doi: 10.1053/j.gastro.2018.02.021. Epub 2018 Feb 17. PubMed PMID: 29458155; PubMed Central PMCID: PMC5985207 10.1053/j.gastro.2018.02.021 29458155 Oruç Z Kaplan M A Effect of exercise on colorectal cancer prevention and treatment. World J Gastrointest Oncol 2019 10.4251/wjgo.v11.i5.348. Review. PubMed PMID: 31139306; PubMed Central PMCID: PMC6522766 11 5 348 366 10.4251/wjgo.v11.i5.348 31139306 Bradbury K E Murphy N Key T J Diet and colorectal cancer in UK Biobank: a prospective study 2019 Int 17. pii: dyz064. doi: 10.1093/ije/dyz064. [Epub ahead of print] PubMed PMID: 30993317 10.1093/ije/dyz064 30993317 dyz064 Fedirko V Tramacere I Bagnardi V Rota M Scotti L Islami F Negri E Straif K Romieu I La Vecchia C Boffetta P Jenab M Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011 Sep;22(9): 1958-72. doi: 10.1093/annonc/mdq653. Epub 2011 Feb 9. Review. PubMed PMID: 21307158 10.1093/annonc/mdq653 21307158 VieiraA RAbarLDSMChanVingelieneSPolemitiEStevensCGreenwoodDNoratTFoods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol2017 doi: 10.1093/annonc/mdx171. Review. PubMed PMID: 2881788180210.1093/annonc/mdx17128407090 Pericleous M Mandair D Caplin M E Diet and supplements and their impact on colorectal cancer J Gastrointest Oncol Review. PubMed PMID: 24294513; PubMed Central PMCID: PMC3819783 4 4 409 23 10.3978/j.issn.2078-6891.2013.003 24294513 Chen Z Wang P P Woodrow J Zhu Y Roebothan B Mclaughlin J R Parfrey P S Dietary patterns and colorectal cancer: results from a Canadian population-based study 2015 Nutr PubMed PMID: 25592002; PubMed Central PMCID: PMC4326290 14 8 1 9 10.1186/1475-2891-14-8 25592002 2019 National Cancer Institute. Financial Burden of Cancer Care Available From:https://progressreport.cancer.gov/after/economic_burden American Cancer Society. Colorectal Cancer Facts & Figures. Available from:https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2019.pdf 2019 Gellad Z F Provenzale D Colorectal cancer: national and international perspective on the burden of disease and public health impact Gastroenterology. 2010 Jun;138(6): 2177-90. doi: 10.1053/j.gastro.2010.01.056. Review. PubMed PMID: 20420954 10.1053/j.gastro.2010.01.056 20420954 Cancer World Research Fund International. Colorectal cancer statistics. Available from:https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics 2003 Rodriguez-Bigas MA, Lin EH, Crane CH. Stage IV Colorectal Cancer. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; Available from: https://www.ncbi.nlm.nih.gov/books/NBK13267/ Lee S D Choe J W Lee B J Kang M H Joo M K Kim J H Yeon J E Park J J Kim J S Bak Y T Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression 2015 10.3748/wjg.v21.i2.465. PubMed PMID: 25593461; PubMed Central PMCID: PMC4292277 21 2 465 74 World 10.3748/wjg.v21.i2.465 25593461 Yang Y Zhang J Weiss N S Guo L Zhang L Jiang Y Yang Y The consumption of chili peppers and the risk of colorectal cancer: a matched case-control study. World J Surg Oncol 2019 PubMed PMID: 30995922; PubMed Central PMCID: PMC6472026 17 71 1 7 10.1186/s12957-019-1615-7 30995922 Bar-Shalom R Bergman M Grossman S Azzam N Sharvit L Fares F Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis. Front Oncol 2019 10;9: 227. doi: 10.3389/fonc.2019.00227. eCollection 2019. PubMed PMID: 31024836; PubMed Central PMCID: PMC6469364 10.3389/fonc.2019.00227 31024836 Tong J Shen Y Zhang Z Hu Y Zhang X Han L Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway. Biosci Rep 2019 pii: BSR20190452. doi: 10.1042/BSR20190452. Print 39 5 6522743 10.1042/BSR20190452 30967496 BSR20190452 Aggarwal B Prasad S Sung B Krishnan S Guha S Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature. Curr Colorectal Cancer Rep 2013 PubMed PMID: 23814530; PubMed Central PMCID: PMC3693477 9 1 37 56 23814530 Kumar S Agnihotri N Piperlongumine a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer. Biomed Pharmacother 2019 Jan;109: 1462-1477. doi: 10.1016/j.biopha.2018.10.182. Epub 2018 Nov 13. PubMed PMID: 30551398 10.1016/j.biopha.2018.10.182 30551398 Xu J Long Y Ni L Yuan X Yu N Wu R Tao J Zhang Y Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer 2019 PubMed PMID: 31208348; PubMed Central PMCID: PMC6580644 19 589 1 20 10.1186/s12885-019-5791-1 31208348 Dai W Mu L Cui Y Li Y Chen P Xie H Wang X Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis. Med Sci Monit. 2019 Jan 25;25: 730-738. doi: 10.12659/MSM.912082. PubMed PMID: 30681073; PubMed Central PMCID: PMC6357823 10.12659/MSM.912082 30681073 González-Sarrías A MÁ Núñez-Sánchez Tomé-Carneiro J Tomás-Barberán F A García-Conesa M T Espín J C Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res 2016 Apr;60(4): 701-16. doi: 10.1002/mnfr.201500780. Epub 2015 Dec 29. PubMed PMID: 26634414 10.1002/mnfr.201500780 26634414 Nuñez-Sánchez M A Dávalos A González-Sarrías A Casas-Agustench P Visioli F Monedero-Saiz T García-Talavera N V Gómez-Sánchez M B Sánchez-Álvarez C García-Albert A M Rodríguez-Gil F J Ruiz-Marín M Pastor-Quirante F A Martínez-Díaz F Tomás-Barberán F A García-Conesa M T Espín J C MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: Critical issues to discern between modulatory effects and potential artefacts. Mol Nutr Food Res 2015 Oct;59(10): 1973-86. doi: 10.1002/mnfr.201500357. Epub 2015 Jul 20. PubMed PMID: 26105520 10.1002/mnfr.201500357 26105520 Nuñez-SánchezM AGonzález-SarríasAGarcía-VillalbaRMonedero-SaizTGarcía-TalaveraN VGómez-SánchezM BSánchez-ÁlvarezCGarcía-AlbertA MRodríguez-GilF JRuiz-MarínMPastor-QuiranteF AMartínez-DíazFTomás-BarberánF AEspínJ CGarcía-ConesaM TGene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial. J Nutr Biochem2017Apr;42: 126-133. doi: 10.1016/j.jnutbio.2017.01.014. Epub28183047 PubMed PMID: 10.1016/j.jnutbio.2017.01.01428183047 Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors 2018 pii: E28. doi: 10.3390/nu11010028. PubMed PMID: 30583518; PubMed Central PMCID: PMC6356708 11 1 Nutrients 10.3390/nu11010028 30583518 E28 Bogachek M V Park J M De Andrade JP Lorenzen A W Kulak M V White J R Gu V W Wu V T Weigel R J Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas. Stem Cell Reports. 2016 Dec 13;7(6): 1140-1151. doi: 10.1016/j.stemcr.2016.11.001. Epub 2016 Dec 1. PubMed PMID: 27916539; PubMed Central PMCID: PMC5161532 10.1016/j.stemcr.2016.11.001 27916539 Gong X Chen Z Han Q Chen C Jing L Liu Y Zhao L Yao X Sun X Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP 2018 PubMed PMID: 29783958; PubMed Central PMCID: PMC5963096 18 578 1 15 10.1186/s12885-018-4463-x 29783958 Zeng A Hua H Liu L Zhao J Corrigendum to &apos;Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo&apos; 2019 Bioorg. Med. Chem Bioorg Med Chem. 2019 Aug 12: 115024. doi: 10.1016/j.bmc.2019.07.040. [Epub ahead of print] PubMed PMID: 27 2546 2552 10.1016/j.bmc.2019.07.040 31416739 Dutta D Paul B Mukherjee B Mondal L Sen S Chowdhury C Debnath M C Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo. Sci Rep 2019 PubMed PMID: 31395908; PubMed Central PMCID: PMC6687831 9 11506 1 20 10.1038/s41598-019-47743-y 31395908 Toden S Okugawa Y Buhrmann C Nattamai D Anguiano E Baldwin N Shakibaei M Boland C R Goel A Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer. Cancer Prev Res (Phila) 2015 8 5 431 43 10.1158/1940-6207.CAPR-14-0354 25712055 Leu J D Wang B S Chiu S J Chang C Y Chen C C Chen F D Avirmed S Lee Y J Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models. Oncol Lett 2016 Dec;12(6): 4975-4982. doi: 10.3892/ol.2016.5345. Epub 2016 Nov 2. PubMed PMID: 28105204; PubMed Central PMCID: PMC5228362 10.3892/ol.2016.5345 28105204 Huang Y T Lin C I Chien P H Tang T T Lin J Chao J I The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact 2014 5;220: 41-50. doi: 10.1016/j.cbi.2014.06.006. Epub 2014 Jun 12. PubMed PMID: 24931875 10.1016/j.cbi.2014.06.006 24931875 YitC CDasN PCytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett19948216572 PubMed PMID: 8033070 Zhang L Yang X Li X Li C Zhao L Zhou Y Hou H Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting 2015 FoxO3a. Int J Mol Med. 2015 Oct;36(4): 957-66. doi: 10.3892/ijmm.2015.2324. Epub 4564095 10.3892/ijmm.2015.2324 26310353 Jin J Lin G Huang H Xu D Yu H Ma X Zhu L Ma D Jiang H Capsaicin mediates cell cycle arrest and apoptosis in human colon cancer cells via stabilizing and activating p53 2014 Int J Biol Sci 10 3 285 95 10.7150/ijbs.7730 24643130 Lee S H Clark R Anti-Tumorigenic Effects of Capsaicin in Colon Cancer J Food Chem Nanotechnol 2016 162 167 10.17756/jfcn.2016-025 YangJLiT ZXuG HLuoB BChenY XZhangTLow-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathwaysNeoplasma60436472 PubMed PMID: 10.4149/neo_2013_04823581408 Ozmen N Kaya-Sezginer E Bakar-Ates F The Cellular Uptake and Apoptotic Efficiency of Colchicine is Correlated with Downregulation of MMP-9 mRNA Expression in SW480 Colon Cancer Cells. Anticancer Agents Med Chem 18 13 1927 1933 10.2174/1871520618666180821102047 30129419 Huang Z Xu Y Peng W Colchicine induces apoptosis in HT29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol Med Rep 2015 Oct;12(4): 5939-44. doi: 10.3892/mmr.2015.4222. Epub 2015 Aug 12. PubMed PMID: 26299305 10.3892/mmr.2015.4222 26299305 Zhang T Chen W Jiang X Liu L Wei K Du H Wang H Li J Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo. Biosci Rep 2019 15;39(1). pii: BSR20181802. doi: 10.1042/BSR20181802. Print 6331673 10.1042/BSR20181802 30429232 BSR20181802 Saud S M Li W Morris N L Matter M S Colburn N H Kim Y S Young M R Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 2014 Dec;35(12): 2778-86. doi: 10.1093/carcin/bgu209. Epub 2014 Oct 3. PubMed PMID: 25280562; PubMed Central PMCID: PMC4247523 10.1093/carcin/bgu209 25280562 Altamemi I Murphy E A Catroppo J F Zumbrun E E Zhang J McClellan J L Singh U P Nagarkatti P S Nagarkatti M Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis 2014 in Apc(Min/+) mice. J Pharmacol Exp Ther. 2014 Jul;350(1): 99-109. doi: 10.1124/jpet.114.213306. Epub 4056272 10.1124/jpet.114.213306 24817032 Chung S S Wu Y Okobi Q Adekoya D Atefi M Clarke O Dutta P Vadgama J V Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells. Mediators Inflamm. 2017;2017: 5958429. doi: 10.1155/2017/5958429. Epub 2017 Jun 6. PubMed PMID: 28676732; PubMed Central PMCID: PMC5476880 10.1155/2017/5958429 28676732 Reddivari L Charepalli V Radhakrishnan S Vadde R Elias R J Lambert J D Vanamala J K Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis 2016 BMC Complement Altern Med PubMed PMID: 27506388; PubMed Central PMCID: PMC4977641 16 278 1 12 10.1186/s12906-016-1254-2 27506388 Kumazaki M Noguchi S Yasui Y Iwasaki J Shinohara H Yamada N Akao Y Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. J Nutr Biochem 2013 Nov;24(11): 1849-58. doi: 10.1016/j.jnutbio.2013.04.006. Epub 2013 Aug 16. PubMed PMID: 23954321 10.1016/j.jnutbio.2013.04.006 23954321 Raja S B Rajendiran V Kasinathan N K A P Venkatabalasubramanian S Murali M R Devaraj H Devaraj S N Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression. Food Chem Toxicol 2017 Aug;106(Pt A): 92-106. doi: 10.1016/j.fct.2017.05.006. Epub 2017 May 4. PubMed PMID: 28479391 10.1016/j.fct.2017.05.006 28479391 Yang L Liu Y Wang M Qian Y Dong X Gu H Wang H Guo S Hisamitsu T Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis. Mol Med Rep 2016 Nov;14(5): 4559-4566. doi: 10.3892/mmr.2016.5818. Epub 2016 Oct 10. PubMed PMID: 27748879; PubMed Central PMCID: PMC5101998 10.3892/mmr.2016.5818 27748879 KimH JKimS KKimB SLeeS HParkY SParkB KKimS JKimJChoiCKimJ SChoS DJungJ WRohK HKangK SJungJ YApoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem20105815864350 PubMed PMID: 10.1021/jf101510z20681654 Refolo M G D&apos;Alessandro R Malerba N Laezza C Bifulco M Messa C Caruso M G Notarnicola M Tutino V Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines. J Cell Physiol 2015 Dec;230(12): 2973-80. doi: 10.1002/jcp.25026. PubMed PMID: 25893829 10.1002/jcp.25026 25893829 Zhang X A Zhang S Yin Q Zhang J Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacogn Mag 2015 PubMed PMID: 25829782; PubMed Central PMCID: PMC4378141 11 42 404 9 10.4103/0973-1296.153096 25829782 James S Aparna J S Paul A M Lankadasari M B Mohammed S Binu V S Santhoshkumar T R Reshmi G Harikumar K B Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression. Sci Rep 2017 PubMed PMID: 29066742; PubMed Central PMCID: PMC5655681 7 1 13945 10 10.1038/s41598-017-14253-8 29066742 Park S Gwak J Han S J Oh S Cardamonin suppresses the proliferation of colon cancer cells by promoting β-catenin degradation Biol Pharm Bull Epub 2013 Mar 29. PubMed PMID: 36 6 1040 4 23538439 Lu S Lin C Cheng X Hua H Xiang T Huang Y Huang X Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway in vitro. Oncol Lett 2018 Jun;15(6): 9641-9646. doi: 10.3892/ol.2018.8580. Epub 2018 Apr 26. PubMed PMID: 29928339; PubMed Central PMCID: PMC6004643 10.3892/ol.2018.8580 29928339 Jiang Z Cao Q Dai G Wang J Liu C Lv L Pan J Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling. Onco Targets Ther 2019 9;12: 509-518. doi: 10.2147/OTT.S187817. eCollection 2019. PubMed PMID: 30666129; PubMed Central PMCID: PMC6331187 10.2147/OTT.S187817 30666129 Gao Y Zhou S Pang L Yang J Li H J Huo X Qian S Y Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer. Free Radic Res 2019 Epub 2019 Feb 18. PubMed PMID: 53 3 324 334 10.1080/10715762.2019.1575512 30773944 Moreira H Szyjka A Gąsiorowski K Chemopreventive activity of celastrol in drug-resistant human colon carcinoma cell cultures. Oncotarget 2018 9 30 21211 21223 10.18632/oncotarget.25014 29765532 Bufu T X Yilin Z Di Gege L Xi C Ling W Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway. Anticancer Drugs 2018 Jul;29(6): 530-538. doi: 10.1097/CAD.0000000000000621. PubMed PMID: 29553945 10.1097/CAD.0000000000000621 29553945 Xiao-Pei H Ji-Kuai C Xue W Dong Y F Yan L Xiao-Fang Z Ya-Min P Wen-Jun C Jiang-Bo Z Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol. Biosci Rep 2018 20; 38(6). pii: BSR20181233. doi: 10.1042/BSR20181233. Print 2018 Dec 21. PubMed PMID: 30333251; PubMed Central PMCID: PMC6246769 10.1042/BSR20181233 30333251 BSR20181233 Chen L Jiang K Chen H Tang Y Zhou X Tan Y Yuan Y Xiao Q Ding K Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway 2018 Cancer Manag Res.; 11 95 105 10.2147/CMAR.S169476 30588113 Murillo G Salti G I Kosmeder JW 2nd Pezzuto J M Mehta R G Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest 2002 Eur Dec;38(18): 2446-54. PubMed PMID: 12460790 12460790 Lokhande K B Nagar S Swamy K V Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach. Sci Rep 2019 PubMed PMID: 30741976; PubMed Central PMCID: PMC6370771 9 1 1 13 10.1038/s41598-018-38332-6 30741976 Kang W Zheng X Wang P Guo S Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro 2018 Int J Mol Med Jun;41(6): 3157-3166. doi: 10.3892/ijmm.2018.3532. Epub 2018 Mar 5. PubMed PMID: 29512685; PubMed Central PMCID: PMC5881843 10.3892/ijmm.2018.3532 29512685 Diosgenina naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett20072552194204 PubMed PMID: 17555873 Lepage C Léger D Y Bertrand J Martin F Beneytout J L Liagre B Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett 2011 10.1016/j.canlet.2010.12.003. Epub 2010 Dec 30. PubMed PMID: 301 2 193 202 10.1016/j.canlet.2010.12.003 21195543 Jesus M Martins A P Gallardo E Silvestre S Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology 2016 J Anal Methods Chem; Epub 2016 Dec 28. Review. PubMed PMID: 28116217; PubMed Central PMCID: PMC5225340 1 16 10.1155/2016/4156293 28116217 Sethi G Shanmugam M K Warrier S Merarchi M Arfuso F Kumar A P Bishayee A 2018 Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review. Nutrients; 10(5). pii: E645. doi: 10.3390/nu10050645. Review. PubMed PMID: 29783752; PubMed Central PMCID: PMC5986524 10.3390/nu10050645 29783752 E645 Dai G Ding K Cao Q Xu T He F Liu S Ju W Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2 Eur J Pharmacol. 2019 Sep 15;859: 172525. doi: 10.1016/j.ejphar.2019.172525. Epub 2019 Jul 6. PubMed PMID: 31288005 10.1016/j.ejphar.2019.172525 31288005 Gu J Cui C F Yang L Wang L Jiang X H Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway. Oncol Res 2019 10.3727/096504018X15150662230295. Epub 2018 Jan 4. PubMed PMID: 27 2 193 202 10.3727/096504018X15150662230295 29301594 Saunders I T Mir H Kapur N Singh S Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell Int 2019 PubMed PMID: 31011292; PubMed Central PMCID: PMC6466701 1 18 10.1186/s12935-019-0820-3 31011292 Wang Y Luo Q He X Wei H Wang T Shao J Jiang X Emodin Induces Apoptosis of Colon Cancer Cells via Induction of Autophagy in a ROS-Dependent Manner. Oncol Res 2018 10.3727/096504017X15009419625178. Epub 2017 Jul 25. PubMed PMID: 26 6 889 899 10.3727/096504017X15009419625178 28762328 Wu T Wang C Wang W Hui Y Zhang R Qiao L Dai Y Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis Oncoimmunology. 2018 Aug 24;7(11):e1498437. doi: 10.1080/2162402X.2018.1498437. eCollection 2018. PubMed PMID: 30377563; PubMed Central PMCID: PMC6205065 10.1080/2162402X.2018.1498437 30377563 DaiYJiaoHTengGWangWZhangRWangYHebbardLGeorgeJQiaoLEmbelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther2014135120616 PubMed PMID: 10.1158/1535-7163.MCT-13-037824651526 Wu T Dai Y Wang W Teng G Jiao H Shuai X Zhang R Zhao P Qiao L Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer Oncotarget. 2016 Apr 12;7(15): 19548-58. doi: 10.18632/oncotarget.6969. PubMed PMID: 26799669; PubMed Central PMCID: PMC4991400 10.18632/oncotarget.6969 26799669 Cheng C Dong W Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells 2018 Med Sci Monit; 10.12659/MSM.908400. PubMed PMID: 30199885; PubMed Central PMCID: PMC6142869 24 6331 6339 10.12659/MSM.908400 30199885 Bedi D Henderson H J Manne U Samuel T Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells. Medicines 2019 pii: E51. doi: 10.3390/medicines6020051. PubMed PMID: 31022845; PubMed Central PMCID: PMC6631458 6 2 (Basel) 10.3390/medicines6020051 31022845 E51 Yang N Zhao Y Wang Z Liu Y Zhang Y Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway. Mol Med Rep 2017 Feb;15(2): 929-935. doi: 10.3892/mmr.2016.6081. Epub 2016 Dec 28. PubMed PMID: 28035355 10.3892/mmr.2016.6081 28035355 Kang K A Piao M J Ryu Y S Hyun Y J Park J E Shilnikova K Zhen A X Kang H K Koh Y S Jeong Y J Hyun J W Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells 2017 Int Oct;51(4): 1169-1178. doi: 10.3892/ijo.2017.4091. Epub 2017 Aug 2. PubMed PMID: 28791416 10.3892/ijo.2017.4091 28791416 A Di Francesco Falconi A C Di Germanio MV Micioni Di Bonaventura Costa A Caramuta S Del Carlo M Compagnone D Dainese E Cifani C Maccarrone M D&apos;Addario C Extravirgin olive oil up-regulates CB tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms. J Nutr Biochem 2015 Mar;26(3): 250-8. doi: 10.1016/j.jnutbio.2014.10.013. Epub 2014 Dec 3. PubMed PMID: 25533906 10.1016/j.jnutbio.2014.10.013 25533906 Huang G M Sun Y Ge X Wan X Li C B Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways 2015 10.3748/wjg.v21.i20.6194. PubMed PMID: 26034354; PubMed Central PMCID: PMC4445096 21 20 6194 205 World 10.3748/wjg.v21.i20.6194 26034354 Tsoukas M A Ko B J Witte T R Dincer F Hardman W E Mantzoros C S Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation. J Nutr Biochem 2015 Jul;26(7): 776-83. doi: 10.1016/j.jnutbio.2015.02.009. Epub 2015 Apr 1. PubMed PMID: 25882694 10.1016/j.jnutbio.2015.02.009 25882694 KimJLeeJOhJ HChangH JSohnD KShinAKimJAssociations among dietary seaweed intake, c-MYC rs6983267 polymorphism, and risk of colorectal cancer in a Korean population: a case-control study2019Eur12101007 [Epub ahead of print] PubMed PMID: 10.1007/s00394-019-02046-w31300834 Zhao Y Zheng Y Wang J Ma S Yu Y White W L Yang S Yang F Lu J Fucoidan Extracted from Undaria pinnatifida: Source for Nutraceuticals/Functional Foods. Mar Drugs 2018 9;16(9). pii: E321. doi: 10.3390/md16090321. Review. PubMed PMID: 30205616; PubMed Central PMCID: PMC6164441 10.3390/md16090321 30205616 E321 Tsai H L Tai C J Huang C W Chang F R Wang J Y Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial. Mar Drugs 2017 21;15(4). pii: E122. doi: 10.3390/md15040122. PubMed PMID: 28430159; PubMed Central PMCID: PMC5408268 10.3390/md15040122 28430159 E122 Wang S K Li Y White W L Lu J Extracts from New Zealand Undaria pinnatifida Containing Fucoxanthin as Potential Functional Biomaterials against Cancer in Vitro. J Funct Biomater 2014 10.3390/jfb5020029. PubMed PMID: 24956438; PubMed Central PMCID: PMC4099972 5 2 29 42 10.3390/jfb5020029 24956438 Han Y S Lee J H Lee S H Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep 2015 Sep;12(3): 3446-3452. doi: 10.3892/mmr.2015.3804. Epub 4526071 10.3892/mmr.2015.3804 25998232 Han Y S Lee J H Lee S H Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling. Biomol Ther (Seoul) 2015 May;23(3): 225-32. doi: 10.4062/biomolther.2014.136. Epub 4428714 10.4062/biomolther.2014.136 25995820 Chen L M Liu P Y Chen Y A Tseng H Y Shen P C Hwang P A Hsu H L Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression. Sci Rep 2017 PubMed PMID: 28928376; PubMed Central PMCID: PMC5605496 7 11864 1 12 10.1038/s41598-017-12111-1 28928376 Kim S-K Karagozlu M Z Chapter 17. Marine algae: Natural Product Source for the gastrointestinal Cancer Treatment. In: Marine Medicinal Foods: Implications and Applications 2011 ISBN Macro and Microalgae, Volume 64 of Advances in Food and Nutrition Research, ISSN 1043-4526. Editors: Se-Kwon Kim, Steve 0123876699 9780123876690 Taylor Publisher:Academic Press Bakunina I Chadova O Malyarenko O Ermakova S The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α-N-Acetylgalactosaminidase of Human Colon Carcinoma Cells. Mar Drugs 2018 10;16(5). pii: E155. doi: 10.3390/md16050155. PubMed PMID: 29748462; PubMed Central PMCID: PMC5983286 10.3390/md16050155 29748462 E155 Kim I H Kwon M J Nam T J Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells. Mol Med Rep 2017 Jun;15(6): 4116-4122. doi: 10.3892/mmr.2017.6520. Epub 5436236 10.3892/mmr.2017.6520 28487956 Tsai C F Yeh W L Chen J H Lin C Huang S S Lu D Y Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression Int J Mol Sci. 2014 Mar 4;15(3): 3889-903. doi: 10.3390/ijms15033889. PubMed PMID: 24599080; PubMed Central PMCID: PMC3975374 10.3390/ijms15033889 24599080 Kim H Y Kim Y M Hong S Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a. Sci Rep 2019 PubMed PMID: 31263239; PubMed Central PMCID: PMC6603017 9 9457 1 10 10.1038/s41598-019-45924-3 31263239 Nagendraprabhu P Sudhandiran G Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 2011 29 2 207 24 10.1007/s10637-009-9342-5 19876598 Hormozi M Ghoreishi S Baharvand P Astaxanthin induces apoptosis and increases activity of antioxidant enzymes in LS-180 cells. Artif Cells Nanomed Biotechnol 2019 Dec;47(1): 891-895. doi: 10.1080/21691401.2019.1580286. PubMed PMID: 30873887 10.1080/21691401.2019.1580286 30873887 YasuiYHosokawaMMikamiNMiyashitaKTanakaTDietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem Biol Interact201119317987 PubMed PMID: 10.1016/j.cbi.2011.05.00621621527 Liu X Song M Gao Z Cai X Dixon W Chen X Cao Y Xiao H Stereoisomers of Astaxanthin Inhibit Human Colon Cancer Cell Growth by Inducing G2/M Cell Cycle Arrest and Apoptosis. J Agric Food Chem 2016 10.1021/acs.jafc.6b03636. Epub 2016 Oct 11. PubMed PMID: 64 41 7750 7759 10.1021/acs.jafc.6b03636 27726394 Wayakanon K Rueangyotchanthana K Wayakanon P Suwannachart C The inhibition of Caco-2 proliferation by astaxanthin from Xanthophyllomyces dendrorhous 2018 J Med Microbiol Apr;67(4): 507-513. doi: 10.1099/jmm.0.000710. Epub 2018 Mar 5. PubMed PMID: 29504932 10.1099/jmm.0.000710 29504932 Tanaka T Kawamori T Ohnishi M Makita H Mori H Satoh K Hara A Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 1995 Dec;16(12): 2957-63. PubMed PMID: 8603470 8603470 Terasaki M Iida T Kikuchi F Tamura K Endo T Kuramitsu Y Tanaka T Maeda H Miyashita K Mutoh M Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice. J Nutr Biochem 2019 Feb;64: 198-205. doi: 10.1016/j.jnutbio.2018.10.007. Epub 2018 Oct 25. PubMed PMID: 30530259 10.1016/j.jnutbio.2018.10.007 30530259 Terasaki M Masaka S Fukada C Houzaki M Endo T Tanaka T Maeda H Miyashita K Mutoh M Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice In Vivo. 2019 Mar-Apr;33(2): 365-374. doi: 10.21873/invivo.11483. PubMed PMID: 30804114; PubMed Central PMCID: PMC6506301 10.21873/invivo.11483 30804114 Terasaki M Matsumoto N Hashimoto R Endo T Maeda H Hamada J Osada K Miyashita K Mutoh M Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine 2018 J Clin Biochem Nutr 64 1 52 58 10.3164/jcbn.18-45 30705512 Das S K Hashimoto T Shimizu K Yoshida T Sakai T Sowa Y Komoto A Kanazawa K Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim Biophys Acta 2005 Epub 2005 Oct 3. PubMed PMID: 1726 3 328 35 16236452 HosokawaMKudoMMaedaHKohnoHTanakaTMiyashitaKFucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta2004167511139 PubMed PMID: 15535974 KimJ MArakiSKimD JParkC BTakasukaNBaba-ToriyamaHOtaTNirZKhachikFShimidzuNTanakaYOsawaTUrajiTMurakoshiMNishinoHTsudaHChemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis1998 Jan;19(1): 81-5. PubMed PMID: 9472697 9472697 Konishi I Hosokawa M Sashima T Kobayashi H Miyashita K Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp Biochem Physiol C Toxicol Pharmacol 2006 Jan-Feb;142(1-2): 53-9. Epub 2005 Dec 7. PubMed PMID: 16337836 16337836 Kim J Lee J Oh J H Chang H J Sohn D K Kwon O Shin A Kim J Dietary Lutein Plus Zeaxanthin Intake and DICER1 rs3742330 A Polymorphism Relative to Colorectal Cancer Risk. Sci Rep. 2019 Mar 4;9(1): 3406. doi: 10.1038/s41598-019-39747-5. PubMed PMID: 30833603; PubMed Central PMCID: PMC6399314 10.1038/s41598-019-39747-5 30833603 Reynoso-Camacho R González-Jasso E Ferriz-Martínez R Villalón-Corona B Loarca-Piña G F Salgado L M Ramos-Gomez M Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and β-catenin proteins Nutr Cancer PubMed PMID: 63 1 39 45 10.1080/01635581.2010.516477 21128180 Grudzinski W Piet M Luchowski R Reszczynska E Welc R Paduch R Gruszecki W I Different molecular organization of two carotenoids, lutein and zeaxanthin, in human colon epithelial cells and colon adenocarcinoma cells. Spectrochim Acta A Mol Biomol Spectrosc 2018 5;188: 57-63. doi: 10.1016/j.saa.2017.06.041. Epub 2017 Jul 5. PubMed PMID: 28689079 10.1016/j.saa.2017.06.041 28689079 Kohler L N Harris R B Oren E Roe D J Lance P Jacobs E T Adherence to Nutrition and Physical Activity Cancer Prevention Guidelines and Development of Colorectal Adenoma. Nutrients. 2018 Aug 16;10(8). pii: E1098. doi: 10.3390/nu10081098. PubMed PMID: 30115827; PubMed Central PMCID: PMC6115749 10.3390/nu10081098 30115827 E1098 Wang Z J Ohnaka K Morita M Toyomura K Kono S Ueki T Tanaka M Kakeji Y Maehara Y Okamura T Ikejiri K Futami K Maekawa T Yasunami Y Takenaka K Ichimiya H Terasaka R Dietary polyphenols and colorectal cancer risk: the Fukuoka colorectal cancer study 2013 10.3748/wjg.v19.i17.2683. PubMed PMID: 23674876; PubMed Central PMCID: PMC3645387 19 17 2683 90 World 10.3748/wjg.v19.i17.2683 23674876 Alam M N Almoyad M Huq F Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. Biomed Res Int 2018 5820674 10.1155/2018/4154185 29568751 Murphy N Achaintre D Zamora-Ros R Jenab M Boutron-Ruault M C Carbonnel F Savoye I Kaaks R Kühn T Boeing H Aleksandrova K Tjønneland A Kyrø C Overvad K Quirós J R Sánchez M J Altzibar J M María Huerta J Barricarte A Khaw K T Bradbury K E Perez-Cornago A Trichopoulou A Karakatsani A Peppa E Palli D Grioni S Tumino R Sacerdote C Panico S HBA Bueno-de-Mesquita Peeters P H Rutegård M Johansson I Freisling H Noh H Cross A J Vineis P Tsilidis K Gunter M J Scalbert A A prospective evaluation of plasma polyphenol levels and colon cancer risk. Int J Cancer. doi: 10.1002/ijc.31563. [Epub ahead of print] PubMed PMID: 29696648; PubMed Central PMCID: 2018 6175205 10.1002/ijc.31563 29696648 Mileo A M Nisticò P Miccadei S Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer. Front Immunol 2019 11;10: 729. doi: 10.3389/fimmu.2019.00729. eCollection 2019. Review. PubMed PMID: 31031748; PubMed Central PMCID: PMC6470258 10.3389/fimmu.2019.00729 31031748 Zamora-Ros R Cayssials V Jenab M Rothwell J A Fedirko V Aleksandrova K Tjønneland A Kyrø C Overvad K Boutron-Ruault M C Carbonnel F Mahamat-Saleh Y Kaaks R Kühn T Boeing H Trichopoulou A Valanou E Vasilopoulou E Masala G Pala V Panico S Tumino R Ricceri F Weiderpass E Lukic M Sandanger T M Lasheras C Agudo A Sánchez M J Amiano P Navarro C Ardanaz E Sonestedt E Ohlsson B Nilsson L M Rutegård M Bueno-de-Mesquita B Peeters P H Khaw K T Wareham N J Bradbury K Freisling H Romieu I Cross A J Vineis P Scalbert A Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur 2018 33 11 1063 1075 10.1007/s10654-018-0408-6 29761424 Ishida Y Gao R Shah N Bhargava P Furune T Kaul S C Terao K Wadhwa R Anticancer Activity in Honeybee Propolis: Functional Insights to the Role of Caffeic Acid Phenethyl Ester and Its Complex With γ-Cyclodextrin. Integr Cancer Ther 2018 Sep;17(3): 867-873. doi: 10.1177/1534735417753545. Epub 2018 Feb 2. PubMed PMID: 29390900; PubMed Central PMCID: PMC6142091 10.1177/1534735417753545 29390900 Stähli A Maheen C U Strauss F J Eick S Sculean A Gruber R Caffeic acid phenethyl ester protects against oxidative stress and dampens inflammation via heme oxygenase 1. Int J Oral Sci 2019 PubMed PMID: 30783082; PubMed Central PMCID: PMC6381107 11 6 1 8 10.1038/s41368-018-0039-5 30783082 Murtaza G Karim S Akram M R Khan S A Azhar S Mumtaz A Bin Asad MH Caffeic acid phenethyl ester and therapeutic potentials. Biomed Res Int 2014 Epub 1 9 10.1155/2014/145342 24971312 Robertson J Raizer J Hodges J S Gradishar W Allen J A Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients 2018 J Peripher Nerv Syst. 2018 Jun;23(2): 129-133. doi: 10.1111/jns.12271. Epub 29696771 10.1111/jns.12271 29696771 Zang X Lee J B Deshpande K Garbuzenko O B Minko T Kagan L Prevention of paclitaxel-induced neuropathy by formulation approach. J Control Release 2019 10.1016/j.jconrel.2019.04.013. Epub 2019 Apr 11. PubMed PMID: 30981814; PubMed Central PMCID: PMC6708409 10 109 116 10.1016/j.jconrel.2019.04.013 30981814 Vahdat L Papadopoulos K Lange D Leuin S Kaufman E Donovan D Frederick D Bagiella E Tiersten A Nichols G Garrett T Savage D Antman K Hesdorffer C S Balmaceda C Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res 2001 May;7(5): 1192-7. PubMed PMID: 11350883 11350883 Kaur S Muthuraman A Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice 2019 Toxicol Rep; 10.1016/j.toxrep.2019.06.001. eCollection 2019. PubMed PMID: 31211096; PubMed Central PMCID: PMC6562321 6 505 513 10.1016/j.toxrep.2019.06.001 31211096 Chou C K Huang H W Yang C F Dahms H U Liang S S Wang T N Kuo P L Hsi E Tsai E M Chiu C C Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes. Environ Toxicol 2019 Apr;34(4): 401-414. doi: 10.1002/tox.22694. Epub 2019 Feb 5. PubMed PMID: 30720231 10.1002/tox.22694 30720231 Xu H Krystal G W Actinomycin D decreases Mcl-1 expression and acts synergistically with ABT-737 against small cell lung cancer cell lines. Clin Cancer Res 2010 16 17 4392 400 10.1158/1078-0432.CCR-10-0640 20732961 Merkel O Wacht N Sifft E Melchardt T Hamacher F Kocher T Denk U Hofbauer J P Egle A Scheideler M Schlederer M Steurer M Kenner L Greil R Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia. Leukemia. 2012 Dec;26(12): 2508-16. doi: 10.1038/leu.2012.147. Epub 2012 Jun 1. PubMed PMID: 22743622 10.1038/leu.2012.147 22743622 Ishii M Iwai M Harada Y Kishida T Asada H Shin-Ya M Itoh Y Imanishi J Okanoue T Mazda O Soluble TRAIL gene and actinomycin D synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver. Cancer Lett 2007 245 12 134 43 16478647 Pinto A Pocard M Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature. Pleura Peritoneum 2019 4 2 1 11 10.1515/pp-2019-0006 31388562 Symer M M Yeo H L Recent advances in the management of anal cancer F1000Res. 2018 Sep 28;7. pii: F1000 Faculty Rev-1572. doi: 10.12688/f1000research.14518.1. eCollection 2018. Review. PubMed PMID: 30345012; PubMed Central PMCID: PMC6173125 10.12688/f1000research.14518.1 30345012 F1000 Tan L T Chan K G Pusparajah P Yin W F Khan T M Lee L H Goh B H Mangrove derived Streptomyces sp. MUM265 as a potential source of antioxidant and anticolon-cancer agents. BMC Microbiol 2019 PubMed PMID: 30760201; PubMed Central PMCID: PMC6375222 1 10 1186 10.1186/s12866-019-1409-7 30760201 Sakamoto K Ito S Hashimoto N Hasegawa Y Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma. BMC Cancer 2017 PubMed PMID: 28784103; PubMed Central PMCID: PMC5547483 17 526 1 4 10.1186/s12885-017-3521-0 28784103 YuHZhangZHuangHWangYLinBWuSMaJChenBHeZWuJZhaoZZhangHInhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from Eucheuma. Food Funct201910631983208 PubMed PMID: 10.1039/c9fo00308h31165849 Lan C Wolf S L Tsang W W Tai chi exercise in medicine and health promotion. Evid Based Complement Alternat Med 2013 Epub 2013 Nov 11. PubMed PMID: 24319474; PubMed Central PMCID: PMC3844234 1 3 10.1155/2013/298768 24319474 Streckmann F Balke M Lehmann H C Rustler V Koliamitra C Elter T Hallek M Leitzmann M Steinmetz T Heinen P Baumann F T Bloch W The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP. BMC Cancer 2018 PubMed PMID: 29316888; PubMed Central PMCID: PMC5761113 18 62 1 10 10.1186/s12885-017-3866-4 29316888 Elkins G White J Patel P Marcus J Perfect M M Montgomery G H Hypnosis to manage anxiety and pain associated with colonoscopy for colorectal cancer screening: Case studies and possible benefits. Int J Clin Exp Hypn 2006 Oct;54(4): 416-31. PubMed PMID: 16950684 16950684 Cossu G Saba L Minerba L Mascalchi M Colorectal Cancer Screening: The Role of Psychological, Social and Background Factors in Decision-making Process 2018 Clin Pract Epidemiol Ment Health; Review. PubMed PMID: 29643929; PubMed Central PMCID: PMC5872199 14 63 69 10.2174/1745017901814010063 29643929 Montgomery G H Schnur J B Kravits K Hypnosis for cancer care: over 200 years young 2013 CA Cancer Jan;63(1): 31-44. doi: 10.3322/caac.21165. Epub 2012 Nov 20. Review. PubMed PMID: 23168491; PubMed Central PMCID: PMC3755455 10.3322/caac.21165 23168491 Miller S J Schnur J B Montgomery G H Jandorf L AFRICAN-AMERICANS&apos; AND LATINOS&apos; PERCEPTIONS OF USING HYPNOSIS TO ALLEVIATE DISTRESS BEFORE A COLONOSCOPY. Contemp Hypn Integr Ther. 2011 Sep;28(3): 196-203. PubMed PMID: 26566440; PubMed Central PMCID: PMC4640674 26566440 Umezawa S Higurashi T Uchiyama S Sakai E Ohkubo H Endo H Nonaka T Nakajima A Visual distraction alone for the improvement of colonoscopy-related pain and satisfaction 2015 10.3748/wjg.v21.i15.4707. PubMed PMID: 25914482; PubMed Central PMCID: PMC4402320 21 15 4707 14 World 10.3748/wjg.v21.i15.4707 25914482 Lee D W Chan A C Wong S K Fung T M Li A C Chan S K Mui L M Ng E K Chung S C Can visual distraction decrease the dose of patient-controlled sedation required during colonoscopy? A prospective randomized controlled trial. Endoscopy 2004 Mar;36(3): 197-201. PubMed PMID: 14986215 14986215 Xiaolian J Xiaolin L Lan Z H Effects of visual and audiovisual distraction on pain and anxiety among patients undergoing colonoscopy. Gastroenterol Nurs 2015 Jan-Feb;38(1): 55-61. doi: 10.1097/SGA.0000000000000089. PubMed PMID: 25636013 10.1097/SGA.0000000000000089 25636013 Leung F W Methods of reducing discomfort during colonoscopy. Dig Dis Sci 2008 Jun;53(6): 1462-7. Review. PubMed PMID: 17999189 17999189 De Silva AP Niriella M A Nandamuni Y Nanayakkara S D Perera K R Kodisinghe S K Subasinghe K C Pathmeswaran A de Silva HJ Effect of audio and visual distraction on patients undergoing colonoscopy: a randomized controlled study Endosc Int Open. 2016 Nov;4(11):E1211-E1214. Epub 2016 Oct 20. PubMed PMID: 27853748; PubMed Central PMCID: PMC5110335 27853748 Sun H Huang H Ji S Chen X Xu Y Zhu F Wu J The Efficacy of Cognitive Behavioral Therapy to Treat Depression and Anxiety and Improve Quality of Life Among Early-Stage Breast Cancer Patients. Integr Cancer Ther 2019 Jan-Dec;18: 1534735419829573. doi: 10.1177/1534735419829573. PubMed PMID: 30791739; PubMed Central PMCID: PMC6432673 10.1177/1534735419829573 30791739 EichlerCPiaMSibylleMSauerwaldAFriedrichWWarmMCognitive behavioral therapy in breast cancer patients--a feasibility study of an 8 week intervention for tumor associated fatigue treatmentAsian Pac J Cancer Prev16310637 PubMed PMID: 25735332 Ye M Du K Zhou J Zhou Q Shou M Hu B Jiang P Dong N He L Liang S Yu C Zhang J Ding Z Liu Z A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients Psychooncology. 2018 Jul;27(7): 1695-1703. doi: 10.1002/pon.4687. Epub 2018 Mar 26. PubMed PMID: 29500842 10.1002/pon.4687 29500842 Kucherer S Ferguson R J Cognitive behavioral therapy for cancer-related cognitive dysfunction. Curr Opin Support Palliat Care 2017 Mar;11(1): 46-51. doi: 10.1097/SPC.0000000000000247. Review. PubMed PMID: 27898511; PubMed Central PMCID: PMC5285475 10.1097/SPC.0000000000000247 27898511 Qiu H Ren W Yang Y Zhu X Mao G Mao S Lin Y Shen S Li C Shi H Jiang S He J Zhao K Fu Y Hu X Gu Y Wang K Guo X He J Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial 2018 Neuropsychiatr Dis Treat; 14 2665 2673 10.2147/NDT.S171297 30349264 McCarthyM SMatthewsE EBattagliaCMeekP MFeasibility of a Telemedicine-Delivered Cognitive Behavioral Therapy for Insomnia in Rural Breast Cancer Survivors. Oncol Nurs Forum2018455607618 PubMed PMID: 10.1188/18.ONF.607-61830118453 Wal M van de Servaes P Berry R Thewes B Prins J Cognitive Behavior Therapy for Fear of Cancer Recurrence: A Case Study. J Clin Psychol Med Settings 2018 PubMed PMID: 29468568; PubMed Central PMCID: PMC6209054 25 4 390 407 10.1007/s10880-018-9545-z 29468568 Daniels S Cognitive Behavior Therapy for Patients With Cancer. J Adv Pract Oncol 2015 Jan-Feb;6(1): 54-6. Review. PubMed PMID: 26413374; PubMed Central PMCID: PMC4577033 26413374 Yi J C Syrjala K L Anxiety and Depression in Cancer Survivors. Med Clin North Am 2017 Nov;101(6): 1099-1113. doi: 10.1016/j.mcna.2017.06.005. Epub 2017 Aug 18. Review. PubMed PMID: 28992857; PubMed Central PMCID: PMC5915316 10.1016/j.mcna.2017.06.005 28992857 Silva N M MAD Santos Rosado S R Galvão C M Sonobe H M Psychological aspects of patients with intestinal stoma: integrative review. Rev Lat Am Enfermagem 2017 Review. English, Portuguese, Spanish. PubMed PMID: 29236836; PubMed Central PMCID: PMC5738853 25 0 2950 10 10.1590/1518-8345.2231.2950 29236836 Mosher C E Winger J G Given B A Shahda S Helft P R A systematic review of psychosocial interventions for colorectal cancer patients. Support Care Cancer 2017 25 7 2349 2362 10.1007/s00520-017-3693-9 28434094 Sandler C X Goldstein D Horsfield S Bennett B K Friedlander M Bastick P A Lewis C R Segelov E Boyle F M MTM Chin Webber K Barry B K Lloyd A R Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. J Pain Symptom Manage 2017 Jul;54(1): 74-84. doi: 10.1016/j.jpainsymman.2017.03.015. Epub 28502786 10.1016/j.jpainsymman.2017.03.015 28502786 Arch J J Mitchell J L Genung S R Fisher R Andorsky D J Stanton A L A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry (&apos;Valued Living&apos;): study protocol. BMC Cancer 2019 PubMed PMID: 30658621; PubMed Central PMCID: PMC6339433 1 11 10.1186/s12885-019-5289-x 30658621 Zhu G Zhang X Wang Y Xiong H Zhao Y Sun F Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails. Onco Targets Ther; 9 : 2153-68. doi: 10.2147/OTT.S97864. eCollection 2016. PubMed PMID: 27110131; PubMed Central PMCID: 2016 4835133 10.2147/OTT.S97864 27110131 Okuyama S Jones W Ricklefs C Tran Z V Psychosocial telephone interventions for patients with cancer and survivors: a systematic review. Psychooncology 2015 Aug;24(8): 857-70. doi: 10.1002/pon.3704. Epub 2014 Oct 18. Review. PubMed PMID: 25328103 10.1002/pon.3704 25328103 DongBXieCJingXLinLTianLYoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis. Breast Cancer Res Treat2019 Review. PubMed PMID: 177151610.1007/s10549-019-05278-w31127466 El-Hashimi D Gorey K M Yoga-Specific Enhancement of Quality of Life Among Women With Breast Cancer: Systematic Review and Exploratory Meta-Analysis of Randomized Controlled Trials. J Evid Based Integr Med 2019 Jan-Dec;24: 2515690X19828325. doi: 10.1177/2515690X19828325. PubMed PMID: 30791697; PubMed Central PMCID: PMC6388460 10.1177/2515690X19828325 30791697 Wei C W Wu Y C Chen P Y Chen P E Chi C C Tung T H Effectiveness of Yoga Interventions in Breast Cancer-Related lymphedema: A systematic review. Complement Ther Clin Pract 2019 Aug;36: 49-55. doi: 10.1016/j.ctcp.2019.05.004. Epub 2019 May 25. Review. PubMed PMID: 31383443 10.1016/j.ctcp.2019.05.004 31383443 Sohl S J Danhauer S C Birdee G S Nicklas B J Yacoub G Aklilu M Avis N E A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study. Complement Ther Med 2016 Apr;25: 139-42. PubMed PMID: 26977123; PubMed Central PMCID: PMC4788038 26977123 Cramer H Pokhrel B Fester C Meier B Gass F Lauche R Eggleston B Walz M Michalsen A Kunz R Dobos G Langhorst J A randomized controlled bicenter trial of yoga for patients with colorectal cancer. Psychooncology 2016 10.1002/pon.3927. Epub 2015 Jul 29. PubMed PMID: 25 4 412 20 10.1002/pon.3927 26228466 Durrani S Contreras J Mallaiah S Cohen L Milbury K The Effects of Yoga in Helping Cancer Patients and Caregivers Manage the Stress of a Natural Disaster: A Brief Report on Hurricane Harvey. Integr Cancer Ther 2019 Jan-Dec;18: 1534735419866923. doi: 10.1177/1534735419866923. PubMed PMID: 31364416; PubMed Central PMCID: PMC6669833 10.1177/1534735419866923 31364416 Zhang X Wang X Zhang B Yang S Liu D Effects of acupuncture on breast cancer-related lymphoedema: a systematic review and meta-analysis of randomised controlled trials. Acupunct Med 2019 PubMed PMID: 37 1 16 24 10.1136/acupmed-2018-011668 30845813 Bao T Iris Zhi W Vertosick E A Li Q S DeRito J Vickers A Cassileth B R Mao J J Van Zee KJ Acupuncture for breast cancer-related lymphedema: a randomized controlled trial. Breast Cancer Res Treat 2018 170 1 77 87 10.1007/s10549-018-4743-9 29520533 Zhu H Li J Peng Z Huang Y Lv X Song L Zhou G Lin S Chen J He B Qin F Liu X Dai M Zou Y Dai S Effectiveness of acupuncture for breast cancer related lymphedema: protocol for a single-blind, sham-controlled, randomized, multicenter trial. BMC Complement Altern Med 2017 PubMed PMID: 28934950; PubMed Central PMCID: PMC5609040 17 467 1 9 10.1186/s12906-017-1980-0 28934950 Pan Y Yang K Shi X Liang H Shen X Wang R Ma L Cui Q Yu R Dong Y Clinical Benefits of Acupuncture for the Reduction of Hormone Therapy-Related Side Effects in Breast Cancer Patients: A Systematic Review. Integr Cancer Ther 2018 PubMed PMID: 30117343; PubMed Central PMCID: PMC6142070 17 3 602 618 10.1177/1534735418786801 30117343 Hasenoehrl T Keilani M Palma S Crevenna R Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil 2019 [Epub ahead of print] PubMed PMID: 1 10 10.1080/09638288.2018.1514663 30638093 Duyur Cakıt B Pervane Vural S Ayhan F F Complex Decongestive Therapy in Breast Cancer-Related Lymphedema: Does Obesity Affect the Outcome Negatively? Lymphat Res Biol 2019 Feb;17(1): 45-50. doi: 10.1089/lrb.2017.0086. Epub 2018 Oct 3. PubMed PMID: 30281384 10.1089/lrb.2017.0086 30281384 Jeffs E Ream E Taylor C Bick D Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review. JBI Database System Rev Implement Rep 2018 PubMed PMID: 29419623; PubMed Central PMCID: PMC5828398 16 2 453 506 10.11124/JBISRIR-2016-003185 29419623 Myers J S Mitchell M Krigel S Steinhoff A Boyce-White A K Van Goethem Valla M Dai J He J Liu W Sereika S M Bender C M Qigong intervention for breast cancer survivors with complaints of decreased cognitive function. Support Care Cancer 2019 27 4 1395 1403 10.1007/s00520-018-4430-8 30128855 Cifu G Power M C Shomstein S Arem H Mindfulness-based interventions and cognitive function among breast cancer survivors: a systematic review. BMC Cancer 2018 PubMed PMID: 30477450; PubMed Central PMCID: PMC6260900 18 1163 1 13 10.1186/s12885-018-5065-3 30477450 Smith L Gordon D Scruton A Yang L The potential yield of Tai Chi in cancer survivorship. Future Sci OA 2016 PubMed PMID: 28116134; PubMed Central PMCID: PMC5242198 20 2 4 10.4155/fsoa-2016-0049 28116134 Dennis D L Waring J L Payeur N Cosby C Daudt H M Making lifestyle changes after colorectal cancer: insights for program development. Curr Oncol 2013 Dec;20(6):e493-511. doi: 10.3747/co.20.1514. PubMed PMID: 24311950; PubMed Central PMCID: PMC3851346 10.3747/co.20.1514 24311950 Fong S S Ng S S Luk W S Chung J W Chung L M Tsang W W Chow L P Shoulder Mobility, Muscular Strength, and Quality of Life in Breast Cancer Survivors with and without Tai Chi Qigong Training. Evid Based Complement Alternat Med; doi: 10.1155/2013/787169. Epub 2013 3655570 10.1155/2013/787169 23710237 Shin E S Seo K H Lee S H Jang J E Jung Y M Kim M J Yeon J Y Massage with or without aromatherapy for symptom relief in people with cancer. Cochrane Database Syst Rev 2016 3;(6):CD009873. doi: 10.1002/14651858.CD009873.pub3. Review. PubMed PMID: 27258432 10.1002/14651858.CD009873.pub3 27258432 Imanishi J Kuriyama H Shigemori I Watanabe S Aihara Y Kita M Sawai K Nakajima H Yoshida N Kunisawa M Kawase M Fukui K Anxiolytic effect of aromatherapy massage in patients with breast cancer. Evid Based Complement Alternat Med 2009 Mar;6(1): 123-8. doi: 10.1093/ecam/nem073. Epub 2007 Jul 4. PubMed PMID: 18955225; PubMed Central PMCID: PMC2644279 10.1093/ecam/nem073 18955225 Fiorelli A Morgillo F Milione R Pace M C Passavanti M B Laperuta P Aurilio C Santini M Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function and medication Eur J Cardiothorac Surg. 2012 Apr;41(4): 861-8; discussion 868. doi: 10.1093/ejcts/ezr108. Epub 2011 Dec 16. PubMed PMID: 22219414 10.1093/ejcts/ezr108 22219414 Chubak J Hawkes R Animal-Assisted Activities: Results From a Survey of Top-Ranked Pediatric Oncology Hospitals. J Pediatr Oncol Nurs 2016 Epub 2015 Nov 20. PubMed PMID: 26589356; PubMed Central PMCID: PMC4874916 33 4 289 96 10.1177/1043454215614961 26589356 Vahed N Kabiri N Oskouei M M Gavgani V Z Khatooni A A Sadooghi N 2017 130: THE EFFECT OF MUSIC IN OPERATING ROOM: A SYSTEMATIC REVIEW. BMJ Open. 2017; (Suppl1): bmjopen-2016-015415.130. 7(0): A1-A78 10 1136 10.1136/bmjopen-2016-015415.130 Chubak J Therapy-dog visits for kids with cancer: A safe way to induce smiles? Web Kaiser Permanente Washington Health Research Institute 2017